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Abstract
This thesis describes a genetic and molecular study of programmed cell death in
the nematode Caenorhabditis elegans. Programmed cell death is a process common to all
metazoans examined, and plays an important role in development and disease. Work
on C. elegans has demonstrated that in this organism programmed cell death also
constitutes a major cell fate. Morphologically, programmed cell deaths in C. elegans are
similar to programmed cell deaths found in other organisms, including mammals.
These similarities can be demonstrated both on the light microscope and the electron
microscope levels, and have suggested that the underlying molecular mechanisms of
programmed cell death are similar between worm and man.
To characterize the molecular components of cell death in C. elegans we have
analyzed the cell death gene ced-3. Mutations in ced-3 abolish all programmed cell
deaths, suggesting that this gene is necessary for the proper execution of the death
program. We have shown that this gene encodes a cysteine protease of the Interleukin-
1f converting enzyme (ICE) class and together ced-3 and ICE define a novel family of
cyst-eine proteases. ICE and subsequently identified family members have been shown
to induce cell death in mammals. We have characterized the phenotypes of ced-3
mutants and determined the mutated sites in these mutants. This study has revealed
that sites crucial for ced-3 function, are conserved with other members of this protease
family, and suggest that ced-3 has cell death activities independent of its proteolytic
activity. These experiments are described in chapters 1 and 4.
The cell death gene ced-4 is necessary for the proper execution of programmed
cell death, and the cell death gene ced-9 is required to negatively regulate the activities
of ced-3 and ced-4. Here we present a possible pathway for the action of these three
genes in which we propose that ced-9 acts to negatively regulate ced-4, which, in turn,
can act to activate ced-3. These experiments also suggest that all three genes act in a cell-
autonomous fashion and that the activity of these genes is likely to be present in many
cells throughout the animal, including cells that do not die. These experiments are
described in chapter 2.
Finally, we have demonstrated that the gene ced-4 can encode two alternative
transcripts which have opposite effects. The ced-4S transcript can kill cells, and the ced-
4L transcript can protect cells from death. We present both genetic and molecular
evidence that the activity of both transcripts is important in vivo. We also suggest that
the ced-9 gene acts to negatively regulate both ced-4S and ced-4L, so that ced-9 can have
both killing and protecting activities by inhibiting either ced-4L or ced-4S respectively.
These experiments are described in chapter 3 and together with chapter 2 suggest a
network of post-translational regulatory interactions which control cell death in C.
elegans. Because of the molecular similarities between cell death components in
mammals and in C. elegans we suggest that a similar regulatory network exists in
mammals as well.
Thesis Supervisor: Dr. H. Robert Horvitz
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Chapter 1
Programmed cell death in Caenorhabditis elegans
Shai Shaham and H. Robert Horvitz
Howard Hughes Medical Institute, Department of Biology, Room 68-425
Massachusetts Institute of Technology, Cambridge, MA 02139
This chapter will be submitted as a review article to Trends in Genetics
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Abstract
Studies of the nematode Caenorhabditis elegans have given us insights into the
process of programmed cell death in mammals. Both morphological and molecular
similarities exist between programmed cell death in worm and man. Recent work
has established a proposed genetic pathway for programmed cell death in worms. In
this review we summarize what is known of the functions of the genes ced-3, ced-4
and ced-9, which are key regulators of cell death in C. elegans. We also address the
genetic interactions of these genes and discuss the applicability of these results to the
study of mammalian apoptosis. Further analysis of cell death in the nematode is sure
to reveal additional evolutionarily conserved functions required for programmed cell
death.
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Programmed cell death is a fundamental process in the development of
metazoan organisms, as well as in disease processes in humans 1,2. Work on the
nematode Caenorhabditis elegans has revealed that programmed cell death in this small
soil nematode is similar both morphologically and molecularly to the mammalian cell
death process termed apoptosis 2 ,3. Cell death in C. elegans is a common cell fate-- 131 of
the 1090 cells born (>12%) in the hermaphrodite undergo programmed cell death after
birth3 ,4 -- and occurs in a variety of cell types. Work from several laboratories has
established a genetic pathway for programmed cell death that correlates with
observable changes in the dying cells3. A set of genes required for the specification of
cell death in a small number of cells has been identified. These genes6, 7 (ces-1, ces-2,
and egl-1) are thought to be responsible for determining if the generalized cell death
machinery will be turned on in a small subset of cells or not. Three genes9,10, ced-3, ced-
4 and ced-9, are key components in the generalized cell death process which is common
to all cells in C. elegans. Six genes 8, ced-1, ced-2, ced-5, ced-6, ced-7, and ced-10, are
required for the proper degradation of the corpses of cells which have died, and a single
gene1 2 ,13 , nuc-1, is required for the degradation of the DNA of dead cells. In this
review we focus on the generalized cell death machinery encoded in part by the genes
ced-3, ced-4 and ced-9. Recent experiments have suggested that these genes can be
arranged in a genetic pathway illustrated in figure 1 (S. Shaham and H. R. Horvitz,
manuscript in preparation). The evidence leading to this pathway, and the extent to
which we can apply information about the molecular nature and genetic interactions of
these genes to mammals will be discussed as well.
ced-3 is similar to the mammalian enzyme Interleukin-1 P converting enzyme
Mutations in the gene ced-3 prevent programmed cell deaths in C. elegans,
suggesting that this gene is necessary for the proper execution of cell death 9. Over 50
mutations have been currently analyzed both genetically and molecularly (S. Shaham,
B. Davies, and H. R. Horvitz, unpublished data). Most are partial loss-of-function, and
none are good candidates for complete loss-of-function mutations, so that we do not
know the phenotype of animals carrying a ced-3 null mutation. Mosaic analysis of the
ced-3 gene demonstrated that the activity of this gene within a lineage leading to a cell
death is required for that cell death to occur14 , suggesting that ced-3 might act within
dying cells. Recent data (S. Shaham and H. R. Horvitz, manuscript in preparation) has
shown that overexpression of ced-3 in cells that normally live using cell-specific
promoters for the genes mec-7 (expressed in mechanosensory neurons), and unc-30
(expressed in a group of motorneurons) fused to a ced-3 cDNA can cause these cells to
die, supporting the notion that ced-3 acts in a cell-autonomous fashion to regulate cell
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death. The product encoded by the ced-3 gene is similar to the family of mammalian
proteins represented by the cysteine protease Interleukin-1 3 converting enzyme
(ICE) 11. ICE is a cysteine protease needed for the processing of the cytokine IL-1 from
its pro-form to a mature form15,16. Recent experiments have shown that
overexpression of ICE17 and other family members (ICH-118 /NEDD-2 19, CPP322 0,
TX21) in culture can cause cell death, and that a knockout of ICE in mice results in
defects in cell death mediated by the Fas receptor22, suggesting that ICE family
members have a role in mammalian cell death similar to that of ced-3 in C. elegans.
ced-4 encodes death-preventing and death-promoting transcripts
The ced-4 gene encodes two novel proteins, CED-4L (for CED-4Long) and CED-
4S (for CED-4Short) which are produced by alternative splicing (ref. 42; S. Shaham and
H. R. Horvitz, manuscript in preparation). The ced-4L transcript encodes a protein
containing a 24 amino-acid insertion relative to CED-4S. Overexpression of CED-4S in
cells that normally live using the cell-specific promoters for the genes mec-7 and unc-30
(see above) can kill these cells, suggesting that CED-4S acts in a cell-autonomous
fashion to induce programmed cell death. Mosaic analysis of ced-4 also suggests that
the killing activity of this gene is required within the lineages of cells that die 14.
Interestingly, overexpression of the CED-4L transcript using a heatshock promoter
which is ubiquitously expressed will prevent normally-occuring cell deaths (S. Shaham
and H. R. Horvitz, manuscript in preparation), suggesting that this protein normally
acts to prevent cell death.
Loss-of-function mutations in the ced-4 gene which appear to be null by both
genetic9 and molecular42 criteria eliminate both ced-4S and ced-4L transcripts and result
in the absence of programmed cell death, suggesting that ced-4 is crucial for the proper
execution of the death program.
A partial loss-of-function mutation, n2273, in the ced-4 gene acts genetically as if a
death-protecting aspect of ced-4 activity has been disrupted (S. Shaham and H. R.
Horvitz, manuscript in preparation). Animals with this mutation also have a weak
defect in ced-4's killing activity. The mutation has been shown to reside in the splice site
leading to the selective production of the ced-4S product 4 2 and results in the production
of mutant ced-4S and ced-4L transcripts (S. Shaham and H. R. Horvitz, manuscript in
preparation). These observations suggest the tempting conclusion that the genetically-
defined protecting and killing aspects of ced-4 correlate with the alternate transcripts
produced by the gene, however, this assertion has not yet been rigorously
demonstrated.
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CED)-9 is a member of the BCL2 family of proteins
Loss-of-function (If) mutations in the ced-9 gene which appear to represent null
alleles by both genetic and molecular criteria result in a maternal effect lethality 1 0 23.
Animals heterozygous for a ced-9 (If) allele give rise to live homozygous ced-9(lf) animals
which in turn produce only dead embryos. These embryos usually arrest early during
development for an unknown reason. However, a few embryos that develop longer, as
well as embryos which have been derived from animals carrying a weaker loss-of-
function mutation show massive programmed cell death, suggesting that ced-9 normally
acts to prevent programmed cell deaths in cells that normally survive. Why embryos
carrying strong ced-9(lf) alleles arrest early with no apparent cell deaths is not yet
understood.
Overexpression of ced-9 can prevent programmed cell death. This result has been
demonstrated using gene fusions to a ubiquitously expressed heatshock promoter and
showing that cells that normally die can survive23 ,24 , and using gene fusions to the
mec-7 promoter to rescue the ectopic deaths induced by overexpression of the CED-4S
protein (S. Shaham and H. R. Horvitz, manuscript in preparation). Thus, CED-9 is
capable of protecting cells that die normally, as well as cells that die ectopically.
The CED-9 protein is similar in sequence to the BCL2 family of proteins and
contains the BH1 and BH225 interaction domains conserved among members of this
family23 . BCL2 family members have been implicated in both the positive and negative
regulation of programmed cell death2 6-3 2 . The bcl-2 gene has been shown to prevent
programmed cell death in a number of mammalian systems 3 0 -3 2 and in C. elegans2 3,24 .
A knockout of bcl-2 in mice results in excess cell death in the immune system 3 3 .
Furthermore, bcl-2 can functionally substitute for ced-9 in worms, suggesting that these
two proteins act in a similar manner 23. Oncogenic forms of bcl-2 result in
overexpression of the wild-type protein in B cells and lead to increased cell survival30 -
32,34. This result is similar to the prevention of cell death by overexpressing the ced-9
gene. However, ced-9 and bcl-2 are different in at least one respect. A unique gain-of-
function missense mutation 3 5 in the BH1 domain of ced-9 is capable of preventing cell
death in C. elegans but does not seem to result in overexpression of wild-type ced-9.
When this mutation was introduced into bcl-2 not only did it not enhance its activity,
but completely abolished its death-preventing capacity25. The possible nature of this
mutation is discussed below, however it suggests that ced-9 and bcI-2 can act differently.
ced-3 and ced-4 S act genetically downstream of ced-9
A fundamental approach to understanding how ced-3, ced-4 and ced-9 function is
to assess possible interactions among them. A number of interaction studies suggest
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that these genes interact in a pathway illustrated in figure 1. Two sets of experiments
suggest that ced-3 and ced-4 act genetically downstream of ced-9. First, mutations in the
ced-3 or ced-4 genes can act to prevent the lethality and ectopic cell deaths associated
with loss-of-function mutations in ced-910 (figure 2). Second, ectopic cell death induced
by overexpression of ced-3 or ced-4 in cells that normally survive using the mec-7 or unc-
30 promoters can be enhanced by introducing a chromosomal ced-9(lf) mutation into
transgenic animals carrying the overexpression constructs (S. Shaham and H. R.
Horvitz, manuscript in preparation; figure 2). These results suggests that ced-9 is
normally required to prevent the killing activities of ced-3 and ced-4, and places ced-9
upstream of these genes. Biochemically, this interpretation means that ced-9 could act to
directly inhibit the activities of ced-3 and ced-4, or to inhibit processes which result from
the activities of ced-3 and ced-43 .
ced-9 protection from ced-3-killing requires ced-4
Killing of mechanosensory neurons using Pmec_7ced-3 transgenes can be enhanced
by loss-of-function mutations in the endogenous ced-9 gene in transgenic animals as
described above. Interestingly, mutating ced-9 only seems to have an effect when a
chromosomally wild-type ced-4 gene is present (S. Shaham and H. R. Horvitz,
manuscript in preparation; figure 3). Killing by the Pmec-7ced-3 transgenes does not get
enhanced if null mutations in both ced-9 and ced-4 are introduced in the endogenous
genes. This observation suggests that ced-4 is required to transduce a protecting signal
from ced-9. It is likely that this transduction is mediated by ced-4S (see below) and not
ced-4 L, since null alleles of ced-4 result in the prevention of cell death 6 , suggesting that
the killing activity of ced-4 has been disrupted. However, the activity of ced-4L in this
transgenic system has not been assessed. These observations suggest that ced-4S acts
genetically between ced-9 and ced-3, although other possibilities exist, and those are
discussed below. Also, it is not clear if ced-3 is required to mediate ced-9 protection of
ced-4 -induced killing in this system, a possibility which if true would require additional
interactions in the pathway presented in figure 1.
ced-3 might act genetically downstream of ced-4
Overexpression of a Pmec-7ced-3 transgene resulted in similar killing of
mechanosensory neurons regardless of the state of the endogenous ced-4 gene. Thus,
killing was similar in animals carrying a chromosomally wild-type ced-4 gene and
animals carrying a ced-4 null mutation. However, killing by overexpression of a Pmec-
7ced-4S trangene was greatly reduced if a mutation in the endogenous ced-3 gene was
introduced (S. Shaham and H. R. Horvitz, manuscript in preparation). None of the ced-3
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mutations, including a mutation which results in the most severe cell death phenotype,
was capable of completely preventing Pmec_7ced-4S-induced killing. These results can be
interpreted in a number of ways. If the strongest ced-3 mutation used represents a null
allele, then ced-4S must have the ability to bypass ced-3 and must be able to act both
upstream and in parallel to ced-3, conveying the reduction, but not elimination of cell-
killing by the endogenous ced-3 mutation, respectively. If the strongest ced-3 mutation
used is not a null, then the above possibility still holds, but it is also possible that a
strictly linear genetic pathway exists, and that the reduced, yet significant killing results
from residual ced-3 activity. In any case, it is clear that in either model a linear
component in which ced-4 acts genetically upstream of ced-3 must exist and is thus
drawn in figure 1.
Many of the above conclusions are based on ectopic killing of mechanosensory
neurons and thus, might not be generally applicable to all cells in C. elegans. Further
work using other cell-specific promoters should help in generalizing the interactions of
ced-.3, ced-4S and ced-9 to other cells.
ced-4L might be negatively regulated by ced-9
As described above, overexpression of ced-4L can prevent normally occuring
programmed cell deaths (S. Shaham and H. R. Horvitz, manuscript in preparation).
Interestingly, ubiquitous overexpression of ced-4L can also prevent the lethality
associated with animals carrying ced-9(lf) mutations (S. Shaham and H. R. Horvitz,
manuscript in preparation; figure 4). This observation suggests that ced-4L can bypass
wild-type ced-9 activity, and suggests that ced-4L acts genetically downstream or
parallel to ced-9. Experiments using the n2273 mutation of ced-4 which has been
postulated to be defective primarily in ced-4L function (see above) suggest that ced-9 acts
to negatively regulate the activity of ced-4L (S. Shaham and H. R. Horvitz, manuscript in
preparation). This model relies on the assumption that the two opposing genetic
functions uncovered by n2273 represent the actions of the two ced-4 transcripts and
represent the simplest presentation of the data.
ced-9 negatively regulates both ced-4 L and ced-4 S
Experiments described above suggest that ced-9 acts to negatively regulate both
deathl-preventing (ced-4L) and death-causing (ced-4S) functions. That overexpression of
ced-9 in mechanosensory neurons can protect from killing induced by ced-4S
overexpression in the same cells, in the presence of a complete null allele of ced-4
suggests that ced-9 negatively regulates ced-4S in parallel to negatively regulating ced-4L
(S. Shaham and H. R. Horvitz, manuscript in preparation). This experiment suggests
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that ced-9(lf) mutations could cause either protection or enhancement of cell death.
Recently both of these observations have been demonstrated 35, supporting the pathway
displayed in figure 1. This experiment also demonstrated that ced-9 can act in a cell-
autonomous fashion. Figure 1 represents ced-4L blocking the activity of the earliest
known cell death causing component ced-4S. However, the genetic evidence suggests
that ced-4L could be acting at any place downstream of ced-4S.
Could the ced-9(gf) mutation be a loss-of function mutation?
Introducing the change present in the ced-9 (gf) mutation into bcl-2 completely
abolished the ability of bcl-2 to protect from programmed cell death, and to interact with
bax26, another family member which can induce cell death25. The model elaborated in
the previous sections suggests a mode for ced-9(gf) action which would reconcile the
molecular and functional similarity of ced-9 and bcl-2, with their dissimilar response to a
given mutation. If ced-9(gf) abolished ced-9's ability to inhibit ced-4L but maintained the
interaction with ced-4S, then enhanced cell survival would be predicted in ced-9 (gf)
mutants (as is seen). This model suggests that the ced-9(gf) actually causes a loss of
interaction with ced-4L, consistent with the bcl-2 results, however, other models are
certainly possible.
C. elegans can be used to understand general principles of cell death
Can the work on programmed cell death in worms be applied to the study of
mammalian cell death? A number of similarities exist between cell death in worms and
in mammals. Both processes are morphologically very similar, showing cell shrinkage,
nuclear condensation, and darkening of the cytoplasm. Some of the molecules involved
in cell death in both systems are similar in both sequence and function- ced-9 is similar
to bcI-2 and related family members, ced-3 is similar to ICE and other family members.
The pathway in C. elegans suggests that ced-9 inhibits the activity of ced-3. Work in
mammalian culture has demonstrated that bcl-2 can prevent killing induced by ICE or
ICH-1/NEDD2 overexpressionl7,18, consistent with a pathway in which bcl-2
negatively regulates ICE-like proteins just as ced-9 regulates ced-3. These similarities in
aspects of the cell death pathways suggest that the broader pathway in worms might
exist in mammals as well.
Work in C. elegans has also suggested that the activities of ced-3, ced-4 and ced-9
are likely to be present in many if not all cells in a post-transcriptional state (S. Shaham
and IH. R. Horvitz, manuscript in preparation). This observations parallels experiments
showing that anucleated mammalian cells can still die by apoptosis 36. The latter
experiment has led Raff3 7 to propose that all mammalian cells are post-transcriptionally
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primed to die. The C. elegans experiments suggest a modification of this hypothesis
suggesting that cells in metazoans can regulate the decision to die in a post-
transcriptional manner by interactions of death-promoting and death-preventing
components.
In addition to post-transcriptionally regulating cell death, other modes of
regulating cell death in C. elegans and mammals are similar. In both systems genes
causing or protecting from cell death have to be expressed- suggesting transcriptional
control. In addition, alternative splicing yielding oppositely acting products has been
shown for ced-4, and for the human genes Ich-1 18 and bcl-x2 7, suggesting that splicing is
a key level of control in both these organisms.
Exploring apparent dissimilarities between worms and mammals might reveal
the extent to which worms can be used to model the mammalian process. Although
work in mammals has revealed multiple family members for both bcl-2 and ICE, only
one member of each family has so far been described in worms. The existence or non-
existence of other family members in worms will, in part, determine if the C. elegans
system is as complex as the mammalian one.
A number of issues remain concerning the similarity between bcl-2 and ced-9.
Only ced-9(lf) homozygotes derived from ced-9(lf) parents are embryonically lethal. For
the cl-2 knockout example only bcl-2 (lf) animals derived from heterozygous parents
have been described33. It is possible that if these animals are bred, dead embryos
would be produced as well. Also, ced-9 seems to genetically interact with both positive
and negative regulators of cell death and has a function in both protecting and killing.
The current model for bcl-2 suggests that it only has a protective function. Could bcI-2
have a yet undetected killing function? Will a closer observation of bcl-2(lf) animals
reveal excess cell survival? The answers to these questions will help to assess the
similarity between ced-9 and bcl-2.
A key unanswered question is whether a mammalian homologue of ced-4 exists.
Currently no candidates have been demonstrated, however it might be possible that
only functional ced-4 homologues exist which share little sequence similarity with ced-4.
Finally, one of the most important questions for the understanding of disease
involves the nature and mechanisms of upstream signals that trigger the generalized
cell death machinery. In mammals genes like Fas3 8, p5339 , myc40, nur774 1 and others
have been described. In worms a number of upstream "specification" genes have been
described genetically6 ,7. The molecular characterization of these genes should reveal if
they have known mammalian counterparts.
In conclusion, continued analysis of programmed cell death in C. elegans is likely
to yield a wealth of information about cell death processes in general, and should help
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facilitate our understanding of mammalian cell death.
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Figure 1. A model for the regulation of programmed cell death in C. elegans.
The ced-9 gene product can inhibit the activity of either ced-4S or ced-4L gene
products. ced-3 activity can be enhanced by CED-4S or inhibited by CED-4L, although
we can not rule out a model in which CED-4L inhibits CED-4S, thus indirectly
inhibiting CED-3, or a model in which CED-4L inhibits a target downstream of CED-3.
See -text for additional details.
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Figure 2. Loss-of-function mutations in ced-3 and ced-4 inhibit programmed cell death,
whereas loss-of-function mutations in ced-9, and overexpression of ced-3 and ced-4 cause
cell death.
Rows indicate a given genotype, If, loss-of-function, o/e, overexpression. Model
is based on figure 1. X represents loss of activity. Thicker arrows indicate higher
activity. +, cell death, -, no cell death.
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Figure 3. ced-9 requires ced-4 activity to protect from ced-3-induced death.
Rows indicate a given genotype, If, loss-of-function, o/e, overexpression. Model
is based on figure 1. X represents loss of activity. Thicker arrows indicate higher
activity. +, cell death, ++, enhanced cell death.
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Figure 4. ced-4L can prevent cell death induced by ced-9(lf) mutations.
Rows indicate a given genotype, If, loss-of-function, o/e, overexpression. Model
is based on figure 1. X represents loss of activity. Thicker arrows indicate higher
activity. +, cell death, -, no cell death.
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The C. elegans cell death gene ced-3 encodes a protein similar to mammalian
interleukin-1 converting enzyme
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Summary
We have cloned the C. elegans cell death gene ced-3. A ced-3 transcript is most
abundant during embryogenesis, the stage during which most programmed cell
deaths occur. The predicted CED-3 protein shows similarity to human and murine
interleukin-1 converting enzyme and to the product of the mouse nedd-2 gene,
which is expressed in the embryonic brain. The sequences of 12 ced-3 mutations as
well as the sequences of ced-3 genes from two related nematode species identify sites
of potential functional importance. We propose that the CED-3 protein acts as a
cysteine protease in the initiation of programmed cell death in C. elegans and that
cysteine proteases also function in programmed cell death in mammals.
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Introduction
Cell death occurs as a normal aspect of animal development as well as in tissue
homeostasis and aging (Glucksman, 1950; Ellis et al., 1991a). Naturally occurring or
programmed cell death can act to regulate cell number, to facilitate morphogenesis, to
remove harmful or otherwise abnormal cells, and to eliminate cells that have already
performed their functions. In many cases, gene expression within dying cells is thought
to be required for these cells to die, since the cell death process can be blocked by
inhibitors of RNA and protein synthesis (Stanisic et al., 1978; Cohen and Duke, 1984;
Martin et al., 1988).
During the development of the nematode Caenorhabditis elegans, 131 cells
undergo programmed cell death (Sulston and Horvitz, 1977; Sulston et al., 1983).
Fourteen genes have been identified that function in different steps of the genetic
pathway of programmed cell death in C. elegans (Hedgecock et al., 1983; Ellis and
Horvitz, 1986; Ellis and Horvitz, 1991; Ellis et al., 1991b; Hengartner et al., 1992;
reviewed by Ellis et al., 1991a). Two of these genes, ced-3 and ced-4, play essential roles
in either the initiation or execution of the cell death program, since recessive mutations
in these genes prevent almost all of the cell deaths that normally occur during C.
elegans development. Genetic mosaic analysis indicates that ced-3 and ced-4 most likely
function within cells that die or within their close relatives to cause cell death (Yuan and
Horvitz, 1990). The ced-4 gene encodes a novel protein that is expressed primarily
during embryogenesis, the period during which most programmed cell deaths occur
(Yuan and Horvitz, 1992).
To understand how the ced-3 gene acts to cause cell death, we have cloned this
gene. As deduced from the sequence of a ced-3 cDNA clone, the CED-3 protein is 503
amino acids in length and contains a serine-rich middle region of about 100 amino
acids. We compared the sequences of the CED-3 protein of C. elegans with the inferred
CED-3 protein sequences from the related nematode species C. briggsae and C. vulgaris.
This comparison revealed that the carboxy-terminal portions of these proteins are most
conserved. The non-serine-rich portions of the CED-3 protein are similar to human
interleukin-1l3 (IL-1f3) converting enzyme (ICE), a cysteine protease that can cleave the
inactive 31 kD precursor of IL-1I to generate the active cytokine (Cerretti et al., 1992;
Thornberry et al., 1992). In addition, the C-terminal portions of both the CED-3 and ICE
proteins are similar to the mouse Nedd-2 protein, which is encoded by an mRNA
expressed during mouse embryonic brain development and is down-regulated in adult
brain (Kumar et al., 1992). We suggest that CED-3 acts as a cysteine protease in
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controlling the onset of programmed cell death in C. elegans and that members of the
ced-3 /ICE/nedd-2 gene family might function in programmed cell death in vertebrates.
Results
ced-3 is not essential for viability
All previously described ced-3 alleles were isolated in screens designed to detect
viable mutants in which programmed cell death did not occur (Ellis and Horvitz, 1986).
Such screens might systematically have missed classes of ced-3 mutations that result in
inviability. Since animals of the genotype ced-3/deficiency are viable (Ellis and Horvitz,
1986), we designed a screen that would allow us to isolate recessive lethal alleles of ced-
3, if such alleles could exist (see Experimental Procedures). We obtained four new ced-3
alleles (n1163, n1164, n1165, n1286) in this way. All four of these new mutants are viable
as homozygotes. These new alleles were isolated at a frequency of about 1 in 2500
mutagenized haploid genomes, approximately the frequency expected for the
generation of loss-of-function mutations in an average C. elegans gene (Brenner, 1974;
Meneely and Herman, 1979; Greenwald and Horvitz, 1980).
These observations suggest that animals that lack ced-3 gene activity are viable.
Supporting this hypothesis, we have shown by molecular analysis that three ced-3
mutations are nonsense mutations that seem likely to eliminate ced-3 activity (see
below). Based upon these considerations, we conclude that ced-3 gene activity is not
essential for viability.
ced-3 is contained within a 7.5 kb genomic fragment
To clone the ced-3 gene we used the approach of Ruvkun et al. (1988). Briefly (for
further details see Experimental Procedures), we identified a 5.1 kb EcoRI restriction
fragment that contained Tcl (Emmons et al., 1983), that was present in the C. elegans
Bristol strain N2 but not in the C. elegans Bergerac strain EM1002 and that was closely
linked to ced-3. We named this restriction fragment length polymorphism (RFLP) nP35.
Using Tcl to probe Southern blots of cosmids derived from N2 genomic DNA and
known to contain Tcl (G. Ruvkun, personal communication), we identified two cosmids
(MMM-C1 and MMM-C9) that contained this 5.1 kb EcoRI fragment. These cosmids
overlapped an existing cosmid contig that had been defined as part of the C. elegans
genome project (Coulson et al., 1986, 1988, and personal communication). We used
cosmids from this contig to identify four additional Bristol-Bergerac RFLPs (nP33, nP34,
nP36, nP37). By mapping these RFLPs between the Bristol and Bergerac strains with
respect to the genes unc-30, ced-3 and unc-26, we oriented the contig with respect to the
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genetic map. These experiments narrowed the region containing the ced-3 gene to an
interval spanned by the three cosmids C48D1, W07H6 and C43C9 (Fig. la).
These three cosmids were microinjected (Fire, 1986; J. Sulston, personal
communication) into ced-3 mutant animals to test for rescue of the mutant phenotype.
Specifically, a candidate cosmid and cosmid C14G10, which contains the wild-type unc-
31 gene (R. Hoskins, personal communication), were coinjected into ced-l(el735); unc-
31(e928) ced-3(n717) hermaphrodites, and non-Unc progeny were isolated and observed
to see if the non-Unc phenotype was transmitted to the next generation, thus
establishing a line of transgenic animals. Young first larval stage (L1) progeny of such
transgenic lines were examined for the presence of cell deaths using Nomarski optics to
see whether the Ced-3 phenotype was rescued. Cosmid C14G10 alone does not confer
wild-type ced-3 activity when injected into a ced-3 mutant (data not shown). ced-1 was
used to facilitate scoring of the Ced-3 phenotype (see Experimental Procedures), and
unc-31 was used as a marker for co-transformation (R. Hoskins, personal
communication; Kim and Horvitz, 1990).
As indicated in Fig. la, of the three cosmids tested, only C48D1 rescued the Ced-
3 mutant phenotype. Two non-Unc transgenic lines were obtained, the insertion line
nIsl and the extrachromosomal line nEx2. Both were rescued. Specifically, L1 ced-1
animals contain an average of 23 cell corpses in the head, and L1 ced-1; ced-3 animals
contain an average of 0.3 cell corpses in the head (Ellis and Horvitz, 1986). By contrast,
L1 ced-1; unc-31 ced-3; nIsl and L1 ced-1; unc-31 ced-3; nEx2 animals contained an average
of 16.4 (n=20) and 14.5 (n=20) cell corpses in the head, respectively. From these results,
we concluded that C48D1 contains the ced-3 gene.
To locate ced-3 more precisely within cosmid C48D1, we subcloned this cosmid
and tested the subclones for their abilities to rescue the Ced-3 mutant phenotype (Fig.
lb). From these experiments, we localized ced-3 to a DNA fragment of 7.5 kb (pJ7.5).
ced-3 is transcribed primarily during embryogenesis and independently of ced-4
function
We used the 7.6 kb pJ107 subclone of C48D1 (Fig. lb) to probe a northern blot of
polyA+ RNA derived from the wild-type C. elegans strain N2. This probe hybridized to
a 2.8 kb transcript (data not shown; also see Fig. 2). Although this transcript was
present in 11 different EMS-induced ced-3 mutant strains (data not shown; the mutant
n1164 was not tested), subsequent analysis revealed that all 11 mutants contain
mutations in the genomic DNA that encodes this mRNA (see below), thus establishing
this RNA as a ced-3 transcript. The ced-3 transcript was most abundant during
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embryogenesis, when most programmed cell deaths occur (Sulston and Horvitz, 1977;
Sulston et al., 1983) and was also detected at later stages (Fig. 2).
Since ced-3 and ced-4 are both required for programmed cell death in C. elegans,
and since both are highly expressed during embryonic development (Yuan and Horvitz,
1992; see above), it is possible that one of these genes regulates mRNA levels of the
other. Previous studies showed that ced-3 does not regulate ced-4 mRNA levels (Yuan
and Horvitz, 1992). To determine if ced-4 regulates ced-3 mRNA levels, we probed a
northern blot of RNA prepared from ced-4 mutant embryos with the ced-3 cDNA
subclone pJ118. The abundance and size of ced-3 transcript was normal in the ced-4
mutants n1162 (glutamine to ochre nonsense mutation at codon 40), n1416 (Tc4 insertion
into exon 5), n1894 (tryptophan to opal nonsense mutation at codon 401) and n1920 (G
to A mutation in the intron 3 splice donor site)(Figure 3a). None of the ced-4 mutants
tested has detectable ced-4 RNA (Figure 3b; Yuan and Horvitz, 1992). Thus, ced-4 does
not seem to affect the steady-state levels of ced-3 mRNA.
ced-3 cDNA and genomic sequences
To isolate ced-3 cDNA clones, we used the ced-3 genomic DNA clone pJ40 (Fig.
lb), which rescued the Ced-3 mutant phenotype when microinjected into ced-3 mutant
animals, as a probe to screen a cDNA library prepared from the C. elegans wild-type
strain N2 (Kim and Horvitz, 1990). The 2.5 kb cDNA clone pJ87 was isolated in this
way. On northern blots pJ87 hybridized to a 2.8 kb transcript, and on Southern blots it
hybridized only to bands to which pJ40 also hybridized (data not shown). Thus, pJ87
was derived from an mRNA transcribed entirely from pJ40. To confirm that pJ87
corresponds to a ced-3 cDNA clone, we made a frameshift mutation in the unique SalI
site of pJ40, which corresponds to the unique SalI site in the pJ87 cDNA clone and
disrupts the putative ced-3 open reading frame (see Experimental Procedures; also, Fig.
4a). Constructs containing this frameshift mutation failed to rescue the ced-3 phenotype
when microinjected into Ced-3 mutant animals (six transgenic lines were examined;
data not shown), suggesting that ced-3 activity was eliminated by mutating the putative
ced-3 open reading frame.
We determined the DNA sequence of pJ87 (Fig. 4). pJ87 contains an insert of
2482 bp that can encode a protein of 503 amino acids. pJ87 contains 953 bp of 3'
untranslated sequence, not all of which is essential for ced-3 function, since genomic
constructs that lack the last 380 bp of the 3'-most region (pJ107 and its derivatives, see
Fig. b) rescued the Ced-3 mutant phenotype. The pJ87 cDNA clone ends with a poly-A
sequence (data not shown), suggesting that the 3' end of pJ87 corresponds to the
extreme 3' end of the ced-3 transcript. The 5' end of pJ87 does not contain trans-spliced
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sequences (Bektesh et al., 1988; Huang et al., 1989) and therefore might or might not
include the 5' end of the ced-3 transcript.
To determine the 5' end of the ced-3 transcript, we performed primer extension
experiments (Fig. 5). Two primers containing sequences separated by 177 bp in the
genomic DNA sequence (see below) and by 123 bp in the cDNA sequence were used for
the primer extension reactions: Pexl, starting at position 2305 of the genomic sequence;
and Pex2, starting at position 2482 of the genomic sequence. The Pex2 reaction yielded
two major products of 283 nucleotides and 409 nucleotides, whereas the Pexl reaction
gave one product of 160 nucleotides. The 160 nucleotide product of the Pexl reaction
corresponds to the 283 nucleotide product of the Pex2 reaction, since these products
differ in size by 123 nucleotides. Products of these lengths are consistent with the
presence of a ced-3 transcript that is trans-spliced to a 22 bp C. elegans spliced leader
(Bektesh et al., 1988) at a consensus splice acceptor site at position 2166 of the genomic
sequence. The larger Pex2 product might be a result of priming by the Pex2 primer
from an mRNA other than the ced-3 mRNA or might identify a second ced-3 transcript.
We failed to amplify a ced-3 transcript using primers located between positions 1 and
2166 of the genomic sequence (figure 4a) and primers located in the cDNA (data not
shown), indicating that if an alternate ced-3 transcript exists it is not entirely encoded by
DNA within the minimal rescuing fragment.
If a trans-spliced ced-3 mRNA exists, it should be possible to use the polymerase
chain reaction to amplify a ced-3 product from total C. elegans RNA using primers
specific for spliced leader sequences and ced-3 cDNA sequences. We therefore prepared
cDNA from total C. elegans RNA using reverse transcriptase and amplified the cDNAs
using the primers SL1 (which contains the SL1 spliced leader sequence; Bektesh et al.,
1988) and log-5 (which starts at position 2897 of the genomic sequence). The products
of this reaction were reamplified using the primers SL1 and oligolO (which starts at
position 2344 of the genomic sequence). A product of the expected length (-200 bp) was
cloned into the PCR1000 vector (Invitrogen, San Diego, CA), and its sequence was
determined (data not shown). This sequence confirmed that at least some ced-3
transcripts are trans-spliced to the C. elegans spliced leader SL1 at a consensus splice
acceptor at position 2166 of the genomic sequence. Similar experiments using a primer
containing the SL2 spliced leader sequence (Huang and Hirsh, 1989) failed to identify an
SL2 trans-spliced mRNA. Since the primer extension experiments identified a major ced-
3 mRNA that probably is trans-spliced, it seems likely that a large proportion of ced-3
mRNA is SLI-trans-spliced. Based upon these observations, we propose that the
translational start codon of ced-3 is the first in-frame ATG downstream of the SL1 splice-
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acceptor site at position 2232 of the genomic sequence and that the CED-3 protein is 503
amino acids in length (Fig. 4a).
To define the structure of the ced-3 gene, we determined the genomic sequence of
the ced-3 gene from the plasmid pJ107. The insert in pJ107 is 7653 bp in length (Fig. 4a).
Comparison of the ced-3 genomic and cDNA sequences revealed that the ced-3 gene has
seven introns that range in size from 54 bp to 1195 bp. The four largest introns, as well
as sequences 5' of the start codon (see below), contain repetitive elements, some of
which have been previously identified in non-coding regions of other C. elegans genes,
such as fem-1 (Spence et al., 1990), lin-12 (Yochem and Greenwald, 1989, and personal
communication), glp-1 (Yochem and Greenwald, 1989) and hlh-1 (Krause et al., 1990) as
well as in the cosmids ZK643 and B0303 (Sulston et al., 1992) (Fig. 4b). Genomic
sequence analysis of a ced-3 homolog from the related nematode C. briggsae (J. Yuan
and S. Ledoux, unpublished results) revealed that these repeats are not present in this
nematode species, suggesting that the repeats do not have a role in regulating ced-3
expression. It is possible that such repeats represent active or inactive transposable
elements.
The predicted CED-3 protein is hydrophilic (256/503 residues are charged or
polar) and does not contain any obvious potential transmembrane domains. One region
of the CED-3 protein is rich in serines: from amino acid 107 to amino acid 205, 32 of 99
amino acids are serines.
We determined the sequences of 12 EMS-induced ced-3 mutations (Fig. 4a; Table
1). Eight are missense mutations, three are nonsense mutations, and one alters a
conserved G at the presumptive splice-acceptor site of intron 6.
To identify functionally important regions of the CED-3 protein, we cloned and
determined the genomic sequences of the ced-3 genes from the related nematode species
C. briggsae and C. vulgaris. Sequence comparisons showed that amino acids
corresponding to residues 1-205 of the C. elegans CED-3 protein are less conserved
among the three nematodes (68% identical) than are amino acids corresponding to
residLues 206-503 of the C. elegans CED-3 protein (84% identical) (Fig. 7a). All eight
EMS-induced missense mutations in ced-3 (see above) altered residues that are
conserved among the three species (Fig. 7a). Interestingly, six of these eight mutations
alter residues within the last 100 amino acids of the protein, and none affects the serine-
rich region (Figs. 4a and 6). These results suggest that the carboxy region is important
for ced-3 function and that the serine-rich region might be unimportant or that different
residues within it might be functionally redundant.
CED-3 protein is similar to the mammalian ICE and Nedd-2 proteins
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A search of the GenBank, PIR and SWISS-PROT databases revealed that the non-
serine-rich regions of the CED-3 protein are similar to the human and murine
interleukin-1l (IL-14) convertases (ICE) (Fig. 7a). ICE is a cysteine protease that cleaves
the inactive 31 kD precursor of IL-1 D between Asp 116 and Ala117, releasing a carboxy-
terminal 153 amino-acid polypeptide known as mature IL-1l (Kostura et al., 1989; Black
et al., 1989). The CED-3 proteins from the three Caenorhabditis species and the human
ICE protein share 299% amino acid identity. The most highly conserved region consists
of amino acids 246-360 of the CED-3 protein and amino acids 166-287 of the human ICE
protein: 49 of 115 residues are identical (43% identity). Cysteine 285 is thought to be an
essential component of the active site of ICE (Thornberry et al., 1992). The five-amino-
acid peptide QACRG containing this active cysteine is the longest peptide conserved
among the murine and human ICE proteins and the CED-3 proteins of the three
nematode species.
Active human ICE is composed of two subunits (p20 and p10) that appear to be
proteolytically cleaved from a single proenzyme by the mature enzyme (Thornberry et
al., 1992). Four cleavage sites in the proenzyme have been defined. Only p20 and p10
are necessary for the in vitro enzymatic activity of ICE, suggesting that the three
additional fragments resulting from ICE cleavage are not required for ICE function.
Two of these cleavage sites, Asp-Ser dipeptides at positions 103-104 and 297-298 of ICE,
are conserved in CED-3 (positions 131-132 and 371-372, respectively) (Fig. 7).
The carboxy-terminal portion of the CED-3 protein and the p10 subunit of ICE
are similar to the protein product of the murine gene nedd-2 (Fig. 7a), which is highly
expressed during embryonic brain development and is down-regulated in adult brain
(Kurnar et al., 1992). The C. elegans CED-3 protein and the Nedd-2 protein are 27%
identical, as are the ICE and Nedd-2 proteins (Fig. 7a). The Nedd-2 protein apparently
does not contain the QACRG peptide found at the active site of ICE (Fig. 7a). Six of the
eight known ced-3 missense mutations (n718, n1040, n1129, n1164, n2426 and n2433)
alter amino acids that are identical among the three nematode CED-3 proteins and
human ICE. For example, the mutation n2433 introduces a glycine to serine substitution
at an absolutely conserved glycine near the putative active-site cysteine (Fig. 4a & 7a).
Four mutations (n1129, n1163, n1164, n2426) alter amino acids that are identical among
the nematode CED-3 proteins and the Nedd-2 protein (Fig. 7a).
Discussion
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The genes ced-3 and ced-4 are the only genes known to be required for
programmed cell death to occur in C. elegans (Ellis and Horvitz, 1986). Our genetic and
molecular studies of the ced-3 gene have revealed that this gene shares a number of
features with ced-4: like ced-4 (see Yuan and Horvitz, 1992), ced-3 is not required for
viability and is expressed mostly during embryogenesis, the stage during which 113 of
the 131 programmed cell deaths occur (Sulston et al., 1983). Furthermore, just as ced-3
gene function is not required for ced-4 gene expression (Yuan and Horvitz, 1992), ced-4
gene function is not required for ced-3 gene expression. Thus, these two genes do not
appear to control the onset of programmed cell death by acting sequentially in a
transcriptional regulatory cascade.
The CED-4 protein is novel in sequence, and the only hint concerning its function
is that two regions of the protein show some similarity to the EF-hand motif, which
binds calcium (Yuan and Horvitz, 1992). For this reason we have suggested that the
CED-4 protein and hence programmed cell death in C. elegans might be regulated by
calcium. However, no direct evidence for this hypothesis has yet been obtained. The
CED-3 protein similarly contains a region that offers a clue about possible function: a
region of 99 amino acids contains 32 serines. Since serines are common
phosphorylation sites (Edelman et al., 1987), it is possible that the CED-3 protein and
hence programmed cell death in C. elegans are regulated by phosphorylation.
Phosphorylation has previously been suggested to function in cell death (McConkey et
al. 1990). Although the precise sequence of the serine-rich region varies among the
three Caenorhabditis species studied, the relatively high number of serines is conserved
(32, 31, and 33 in C. elegans, C. briggsae and C. vulgaris, respectively). None of the
mutations in ced-3 affects the serine-rich region. These observations are consistent with
the hypothesis that the presence of serines is more important than the precise amino
acid sequence within this region.
Much more striking than the presence of the serine-rich region in the CED-3
protein is the similarity between the non-serine-rich regions of CED-3 and the human
and murine interleukin-1 3 converting enzymes (ICE). Human ICE was identified as a
substrate-specific protease that cleaves the 31 kD pro-interleukin-1 between Asp 116
and Ala1 1 7 to produce the mature 17.5 kD interleukin-1 3 (IL-1 f3). IL-1 [3 is a cytokine
involved in mediating a wide range of biological responses, including inflammation,
septic shock, wound healing, hematopoiesis and the growth of certain leukemias
(Dinarello, 1991; diGiovine and Duff, 1990). A specific inhibitor of ICE, the crmA gene
product of Cowpox virus, prevents the proteolytic activation of interleukin-13 (Ray et
al.,1992) and inhibits the host inflammatory response (Ray et al., 1992). Cowpox virus
carrying a deleted crmA gene is unable to suppress the inflammatory response of chick
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embryos, resulting in a reduction in the number of virus-infected cells and less damage
to the host (Palumbo et al., 1989). These observations indicate the importance of ICE in
bringing about the inflammatory response.
A region of 115 amino acids (residues 246-360 of CED-3) shows the highest
identity (43%) between the C. elegans CED-3 protein and the human ICE protein. This
region contains a conserved pentapeptide QACRG (positions 356-360 of the CED-3
protein), which contains a cysteine known to be essential for ICE function. Specific
modification of this cysteine in human ICE results in a complete loss of activity
(Thomberry et al., 1992). The ced-3 mutation n2433 alters the conserved glycine in this
pentapeptide and eliminates ced-3 function, suggesting that this glycine is important for
ced-3 activity and might be an integral part of the active site of ICE. Six of the other
seven identified ced-3 missense mutations also affect highly conserved residues that are
likely to be important for the actions of both CED-3 and ICE. Interestingly, the
mutations n718 (position 65 of CED-3) and n1040 (position 27 of CED-3) eliminate ced-3
function in vivo yet alter conserved residues that are not contained in either the mature
p1O or p20 subunits of ICE (Thornberry et al., 1992). It is possible that these residues
have a non-catalytic role in both CED-3 and ICE function, for example, in maintaining a
proper conformation for proteolytic activation. The human ICE proenzyme (p45) can be
proteolytically cleaved at four sites (Asp103, Asp 119, Asp2 9 7 and Asp3 1 6 of ICE) to
generate two peptides (p20 and p10) necessary for in vitro activity (Thornberry et al.,
1992) and three other peptides with as yet undefined functions. At least two of these
cleavage sites are conserved in CED-3, indicating that the CED-3 protein might be
processed as well.
The similarity between the CED-3 and ICE proteins strongly suggests that CED-3
functions as a cysteine protease in controlling programmed cell death by proteolytically
activating or inactivating a substrate protein or proteins. A potential substrate for CED-
3 might be the product of the ced-4 gene. The CED-4 protein contains six aspartate
residues that might be targets of the CED-3 protein. Four of these aspartates are
followed by a serine (Asp151, Asp 184, Asp192 and Asp541 ), and two are followed by an
alanine (Asp25 and Asp459); of the four ICE cleavage sites in the ICE proenzyme, two
are Asp-Ser and one is Asp-Ala. Alternatively, the CED-3 protein might directly cause
cell death by proteolytically cleaving proteins that are crucial for cell viability.
The similarity between CED-3 and ICE defines a new protein family. Thomberry
et al. (1992) suggested that the sequence GDSPG at position 287 of ICE resembles a
GX(S/C)XG motif found in serine and cysteine protease active sites. In the three
nematode CED-3 proteins, however, only the first glycine of this sequence is conserved
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and in mouse ICE the S/C is missing, suggesting that the CED-3/ICE family shares
little sequence similarity with known protease families.
The similarity between CED-3 and ICE suggests not only that CED-3 might
function as a cysteine protease but also that ICE might function in programmed cell
death in vertebrates. Consistent with this hypothesis, after murine peritoneal
macrophages were stimulated with lipopolysaccharide and induced to undergo
programmed cell death by exposure to extracellular ATP, mature active IL-1P was
released into the culture supernatant; by contrast, when cells were injured by scraping,
IL-1P was released exclusively as the inactive proenzyme (Hogoquist et al., 1991).
These results suggest that ICE might be activated upon induction of programmed cell
death. A role for ICE in programmed cell death need not be mediated by IL-1P but
rather could be mediated by another ICE substrate. ICE transcripts have been detected
in cells that do not make IL-13 (Cerretti et al., 1992), suggesting that other ICE substrates
might well exist. Alternatively, members of the CED-3/ICE family other than ICE
might function in vertebrate programmed cell death.
The p10 subunit of ICE and the carboxy-terminal portions of the CED-3 protein
are similar to the protein encoded by the murine nedd-2 gene, which is expressed during
early embryonic brain development (Kumar et al., 1992). Since the Nedd-2 protein
apparently lacks the QACRG active site region and is similar to ICE primarily in the
region of the p10O subunit of ICE, nedd-2 might function non-catalytically to regulate an
ICE or ICE-like p20 subunit. Interestingly, three ced-3 missense mutations alter residues
conserved among the Nedd-2 and CED-3 proteins. nedd-2 gene expression is high
during embryonic brain development (Kumar et al., 1992), when much programmed
cell death occurs (Oppenheim, 1981). These observations suggest that Nedd-2 might
function in programmed cell death.
The C. elegans gene ced-9 protects cells from undergoing programmed cell death
by directly or indirectly antagonizing the activities of ced-3 and ced-4 (Hengartner et al.,
1992). The vertebrate gene bcl-2 acts functionally similarly to ced-9: overexpression of bcl-
2 protects or delays the onset of apoptotic cell death in a variety of vertebrate cell types as
well as in C. elegans (Vaux et al., 1988; Nunez et al. 1990; Garcia et al., 1992; Sentman et
al., 1992; Strasser et al., 1992; Vaux et al., 1992; M. Hengartner and H. R. Horvitz,
unpublished results). Thus, if ICE or another CED-3/ICE family member is involved in
vertebrate programmed cell death, an intriguing possibility is that bcl-2 could act by
modulating its activity. Furthermore, since bcl-2 is a dominant oncogene (overexpression
of bcl-2 as a result of chromosomal translocation occurs in 85% of follicular and 20% of
diffuse B cell lymphomas; Fukuhara et al., 1979; Levine et al. 1985; Yunis et al., 1987), ICE
and other CED-3/ICE family members might be recessive oncogenes: the elimination of
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such cell death genes could prevent normal cell death and promote malignancy, just as
does overexpression of bcl-2.
Experimental Procedures
General Methods and Strains
The techniques used for culturing C. elegans were as described by Brenner
(1974). All strains were grown at 200C. The wild-type strains were C. elegans variety
Bristol strain N2, Bergerac strain EM1002 (Emmons et al., 1983), C. briggsae and C.
vulgaris (V. Ambros, personal communication). Genetic nomenclature follows the
standard C. elegans system (Horvitz et al., 1979). The mutations used have been
described by Brenner (1974) and by Hodgkin et al. (1988) or were isolated by us. These
mutations are listed below.
LG I: ced-1(el735)
LG IV: unc-31(e928), unc-30(e191), ced-3(n717, n718, n1040, n1129, n1163, n1164, n1165,
n1286, n1949, n2426, n2430, n2433), unc-26(e205)
LG V: egl-l(n487, n986)
LG X: dpy-3(e27)
Isolation of additional alleles of ced-3
A non-complementation screen was designed to isolate new alleles of ced-3.
Because animals carrying ced-3(n717) in trans to a deficiency are viable (Ellis and
Horvitz, 1986), we expected animals carrying a complete loss-of-function ced-3 allele
generated by mutagenesis to be viable in trans to ced-3(n717), even if the new allele
caused inviability in homozygotes. We used an egl-l mutation in our screen. Dominant
mutations in egl-l cause the two hermaphrodite-specific neurons known as the HSNs to
undergo programmed cell death (Trent et al., 1983). The HSNs are required for normal
egg-laying, and egl-l hermaphrodites, which lack HSNs, are egg-laying defective. The
mutant phenotype of egl-l is suppressed in a ced-3; egl-l strain because mutations in ced-
3 block programmed cell deaths. egl-l(n986) males were mutagenized with ethyl
methanesulfonate (EMS) (20 mM for four hours; Sigma, St. Louis, MO) and crossed with
ced-3(n717) unc-26(e205); egl-l(n487); dpy-3(e27) hermaphrodites. Most cross progeny
hermaphrodites were egg-laying defective because they were heterozygous for ced-3
and homozygous for egl-1. Rare egg-laying competent animals were picked as
candidates for carrying new alleles of ced-3. Four such animals were isolated from
about 10,000 hermaphrodite F1 cross progeny of EMS-mutagenized animals. These
animals could have carried either a dominant suppressor of the egg-laying defect of egl-
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1 or a recessive mutation in ced-3. To distinguish between the two possibilities, ced-
3(new allele); egl-1 males were mated with egl-1 hermaphrodites, and the progeny (ced-
3/+;egl-1) were scored for suppression of the Egl phenotype. In each case, all of the
progeny were egg-laying defective, suggesting that the new mutation was recessive and
thus likely to be a ced-3 allele.
Cosmid libraries
Two cosmid libraries were used extensively in this work. A Sau3A I partial
digest genomic library of 7000 clones in the vector pHC79 was a gift from G. Benian
(personal communication) and was used to isolate the cosmids MMM-C1 and MMM-
C9. A Sau3A I partial digest genomic library of 6000 clones in the vector pJB8 (Ish-
Horowicz and Burke, 1981) was a gift from A. Coulson and J. Sulston (Coulson et al.,
1986) and was the source of cosmids Jc8, C48D1, and C43C9. W07H6 is in the vector
Lorist 6.
Identification and mapping of RFLPs
To place ced-3 on the physical map we sought to identify Tcl elements closely
linked to ced-3 and specific to either the Bristol N2 or Bergerac EM1002 strains. We
mated Bristol ced-3 unc-26/++ males or Bristol unc-30 ced-3/++ males with Bergerac
hermaphrodites. We isolated recombinants of phenotypes Ced-3 non-Unc-26, Unc-26
non-Ced-3, Unc-30 non-Ced-3, and Ced-3 non-Unc-30 from the progeny of the ced-3 unc-
26 (Bristol)/++(Bergerac) and unc-30 ced-3 (Bristol)/++(Bergerac) animals, respectively.
In this way, we established 15 inbred lines containing copies of chromosome IV derived
from both the Bristol and Bergerac strains and recombinant in the region of ced-3.
By probing DNA from these strains with the Tcl insert of plasmid pCe2001
(Emmons et al., 1983), we identified a 5.1 kb EcoRI Tcl-containing restriction fragment
specific to the Bristol strain and closely linked to ced-3. We named this RFLP nP35.
nP35 was localized to cosmids MMM-C1 and MMM-C9, which were used to identify a
cosmid contig in the ced-3 region (see text for details).
To identify additional RFLPs in the ced-3 region DNAs from the recombinant
inbred Bristol and Bergerac strains were digested with various restriction enzymes and
probed with different cosmids to look for RFLPs between these strains. nP33 is a
HindIII RFLP detected by the "right" end of cosmid Jc8, which is from the Coulson and
Sulston library. The "right" end of Jc8 was made by digesting Jc8 with EcoRI and self-
ligating. nP34 is a Hin dIII RFLP detected by the "left" end of Jc8. The "left" end of Jc8
was made by digesting Jc8 with SalI and self-ligating. nP36 and nP37 are HindIII RFLPs
detected by the cosmids T1OH5 and B0564, respectively.
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We mapped the RFLPs nP33, nP34, nP35, nP36 and nP37 with respect to the
genes unc-30, ced-3 and unc-26. The location of unc-30 on the physical map was
determined by R. Hoskins (personal communication). Southern blots using DNA from
the Ced-3 non-Unc-26 and Unc-26 non-Ced-3 inbred recombinant strains described
above were used to map nP33, nP34 and nP35 (data not shown). Three of three Unc-26
non-Ced-3 recombinants carried the Bristol RFLP nP33, while two of two Ced-3 non-
Unc-26 recombinants showed the Bergerac pattern; thus, nP33 maps very close to or to
the :right of unc-26. For nP34, two of two Ced-3 non-Unc-26 recombinants and two of
three Unc-26 non-Ced-3 recombinants showed the Bergerac pattern; the remaining Unc-
26 non-Ced-3 recombinant showed the Bristol pattern. The genetic distance between
ced-3 and unc-26 is about 0.3 map units (mu). Thus, nP34 maps between ced-3 and unc-
26, about 0.2 mu to the right of ced-3. Similar experiments mapped nP35, defined by the
5.1 kb restriction fragment containing a Bristol-specific Tcl element, to about 0.2 mu to
the right of ced-3. Southern blots of the Unc-30 non-Ced-3, and Ced-3 non-Unc-30
inbred strains described above were used to map nP36 and nP37 (data not shown).
nP36 mapped very close to or to the left of unc-30, since two of two Unc-30 non-Ced-3
recombinants showed the Bristol pattern on Southern blots, and two of two Ced-3 non-
Unc-30 recombinants showed the Bergerac pattern. Similarly, nP37 mapped very close
to or to the left of unc--30 since four of the four Ced-3 non-Unc-30 recombinants showed
the Bergerac pattern on Southern blots, and six of six Unc-30 non-Ced-3 recombinants
showed the Bristol pattern.
Germline transformation
Our procedure for microinjection and germline transformation basically followed
that of A. Fire (1986) with modifications by J. Sulston (personal communication).
Cosmid DNA was CsCl-gradient purified twice. Miniprep DNA was used when
cosmid subclones were injected. Miniprep DNA was prepared from 1.5 ml of an
overnight bacterial culture grown in superbroth (Sambrook et al., 1989). DNA was
extracted by the alkaline lysis method, as described by Sambrook et al. (1989), and was
treated with RNase A (37oC, 30 min) and then with proteinase K (550C, 30 min),
phenol- and then chloroform-extracted, precipitated twice (first in 0.3 M sodium acetate
pH 5.2 and second in 0.1 M potassium acetate, pH 7.2), and resuspended in 5 ul
injection buffer as described by Fire (1986). The DNA concentrations used in injections
were between 100 ug and 1 mg per ml.
Subclones of C48D1 were generated as follows. C48D1 was digested with BamHI
and self-ligated to generate subclone C48D1-28. C48D1-43 was generated by partial
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digestion of C48D1-28 with BglII. pJ40 was generated by digestion of C48D1-43 with
ApaI and BamHI. pJ107 was generated by partial digestion of pJ40 with BglII. pJ7.5 and
pJ7.4 were generated by ExoIII deletion of pJ107.
All transformation experiments used a ced-l(e1735); unc-31(e928) ced-3(n717)
strain. The ced-1 mutation was present to facilitate scoring of the Ced-3 phenotype.
Mutations in ced-1 block the engulfment of corpses generated by programmed cell
death, causing the corpses of dead cells to persist much longer than in the wild type
(Hedgecock et al., 1983). Thus, the presence of a corpse indicates a cell that has
undergone programmed cell death. The Ced-3 phenotype was scored by counting the
number of corpses present in the head of young L1 animals. Cosmid C48D1 or plasmid
subclones were mixed with C14G10 (which contains the unc-31(+) gene) at a weight
ratio of 2:1 or 3:1 to increase the chances that an Unc-31(+) transformant would contain
the cosmid or plasmid being tested. Usually, 20-30 animals were injected in one
experiment. Non-Unc F1 progeny of injected animals were isolated three to four days
later. About 1/2 to 1/3 of the non-Unc progeny transmitted the non-Unc phenotype to
the F2 generation and could be used to establish a line of transgenic animals. The
young L1 progeny of such non-Unc transgenics were checked for the number of dead
cells present in the head using Nomarski optics, as described by Ellis and Horvitz
(1986). Animals of the transgenic line nIsl transmitted the non-Unc phenotype to 100%
of their progeny, implying that the ced-3 and unc-31 transgenes had integrated into the
genome. Non-Unc animals of the transgenic line nEx2 transmitted the non-Unc
phenotype to 50% of their progeny, implying that the ced-3 and unc-31 transgenes were
present on an extra-chromosomal array that is maintained as an unstable free
duplication (Way and Chalfie, 1988).
Isolation of ced-3 cDNAs
To isolate ced-3 cDNA clones, the insert of pJ40 was used as a probe to screen a
cDNA library from the wild-type strain N2 (Kim and Horvitz, 1990). Seven cDNA
clones were isolated, of which four were 3.5 kb in length (e.g., pJ85) and three were 2.5
kb in length (e.g., pJ87). One cDNA clone of each size class was subcloned and
analyzed further. Two experiments showed that pJ85 contained DNA derived from a
ced-3 transcript fused to DNA derived from an unrelated transcript: first, on a northern
blot containing N2 RNA, the pJ85 insert hybridized to two transcripts, one of which did
not hybridize to the pJ40 insert; second, on a Southern blot containing N2 DNA, the
pJ85 insert hybridized to one band in addition to those to which pJ40 hybridized (data
not shown). Plasmid pJ87 contained a 2.5 kb cDNA clone and was determined to
contain the complete coding region for ced-3 (see text). The 5' end of pJ87 contains 25 bp
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of poly-A/T sequence (not shown), which is probably a cloning artifact since it is not
present in the genomic sequence. The cDNA subclone pJ118 was generated by
digesting pJ87 with EcoRI and ligating the resulting 2.2 kb fragment to the pBluescript
SKII[+ vector (Stratagene, La Jolla, CA).
Construction of a ced-3 frameshift mutation
The SalI site in pJ40 is located at position 5850 of the genomic sequence (Figs. lb
and 4a). The construct PSA was obtained by cleaving pJ40 with SalI and filling in the
staggered termini with the Klenow enzyme. By determining the sequence of PSA we
confirmed that it contained the sequence GTCGATCGAC instead of GTCGAC at the
SalIl site and so had a frameshift mutation that should result in the premature
termination of protein synthesis at a UGA codon at position 6335.
Determination of the ced-3 transcription initiation site
Two primers, Pexl (5'TCATCGACTTTTAGATGACTAGAGAACATC3') and
Pex2 (5'GTTGCACTGCTTTCACGATCTCCCGTCTCT3'), were used for primer
extension experiments, which were performed as described by Triezenberg (1987) with
minor modifications. The primers we used to amplify total RNA with the polymerase
chain reaction were SL1 (5'GTTTAATTACCCAAGTTTGAG3') and log-5
(5'CCGGTGACATTGGACACTC3'). Amplification was performed using the GeneAmp
kit (Perkin Elmer Cetus, Norwalk, CT). The products were reamplified using the
primers SL1 and oligolO (5'ACTATTCAACACTTG3'). See text for additional details.
DNA sequence analysis
For DNA sequencing, serial deletions were made according to the procedure of
Henikoff (1984). DNA sequences were determined using the Sequenase kit (US
Biochemical Corp., Cleveland, Ohio) and protocols obtained from the manufacturer.
The CED-3 protein sequence was compared with protein sequences in the
GenBank, PIR and SWISS-PROT databases at the National Center for Biotechnology
Information using the BLAST network service.
Cloning of ced-3 genes from other nematode species
The C. briggsae and C. vulgaris ced-3 genes were isolated from corresponding
phage genomic libraries (C. Link, personal communication) using the ced-3 cDNA
subclone pJ118 as a probe under low-strigency hybridization conditions (5xSSPE
(Sambrook, 1989), 20% formamide, 0.02% ficoll, 0.02% bovine serum albumin, 0.02%
polyvinylpyrrolidone, 1% sodium dodecyl sulfate (SDS) at 400 C overnight) and washed
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in xSSPE and 0.5% SDS twice at room temperature and twice at 420 C for 20 min for
each wash.
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Figure 1. Genetic and physical maps of the ced-3 region of chromosome IV.
(a) Alignment of the genetic and physical maps in the ced-3 region. nP33, nP34, nP35,
nP36, and nP37 are RFLPs between the Bristol N2 and Bergerac EM1002 wild-type C.
elegans strains. The three cosmid clones C43C9, W07H6 and C48D1 were tested for
their abilities to rescue the Ced phenotype of ced-3(n717) animals. The ability of each
cosmid clone to rescue ced-3 mutants and the fraction of independently obtained
transgenic lines that were rescued are indicated on the right. +, rescue; -, no rescue. See
text for data. The results indicate that ced-3 is contained in cosmid C48D1. mu, map
units.
(b) A restriction map of subclones of cosmid C48D1. Bold lines represent cosmid vector
sequences. Subclones were assayed for rescue of the Ced phenotype of ced-3(n717)
animals as in (a). +, rescue; -, no rescue; -/+, weak rescue (fewer than five corpses on
average); the numbers in parentheses indicate the fraction of independently obtained
transgenic lines that were rescued. The smallest fragment that fully rescued the ced-3
mutant phenotype was the 7.5 kb pJ7.5 subclone.
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Figure 2. ced-3 RNA.
A northern blot of polyA+ RNA from mixed stages, embryos, L1 through L4 larvae, and
young adults, probed with the ced-3 cDNA subclone pJ118 (see Experimental
Procedures). pJ118 did not detectably hybridize to RNA derived from glp-1 (q231) adults
(which lack a germ line; Austin and Kimble, 1987) (data not shown), suggesting that the
ced-3 RNA detected in the young adults in this experiment was derived from embryos
within these animals. The level of RNA in each lane can be estimated based upon
hybridization to a control actin 1 probe (Krause and Hirsh, 1984).
57
Nh .I ..; ,
I ii ,,,t
I I '.
I "I.
I . .
I I.
'l ,vt Xilj ' l I
'.$ ,t1 I . ,1, II I ~II, 
*
i
Figure 3. Northern blots of total RNA from wild-type embryos and ced-4(n1162, n1416,
n1894, n1920) embryos probed with (a) the ced-3 cDNA subclone pJ118 (see
Experimental Procedures) or (b) the ced-4 probe SK2-1 and a control actin 1 probe
(Krause and Hirsh, 1984). Unlabelled bands in (a) and (b) correspond to ribosomal
RNA bands. (b) is reprinted from Yuan and Horvitz (1992).
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Figure 4. ced-3 genomic organization, nucleotide sequence, and deduced amino acid
sequence.
(a) The genomic sequence of the ced-3 region, as obtained from plasmid pJ107, which
rescued the Ced-3 mutant phenotype. The deduced amino acid sequence of the CED-3
protein is derived from the DNA sequence of the ced-3 cDNA clone pJ87 and from other
experiments described in the text and in the Experimental Procedures. The likely start
site of translation is marked with a black arrowhead. The 5' end of pJ87 is indicated by
a white arrowhead. The SL1 splice acceptor site of the ced-3 transcript is boxed. The
Sal: site is represented by a bracket. The positions of 12 ced-3 mutations are indicated.
Repetitive elements are indicated as arrows above the relevant sequences. Numbers on
the left indicate nucleotide positions, begining with the start of pJ107. Numbers below
the amino acid sequence indicate amino acid positions. (b) Comparison of repetitive
elements in ced-3 with repetitive elements in the genes fem-1, hlh-1, lin-12, glp-1, and the
cosrnids B0303 and ZK643 (see text for references). In the case of inverted repeats, each
arm of a repeat ("for" or "rev" for "forward" or "reverse," respectively) was compared to
both its partner and to individual arms of the other repeats. Dashes represent gaps in
the sequence to allow optimal alignment except in the consensus sequence where
dashes indicate non-identical residues.
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1 AATCTCAAATAAGTCATAAATATAAAAAAGTATTATTTCTGAGGAAATTTCACTCT
4 61 TTTAGCACAATTAATTTGTTTCAAAAAAAAGTCCATTTTCTAGATTTTTCCGTCTTA
121 TT TATCTCC ATTAA TTATTAAT
A TC
CTTTTT TC CTC CACTCCTC
181 AAAAATTDAACCAAACOCTCTCCCATTGATCCACACTCACCDCCAAAlCA
A A C
241 CTTCCAACATTCCTGTTTTCTCCTTTCCGTTATCTTCCADTCATCTTTCGTTT
301 TTTTTTCTTTTGTAACTGTTTAAT CAATTATTAATCAATT GAATT AA
361 ACTCCCGATTATDTTGCCAGAAAATTCTAATCTCTAAGTCATTTTATAATA
421 TTTAACCTTGTTTTTGCATTGTTTCAAAAACCATCTTTTAA T AACCAT
481 TACTTTACTAATAAAACTACTTTTAAACCTTACCTTTACCTCACCGCTCCCTTTCATC
541 DCTCATACGATTTCDATACTC TCCTA AAAAAAAATAATACGAGG CAATTGTAAAn
601 CAAAAAAATCCTAADATTTCCACATTTTACCTCTCCDDCACCTTCTTCTTACCCC
661 ACCACTCCATCACCTCTTTGCGTCTTCTTCCAAACCACTTACCAAACAGTCTGTAT
721 CTCATTTCTATTCTATTCTCCAT TTTT CAA AATA TTTAAC
781 AATCCAAATCCATTATATTTCTCATCCACCCAAATCACGGTTGAATCTTACATCA
8401 ATCAACCACTAAACCCCTATTTTC CAcATTTCAT T
901 DTCDTCCTTDTATCCTCAACTTDTCCCTTTTTTCTACTCTTCCTATC
961 CACCTTCTCCTCACCTCTCAATTATTTTAAAATTAACTCTCCAATCGTAACTCATA
1021 TCTDCTDCTACAATCCACTTCTTATCTCATCGDCACTCTTACA CCCATCATAAAC
1081 mmTTTCCCAAcTCAATAAACCCAAAACTTCTCCAAATTDTTACCAA
1141 TATATAAATATAAGAATATTTCTCAATTTATDATCTTCCACACTTTCTCT
1201 TCTGTCTAACATcTTATTTTATAATATTTCCTAAAATTCCATTTTATATTA
1261 ATTTATcGTAAATTATAAAATADCACcGAAAACTACATGTTAAAcCTT
Repeat la
1321. TAAATCCCTCCACATTATCCTATTAAAAATCACAAAATTCTGAGAATGCTACTCC
1381. AACATATTACDCAAAATATCTCCTACCAAAACTACATAATTCTTTAAATCACTAC
_ Pp-t ^
1441 TCTADCGCTTTTCGATTTACDDGCTCAATTTTGAAAATAATTTTTTTTCAATTT
1501 TDATAACCCTAAATCCTCACAACCTACADTACTCATTTAAAGATTACTCTATTCTA
1561 DCTACCADATATTTGCDCCCAAATATDATTAATACCATTCTCTGAArTTTGTT
1621 TCCTAATAATTCAAATIGCATTCCACTTTAAAGCCACAATTATTCCA
1681 ATGCGTCTCOCCACDCAAAAATTTGATAACTnAAATTCTCCTTGCATTITTAATTC
1741 AATTACTAAATTTTCDTCAATTPCTTTAAAATTTTTAAAATCAGTTTCTAATATT
1801 TTCCADCTCAAACAAAACAAAAACACAACAACATTTAAAAATCATTTCAAT
1861 TAAAAATAATCTCATTAATTTT TAAAAAAC
1921 GATTCAAAACAAATTTTAAAAAAAAACCCC AAAA TCAAATAAAAA
1981 TTCAADAGCDTCAAAATTICCDATTTACTGACTCACCTTTTTTTCTADTTCADT
2041 DCADTTTDAGTTTTDACDAAACTAGAAAAAATCATAAAAATTACTCAAATC
2101 AOCTGAATTTGAGDACAATGTTTAAAAAAAAACACTATTTTCCAATAATTTCACTCAT
2161 EjJCAGCT.TAAACAC CCATACACACGTCAAC
2221 ATCACCDAADTCATDCCCTADATAAAGACTTCDTADAGAGAACATTATATT
M R Q D R R S L L E R N I MM 
1 10
T(nlO0)
2281 TCTCTAGTCATCTAAAACTCGATGAAATTCTCDAADTTCTCATCAAAAAAGTTA
S S H L K V D E I L V L I A K Q V L N
20 30
2341 ATACTATAATAATATATTAATTDATTTTTAATCAATAATAATTTTAAAAAA
S D N D WIN
40
2401 AATTATAATATAAAAATATTTTTGCACTCATTGDAACGTTCGCDACAACAGACGG
S C T V R E R R 
2461
50
A(n718)
I
AGATCTCAAACAGTCAACAC GAATGTCGTC CTCACCCTTATGATGCTC
I V K A VQ R R D V A DA Y D A L
60 70
2521 TTCCTCTACCAQCCAADACTTG'CTGAATTCTTDAACCTCTCCADATCDTADG
R S T H D L A V L P L A R S
80 90
2581 TTTTTAAAGTTGCDCAAAACAACGGTCTCACGAAAAAADADCDCDATCTAATTT
2641 cAACCCACCDGCACcDTnTTCCTCCDAAAATCDDAAATTATCACTTCCCAAATAT
2701 TTAGTAAATATATTATACTAAADCTCADT DATTA TTA AACTA
2761 ATTTTCTDCC CAAAACCA TAATTTDCCDAAATACT CACACACACC
2821 ACACACATCTCCTTCAAATATCCCTTTTCCATCTTACTCAATCTTCAATCA
V D S N A V F 
100
2881 TDTCC AATTCACCDCAACCATCTCCGACCCCCCTTAGCCCCCCGCTAC
C P P A S H R S R A L S P A Y T
110 120
2941 TTCACCCACCCATTCACCDTGACACGTCTCTTACTDCT TTCACTTCTTATCA
S P T R V H R D S V F T S Y Q
130 140
3001 DGATATCTACTCAAACAAATCTCTTCTCGATCGCTCACTTCATTCATCGATC
D I Y S R A R S R S R S R A L H S D R
150 160
3061 ACACAATTATTCATCCTCCADTCAACCATTTCCCACCAACCTTTATTTATC
H N Y S S PP V N A F P S Q PS
170
Repeat lb
3121 AACACTAAATTCTADAATCDCATTACTCAACATATTTACDCCAAATATCTCDTAGC
3181 GAAAAATACAGTAACCCTTTAAATGACTATTGTAGTGTCGATTTACGGGCTATTTTCG
3241 AAACGAATATATCTCAATTGTGACAACDAATTAATTTCA T TTTTCTT
_ Repeat lb
3301 TTGATTTTTATCAA CAACCTAATTATTCC ACAACACCA CATACT
3361 CTTTAAAGATTACADTAmTTTTCCTTCAAGATATTTTGAAAAGAATTTTAAACATTT
3421 TCAAAAAAATCATCTAACATTCCAAAACCTTTTTCAATTCDCAGATTTTTA
Repeat 2
3481 TTTTTTTCATTCAACATATCTTATTAACACATATAATTATCATTAATGTDAATTTCTT
3541 TAGAAATTTTDCTTTTCTTCTAGTATGCTCTACTTTGAAATTGCTCAACGAAAAAA
3601
3661
3721
3781
3841
3901
3961
4021
4081
4141
4201
4261
TCATTGTTTCWTTCATATGAATGACAAAATADCAATTTTTTATATATTTTCCCCTAT
TCATGTTGTDCAGAAAAATAGTAAAAACGCATG TTTTCGACATTTTTTACATCGA
ACACACCTcACTTCTCCTCAACACACAAACCCAAAATACCCACATCTTTCT
a Repeat 2
GCGTCTCTCGTCTTCACATCTDAAATCDGATCTCCTCCATGTAAAAAAATGTCCAATA
ATTAAAAAATGCATGCmTTTTTTTACACTTTTCTC AACAAATGAATADCQGAAAATGT
ATTAAAATACATTTTTTGTATTICAACATCACATATTAACCCCATTATTTTTTCGTT
DGACAACTTAAAAAGTADAGAATATTAGADC CAAAATTTCTTCAACATATTACC
TTTATTAATTATAATGTTAATAACATATCTTDAATDAAADTCADCAAAAATATGT
CAAACACC TAA AATCAAAAATTCTDCAAAATTGAAAALAATCATTAAAATACA
TMTTCTTTTTCTACATCACATDATOTDAAAAATTAAADDAAATCAAATITCPA
GAGGATATAATTCAATDAAACATTC AAATTAAAATCTGCGAAACGTCAAAAAAGAcGA
AATTTGGTATCAAAATCATCCTAAAACCACATTTCAGCATCCGCCAACTCTTAT
S A N S S F
180
4321 TCACCGATCCTCTCTCTCGATACADTTCAACTCDTAATCCTCATTCAAACCTT
T C S S L Y S S S R N R S F S K A S
190 200
4381 CTCGACCAACTCAATACATATTCCATDAADAGATATAACTTCATCACCAACCA
D P T Q Y I F H D N F V D A P T I
210 220
4441 TAACCTGTTTCGACCAGAAAACCATGTACACAAAcTTCTCCACTCCTCCTCCAATCT
S R V D I K T M Y R N F S P R G M C
230 240
4501 DCCTCATCATAAATAATDAACACTTDACGCAATCCA AC CC
L I I N N H F Q M PT R N C T K A D
250 260
4561 ACAAGGACAATCTTACCGCACATDC TTATATACCTTAT TCCAACGACA
K D N L T N L R C M G Y T V I C K D N
270 280
4621 ATCTGACGAADGGTACACCCAAATTATATTACCCAAACCCAAAT TTTCQGC
L T G R
Repeat 3
4681 CCAAAATTGDICCCCCTCTCCACCAA=TTGTTTAAATDCAAAAATTATAAT
47 1 ATCAAAAAACAAAATTTGAACTTCCGCAAATATACTTACCTADATTCDAAATTCTT
4801 DTTTnCOCGCTACATTATTTTTTTTCTTATTCTATAATA ATTAAA
4861 ACCAGTTAAATTTTCADATAATTTICCATACT AA
A A T
TT
4 921 TTCTCAATTTTCAAAATTATCCAAAAATCACAATTTAAAATT TCTGACATTGCAAAC
4981 GTGTTTCAATATAAATDTAmTTAAAAACMTTAAAAACCACTCCAAACAATAA
5041 AAATCAAAACAACDTCACAATTCAAATTCAAAATTATTCATCCATTTTATTT
5101 CAAAATTTAAAAAATATDAADATAAAAATTTATAACATTTTTCTADATT
5161 TCAAAATTTTTTTAAAAATGAAAAADAGAATGAAAAATCGATTCTAAAAATATCC
JRpeat 3
5221 ACADCTTCCADACDTTDAAATTACATACTCCTTAAAGGCCACACCCCATTTCATT
5281 ACCAAAAATTGTCDDTCDADACCADTACCTAGTTTTTTCCAAAATTCCCAT
5341 TGGACATAAACCTTCCTAATCACCAAAATAAAATTAATCTTCAAAACCAAAAA
5401 ATTCAAAAAAAAADTCAAmTTDTmTTTTDTTTTTCAAAAACCAAAA
5461 AAATcAATCTDAAAATACcAAAAAAAACCCAAAAT CACCCTTCCT
5521 AATGTAAACTGATATTAATTTCCADDCAATDTCCTACAATTCADACTTTECCAAAC
D L L T I R D AK 
290 300
5581 ACGAATCACACGADA ATACTCDGATTCTATCACACAAAAAATTA
S H D S A I L V I L S H N N V I
310 320
5641 TTATTGACTTATATATACCATTACACACGADATATATGATCTTCTCAACC
I V D D I P I S T H E I Y D L L N A A
330 340
A(n2433)
701 CAAATGCTCCCGTCTGGCAATAAGCCGAAAATCDTTTTTTGCA'GGCTTGTCGACC
N A P R L A N K P K I V F V Q A C R 
350 360
5761 GTTCCTTTTTTTAATTAATAATATTTTAAATAAATCATTTTCAAACTC
R
5821 GTCAATGATTCCCAGTCTTCGATTTCTCCACGAGTTCCTCATTTCCTCT
D N G P V L D S V D G V P A F L R R G
370 380
T(n1165)
1
5881 CATGGACAATCCACGGCCATTGTTCAATTTTCTTGGATGTGTGCGCCAAGTTC
W D N R D P L P N F L G C V R P Q V Q
390 400
5941 ACGGTTGCAATTTAATTCTTOAATGAAATATTCCTCAAAATCTAAAATAATTTTT
6001 ATTCCAGAAADTCCCATCAAAATTGCGATATAATTACGAAATTTTATAAAATCAC
Repeat 4
6061 AAACAATCAGCAT ATCTCCGCCCACTTCATCGGATTTTTGAAACTGGCGGA
6121 OTGAATTGCTCATTGTCCADTTTTCATTTAAGCCAATTTAAAAATCGCCTTTTCA
6181 AAATTAAAAATTATTTTTTCAATTTTTTCCAAAAATATTCCGATTATTTTATATTCTTT
A(n717)
6241 GGAGCGAAAGCCCCCTCCTGTAAACATTTTTAAATGATTAATAAATTTTTGCACAA
T(nl949)
6301 GTTC GGAAAAGAAGCCCAGCCAACTACATTCTGATTICATACCAACGACAGCTCAA
VW R P S Q A D I L I A Y A T T A Q
410 420
A(ni286)
6361 TATGTTTCTGACTAAACAGTGCTCGTCGATCATGGTTCATTCAAGCCTCTGTGAATG
Y V S W R N S A R S W I Q A V C V
430 440
T(n1129,n1164)
6421 TTCTCACACACCAAAGGATATCDATTTCTTCACTCCTCACTAAGTCAATAAAA
S T H A K D D V V L L T V N K K
450 460
T(n2430) A(n2426)
6481 GTCGCTTDTGATTTCAACATCACACGGATCAATATTTTGAAACATDCCAGACGTA
V A C F Q T Q S N I L Q P 
470 480
Repeat S
6541 CTTGAAACAAACAATGCATGT CTTTTAAGACACAGAAAAATAGCAAGCTCCT
6601 TTTGCAGCCTGCCCCCTCAACCTACAATTTTACTTTTTACCTAAAATCATTCATTTT
6661 GAATAT TTTATGCTAATTTTTTTGDCTTAAATTTTGAAATADTCATATTTATCGGGTTT
6721 CCTATAAAAATTTATTACCATT DATTTTACTAAAACAATTTTATTC
6781 AACGAAATTTATCATTTTTAAATTAAAAAAAAATAGCAAAATTACATCAACCATCAA
6841 CCATTTAACCAAATTGTTAACTCATTAAAAiATTAATTCAATTTCCACATATT
Repeat 5
6901 ACACGGTTGCCCCGCCCAACTTTCAAAACGACGCTCCGCCTCTTTTCTGTDCCCTTT
T(nll63)
6961 GAAAACAAGCDATCDGTTAATTTTCCCCCC AAATTTAAATTAAATTTCAGATGACATC
M T S
7021 CCCCTGCTCAAAAADTTCTTTCCGAACC C CCAACAAACTCTGCCCTCTAAAATTC
R L L K K F Y F W P A R N S A V *
490 500
7081 ACTCGTATTCATTCCC ATAATTATAATTTCTTATCTTCTCCCCCAGTTCTCTTTCGC
7141 CCAATTAGTTTAAAACCATGTcTATATTTTATCCTATACTCATTTCACTTTATCATTCT
7201 ATCATTCTTTCCCATTTTCACACATTTCCATTTCTCTACATAATCTAAAATTATCAC
7261 GTTTGTCTCTCAACCATAATAATTTTAATAACTCGTTTAATTTGATTACTTGTTGT
7321 GCCCACTATATATCTATTACTACTTCTATCAACAAAATATTTCATAATCATCAC
7381 CCAACCCCACCAACCTACCTACCATATTCATTTTCCDGGAATCATTTCGATTAATT
7441 TTAACCTAA'D GCCACAAAAAATCTAATArTTCAATAACGAATACCATTCCCATC
7501 TCTCCC TCCGAATGCCTCCCGCCTTTAAAGTTCGGAACATTTGGCAATTATGTAT
7561 AAATTTTAGGTCCCCCCCATCATTTCCCGCCCATCATCTCAAATTGCAT T T
7621 CCTGATATCCCGATTCTGGTCCAGCAAGATCT
(4b)
Repeat 1
ced-3 (la, for)
ced--3 (la, rev)
ced-3 (lb, for)
ced-3 (lb, rev)
fem-l (for)
fem-l (rev)
hlh-l (for)
hlh-l(rev)
consensus
ced-3 (la, for)
ced-3 (la, rev)
ced-3 (lb, for)
ced-3 (2b, rev)
fem-l (for)
fem-l (rev)
hlh-l(for)
hlh-l (rev)
consensus
Repeat 2
ced-3(for)
ced-3 (rev)
consensus
ced-3 (for)
ced-3 (rev)
consensus
ced-3(for)
ced-3 (rev)
consensus
ced-3 (for)
ced-3 (rev)
consensus
Repeat 3
ced-3 (for)
ced-3(rev)
lin-12 (for)
lin-12(rev)
BO303(1)
B0303(2)
ZK643(1)
ZK643(2,for],
ZK643 (2,rev
ZK643(3)
glp-l(for)
glp-l(rev)
consensus
ced-3(for)
ced-3(rev)
lin-1. (for)
lin-12(rev)
B0303(1)
BO303(2)
ZK643(1)
ZK643(2,for)
ZK643 (2,rev)
ZK643(3)
glp-l (for)
glp-l(rev)
consensus
Repeat 4
ced-3
lin-12
consensus
Repeat 5
ced-3(for)
ced-3 (rev)
consensus
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-...---------- --- AAATTCTGAGAATGCGCATTACTCAACATATTTGACGCGC-AAATATCTCGTAGCG
..........------------- ------------------- ----------------- TATCTTGAAGCG
GTATTACGGCAACAAAT'AATTATGAGAATGCCTATTGCGCACCATAGTTGACGCGCAAAATATCTCGTAGCG
GATTAACGGT AACACACAATCTGAG A ATGCGTATTGCACAACACATTTGACGCGCAAAATATCTCGTAGCG
CTATTACGGGAGTACAAATTCTGAGAATGCGTACTGCGCAACATATTTGACGCGCAAAATATTTCGTATCG
-------- GGGAGCACAAAATTCTGACTATGAGAAT-GCGTATAA ---- -GCACAAAATATTTCGTAGCG
-TAT-A-GG-A--A-A-AAT--GA--ATG---A-T-C ---- A-A-TTG-CG--CAAAATAT-T-G-A-C-
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AGAACTACAGTAATCCTTTAAATGACTACTGTAGCG ---- -TTGTGACGA-TTTACGGGTTATCAAAATTCGAAA
AAAA-TACAGTAACCCTTTAAA TGTAG -- -- TGTCGA-TTACGGGC- -TCGATTTTCGAAA
AAAACTACTGTAACTCTTTAAAAGAGTACTGTAGCGC - -- TGGTGTCTG-TTTACGGAAATAATT --------
AAAACTACAGTAATCTTT'GAATGACTACTGTAGCGC - --TTGTTTCGA-TTTACGGGCTCGTT ---------
AAAACTACAGTGArTCGTGAAT ACGGTAGGGTCG ----------------------------------
AAAACTACAGTAA'OCGITT ATT GGCTACTGT-GCG ------- TGTTGA-TTTACGGGC ---------------
AAAACTACAGTAAMGTCAAGGGACTACTGTAGCTAGCGCTTGTGTCGA-TTTACGGAGC-TCGATTTT ----
A-AACTAC- -GT-A --- -- A--G--TA--GTAG .--T-GT ....TTTACGG --------- TT-GAAA
1 10 20 30 40 50 60 70 80
TC ATT AAAATATAATTATATTAAGAACTTTATG AAAAA TGGGCTTTTCGTTCTAG
TCATTCAAGATAT( CTTi'TTAACATCTATAATTATCAATAAAGGTAATATCTTGAAGAAATTTTGG -- TTCGCTCTAA
TCATTOAAGATAT(CTTATTAACA- -TATAATTATCA-TAA-G- -AAT-TCTTG-AGAAATTTTGG-- TTTTCG-TCTA-
90 100 110 120 130 140 150 160
TATGCTCTACTTTGAAATT(CTCAACGAAAAAAT-----------CATGTGGTTTGTTCATATGAATGACGAAAAATA
TATTC'TCTACTTTrTAA(,TT(CTCAACGAAAAAATAATGTTAATC - --- ATGTTGAAAAATA
TAT - C CTACTTT'-AA -TTCTCAACGAAAAAAT ----------- CATGTG ------------- ATG- - GAAAAATA
170 180 190 200 210 220 230 240
GCAA- ---- T-TT'TAATATTTT-CCCCTATTCATGTTGTGCAGAAAAATAGTAAAAAAGCGCATGCAT -----
CAAAAAATGTA TATA AACATTTTC CCCCTATTCAT-TTGTGCAGAAAGT-GTAAAAAAACGCATGCATTTTTTACAT
--AA- -- - -T-TTT'T-AA-ATTTT-CCCCTATTCAT-TTGTGCAGAAAA-T-GTAAAAAA-CGCATGCATTTTT --
250 260 270 280 290
- - - -CGACA- TTTTTACATC'GAACGACAGC TCACATGCTGAAGACGAGAGACG
TATTCACATTTTTAC'ATC GACCGAGATCCCATTTCACATGCTGAAGACGAGAGACG
--- -C(;ACA - TTTAC ATC'GA- CGA-A--CA-TTCACATGCTGAAGACGAGAGACG
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CAGCTT'CGAGAGTTTG-AAATTACAGTACTCCTTAAAGGCGCACACCCCATTTGCATTGG
CAGCAACAAATGTTTG-AAATTACAGTAATCTTTAAAGGCGCACACC -------------
CTGCAACGAAAGTCTG-AAATTACAGTACCCCTTAAAGGCGCATA ---------------
--- ------- GTTAG-AAACTAGAGTACCTCTTAAAGGCGCACAT- -CCTTTCCCACCT
CAGCAACAAAAGTTTG--AAATTACAGTGCTCT TTAAAGGCACACACC-TTT ACATT-
CAGAAGCGAAAAATTrG-AAATTACAGTACTCTTTAAACGCTCAA-CCCC'GTTTCTATTCA
------- GATTGTT- GAAAATTACAGTAATCTTTAAAGGCGCACACA-CGTTTGTATTTT
------------ TTTTAACTACAGTACTCTTTAGGAGCGCACA- -TTTTTTCGCATTT
-------- AC 'rR-AACGTCTAGTACTCTTTAAAGGCGC -----------------
C-G--- C -- T- --- AA-TA-AGT----- TTA---GC-CA-A----- TTT ------
70 80 90 100 110
ACCAAAAATTTGTC(GTGT('GAACCAGGTA- C CGTAGTTTTTG - TC - GCAAA
-- -ACAAA-TTGTCTGT('GAGACCGGGCG - CCACA --------------------
AACAAAACTTTGTC(,TGT('GAGACCGGGTA-CCGTAT TAATT ------- GCAAA
ATCGAAATTTGTC;TGTC'GAGACCGGGTAGC -TAATTTTATGC -CAAAAA ---
AACAAAAAAGTGTCGT CTT('GAGACCGGGTA-CCGTGTT GGCGCAAAAATCGCTAT
ATAGAAAG-TTGTCIrmC(GAGACCGGACA-CCGTATTTTTGGCGCAAAATATACCTG
ACAGAAAA-TTTCTTTC'GAGACCGAACA- CAGTATTTTTGGCGGAGAAATTCTAAA
------ -- TTTGTCC:TGTCGAGACCTGG ------------------------------
AACAAATTTTTGTCC;TGGC'GAACCTGATA-CCGTATTTTTAGGTCAAGATTACTAGGTAA
------- GTTTGTCC;T-----------------------
A---- A-----T-TCC; -- C'GAG;ACC ------ C ---- TTT ----- A- -A ------
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AACCAATCAGCATC('TCGATCTCCGCCCACTTCATCGGATTGGTTGAAAGTGGGCGGAGTGAATTGCTGATTGGTC
ACCAATTOCCATACrAATTGATGTTAATTAGCGACTTCGGAATTTCCATACTTAATCTGATTGGTTGAAGAATGGGCAGAGCGAATTGCTGATTGGCC
AACCAA'-AGC--C--TCG---'---C--ACTT-ATC-GATTGGTT--A-A-TGGGC-AG-GAATTGCTGATTGG-C
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TTTTAAG-GACACAGAAAAATAGGCAGAGGCTCCTTT TGC AACCTGCCGCGCGTCAA CC
TTTCAAGCCGCACAGAAAAAGAGGCGGAGCGTCGTT TTGCAAACTTGCCGCGCGCCAACC
TTT-AAG --- -CACAGAAAA-AGGC -GAG- -TC-TTTTGCAA-C -TGCCGCGCG-CAACC
Figure 5. A primer extension experiment to determine the ced-3 transcription initiation
site (see text for details). Lanes 1-4, DNA sequencing reaction products using primer
Pexl and pJ40 as the template. Lanes 5-8, sequencing reaction products using the
primer Pex2 and pJ40 as the template. Lane 9, primer extension reaction products using
primer Pexl and N2 total RNA as template. Lane 10, primer extension reaction
products using primer Pex2 and N2 total RNA as template. Sizes of the primer
extension products are indicated to the right of lane 10.
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Figure 6 Intron-exon structure (represented by lines and boxes, respectively) of the ced-
3 gene and positions of 12 ced-3 mutations. The trans-spliced SL1 leader, the serine-rich
region, the mutations, and the presumptive translational start site (ATG), termination
site (TAA), and polyadenlyation site (AAA) are indicated.
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Figure 7. CED-3 protein.
(a) Comparison of the CED-3 protein sequences from C. elegans, C. briggsae, and C.
vulgaris with the human and mouse interleukin-1l converting enzymes (ICE) and with
the mouse Nedd-2 protein. Amino acids are numbered to the right of each sequence.
Dashes indicate gaps in the sequence to allow optimal alignment. Residues that are
identical among more than half of the proteins and between nematode and mammalian
sequences are boxed. Missense ced-3 mutations are indicated above the comparison
blocks showing the residue in the mutant CED-3 protein and the allele name. Asterisks
indicate potential aspartate self-cleavage sites in the CED-3 protein. Circles indicate
known aspartate self-cleavage sites in human ICE. Residues indicated in boldface
correspond to the highly conserved pentapeptide containing the active cysteine in ICE.
(b) Comparison of structural features of the CED-3 protein and human ICE. The
predicted proteins corresponding to the ICE proenzyme and CED-3 are represented.
The active site in ICE and the predicted active site in CED-3 are indicated by the black
rectangles. The four known cleavage sites in ICE flanking the processed ICE subunits
(p24, which was detected in low quantities when ICE was purified (Thornberry et al.,
1992:), p20, and p10) and two conserved presumptive cleavage sites in the CED-3 protein
are indicated with solid lines and linked with dotted lines. Five other potential cleavage
sites in the CED-3 protein are indicated with dashed lines. The positions of the
aspartate (D) residues at potential cleavage sites are indicated below each diagram. The
carboxy terminus of p24 has not been determined and is indicated by a dotted arrow.
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TABLE 1. Sequences of ced-3 Mutations
Wild-type sequence
ttttgcag I
GGA
CTC
GCA
TCC
CAG
TGG
CAA
GAG
GCT
GGC
Mutant sequence
CAA ttttgcaa I CAA
Substitution or
splice site change
Exon 7 acceptor
AGA
TTC
GTA
TTC
TAG
TGA
TAA
AAG
GTT
AGC
G65R
L27F
A449V
S486F
Q404amber
W428opal
Q412ochre
E483K
A466V
G360S
Amino acid positions correspond to the numbering in Fig. 4a.
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Allele
n717
n718
n1040
n1129, n1164
n1163
nll 65
n1286
21949
n12426
tn2430(
n2433
Chapter 3
Overexpression of either ced-3 or ced-4, two C. elegans cell death genes, can cause
cells that normally live to undergo programmed cell death
Running title: Cell killing by C. elegans cell death genes
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Department of Biology, Room 68-425
Massachusetts Institute of Technology
Cambridge, Massachusetts 02139
This chapter will be submitted for publication
73
Summary
Programmed cell death in the nematode Caenorhabditis elegans requires the actions
of the genes ced-3 and ced-4. We show that overexpression of either ced-3 or ced-4 in
specific neurons is sufficient to cause those neurons, which normally live, to undergo
a process morphologically and kinetically similar to programmed cell death. The
efficacy of cell killing by ced-3 or ced-4 is enhanced if the activity of the cell survival
gene ced-9 is eliminated. Overexpression of ced-3 can kill cells in the absence of
endogenous ced-4, but overexpression of ced-4 kills at most poorly in the absence of
endogenous ced-3. Protection by ced-9 against ced-3-induced killing requires ced-4
function. Our observations indicate that ced-3 and ced-4 can act cell autonomously to
cause programmed cell death and are consistent with a pathway for programmed cell
death in which ced-9 inhibits ced-4 function and ced-4 enhances ced-3 function.
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Introduction
Programmed cell death is a major and apparently universal aspect of metazoan
development and tissue homeostasis (Glilcksman, 1950; Ellis et al., 1991a).
Programmed cell death serves several functions, including the regulation of cell
number, the removal of deleterious cells and the shaping of tissues and organs.
Although a diversity of signals can cause different cells to undergo programmed cell
death (e.g. Barres et al., 1993; Vaux, 1993), the morphology and kinetics of programmed
cell deaths are in many cases highly similar (Stanisic et al., 1978; Cohen and Duke, 1984;
Martin et al., 1988; Arends and Wyllie, 1991), suggesting that the mechanisms
responsible for the programmed deaths of different cell types and of cells in different
organisms could well be the same.
During the development of the nematode Caenorhabditis elegans, 131 of the 1090
somatic cells generated undergo programmed cell death (Sulston and Horvitz, 1977;
Kimble and Hirsh, 1979; Sulston et al., 1983). Thirteen genes that affect various aspects
of the process of programmed cell death in C. elegans have been identified (Hedgecock
et al., 1983; Ellis and Horvitz, 1986; Ellis and Horvitz, 1991; Ellis et al., 1991b;
Hengartner et al., 1992; reviewed by Horvitz et al., 1994). Three of these genes control
the onset of the death process, six act in the phagocytosis of dying cells by their
neighbors, and one functions in the digestion of the DNA of cell corpses. Three
additional genes specify the fate of programmed cell death for a few specific cells that
die during development.
Of the three C. elegans genes that control the onset of programmed cell death,
two -- ced-3 and ced-4 (ced, cell death abnormal) -- are required for programmed cell
death to occur: loss-of-function mutations in either of these genes cause all 131 cells that
normally die instead to survive (Ellis and Horvitz, 1986). By contrast, the third gene --
ced-9 -- is needed to protect cells that normally survive from undergoing programmed
cell death: loss-of-function mutations in ced-9 cause cells that normally live instead to
undergo programmed cell death (Hengartner et al., 1992). The extra cell deaths that
occur in ced-9 loss-of-function mutants require the activities of ced-3 and ced-4,
indicating that ced-9 acts by preventing ced-3 and ced-4 from causing cell death.
Both ced-9 and ced-3 have known mammalian counterparts that function in cell
death. ced-9 encodes a protein similar in sequence to the human proto-oncoprotein Bcl-
2 (Hengartner and Horvitz, 1994), which like the CED-9 protein can protect cells from
programmed cell death (Vaux et al., 1988; Nunez et al., 1990; Hockenbery et al., 1991;
Garcia et al., 1992; Sentman et al., 1992; Strasser et al., 1992; reviewed by Williams and
Smith, 1993). Human bcl-2 expressed in transgenic C. elegans can protect nematode
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cells from undergoing programmed cell death (Vaux et al., 1992; Hengartner and
Horvitz, 1994a). Human bcl-2 also can rescue nematode cells that die as a consequence
of a ced-9 loss-of-function mutation, suggesting that bcl-2 might substitute functionally
for ced-9 (Hengartner and Horvitz, 1994a). Thus, ced-9 and bcl-2 seem to be structurally
similar and at least somewhat functionally interchangeable.
ced-3 encodes a protein similar in sequence to mammalian interleukin-1 3 (IL-1P)
converting enzyme (ICE) (Yuan et al., 1993), a cysteine protease isolated based on its
ability to cleave a 31 kD pro-IL-1 to generate the 17.5 kD mature cytokine (Cerretti et
al., 1992; Thornberry et al., 1992). Overexpression of either CED-3 protein or ICE can
cause rat fibroblasts to undergo programmed cell death (Miura et al., 1993).
Furthermore, the programmed cell death induced when chick dorsal-root ganglion
neurons are deprived of nerve growth factor can be inhibited by expression of the
cowpox virus protein crmA (Gagliardini et al., 1994), an inhibitor of ICE (Ray et al.,
1992); and mice harboring a disruption of the ICE gene are defective in Fas-mediated
apoptosis (Kuida et al., 1995). These observations indicate that cysteine proteases of the
CED-3/ICE family can cause mammalian cells to undergo programmed cell death and
suggest that such proteases act endogenously in the programmed deaths that follow
growth factor deprivation and Fas induction.
Both CED-3 and ICE are similar in sequence to the proteins encoded by the
mouse nedd-2 gene and its human homolog Ich-1, which can cause cell death when
overexpressed in either mouse fibroblasts or neuroblastoma cells (Kumar et al., 1994;
Wang et al., 1994), and to the product of the gene CPP32, which can cause cell death
when overexpressed in insect Sf9 cells (Fernandes-Alnemri et al., 1994). In addition, bcl-
2 can inhibit the cell deaths caused by the expression of the CED-3, ICE (Miura et al.,
1993) or NEDD-2/ICH-1 proteins (Kumar et al., 1994; Wang et al., 1994) or by the
deprivation of nerve growth factor (Gagliardini et al., 1994), suggesting that just as ced-3
function is inhibited by ced-9, the action of ICE-like cysteine proteases can be inhibited
by bcl-2.
Because mutations in either ced-3 or ced-4 block all naturally-occurring
programmed cell deaths in C. elegans (Ellis and Horvitz, 1986), both of these genes
normally must be functional for the proper execution of programmed cell death.
However, this observation does not reveal whether the expression of these genes would
suffice to cause a cell that would otherwise survive instead to undergo programmed cell
death. Nor does this observation reveal whether ced-3 and ced-4 act together, perhaps
encoding two components of a heteromeric protein complex, or sequentially, with the
activity of one needed only to cause the expression or activation of the other. To resolve
these issues, we performed the experiments described below.
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Results
Overexpression of either ced-3 or ced-4 can kill cells that normally live
To test if expression of ced-3 or ced-4 is sufficient to kill cells that normally live,
we placed cDNAs for each of these genes under the control of the promoter for the C.
elegans gene mec-7, which is expressed in the six touch neurons (ALML, ALMR, AVM,
PVM, PLML, and PLMR) and in a few other cells (Savage et al., 1989; M. Chalfie,
personal communication) (see Figure 1A). The Pmec-7ced-3 and Pmec-7ced-4 fusion
constructs were separately injected into wild-type animals, and lines containing
integrated copies of the constructs were established. We obtained three lines (Pmec-7ced-
3-1,--2,-3) containing integrated copies of Pmec-7ced-3 and four lines (Pmec-7ced-4-1, -2, -3,
-4) containing integrated copies of Pmec-7ced-4.
To determine if cells that normally express mec-7 were absent in animals carrying
the Pmec_7ced-3 or Pmec-7ced-4 transgenes, we scored animals for the presence or absence
of the two ALM neurons. We scored the left side of the animal for the presence of the
ALML neuron and the right side for the presence of the ALMR neuron. As shown in
Table 1, we observed that ALM cells were missing in some of the lines we obtained. For
example, ALMs were present on only 9/46 (20%) of sides scored in line Pmec-7ced-3-3
and on only 4/39 (10%) of sides scored in line Pmec-7ced-4-1. We established two lines
containing integrated arrays harboring both a Pmec-7ced-3 and a Pmec-7ced-4 fusion
construct (lines Pmec-7ced-3/4-1 and Pmec-7ced-3/4-2). Wild-type animals carrying these
arrays showed a slight loss of ALM neurons: ALMs were present on 35/37 (95%) and
45/46 (98%) of sides scored, respectively. Wild-type animals not carrying these arrays
always contained both ALMs (n=31), and animals expressing a Pmec-7lacZ construct
(jeIsl, J. Way, personal communication) had ALMs on 40/40 (100%) of sides scored,
suggesting that the presence of an array or the expression of any protein will not kill
these cells (also see below). These results suggest that overexpression of either ced-3 or
ced-4 is sufficient to kill the ALMs in wild-type animals.
Killing by overexpression of ced-3 or ced-4 is better in the presence of a loss-of-
function mutation in the endogenous ced-9 gene
Although as described above overexpression of either ced-3 or ced-4 caused the
deaths of ALM neurons, many ALMs survived in animals transgenic for these cell death
genes. Since the gene ced-9 can protect cells against cell death mediated by ced-3 and
ced-4, it seemed plausible that eliminating endogenous ced-9 function would result in
enhanced killing by a ced-3 or ced-4 transgene. To test this hypothesis, we introduced
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our ced-3 and ced-4 transgene constructs into ced-9(lf); ced-3 or ced-4 ced-9(lf) animals.
(ced-9 (lf) single-mutant animals die, making it impossible to overexpress ced-3 or ced-4 in
such a strain, but ced-9(lf); ced-3 and ced-4 ced-9 (lf) double-mutant animals are viable;
Hengartner et al., 1992).
As shown in Table 2A, lines containing a Pmec-7ced-3 transgene and the
chromosomal mutation ced-9(n2812) had fewer ALMs than did lines containing the
corresponding transgene in the presence of the wild-type ced-9 gene. For example, for
the Pmec-7ced-3-3 transgene, ALMs were present on 0/29 (0%) of sides scored in a ced-9;
ced-3 background, yet were present on 16/34 (47%) of sides scored in a ced-3
background. Similarly, lines containing a Pmec-7ced-4 transgene and the chromosomal
mutation ced-9(n2812) had fewer ALMs than did lines containing the corresponding
transgene in the presence of the wild-type ced-9 gene (Table 2B). For the Pmec-7ced-4 1
transgene, ALMs were present on 0/30 (0%) of sides scored in a ced-4 ced-9 background,
yet were present on 12/28 (43%) of sides scored in a ced-4 background. Lines containing
integrated copies of both a ced-3 and a ced-4 transgene also showed fewer ALMs
surviving in a ced-9(n2812) background (Tables 2A and 2B). In line Pmec-7ced-3/4-1, for
example, ALMs were present on only 16/37 (43%) of the sides scored in a ced-9; ced-3
background, but were present on 40/40 (100%) of sides scored in a ced-3 background
alone (Table 2A). We suspect that the double transgenes were not expressed at levels as
high as the single transgenes (see below), which might explain why killing in these lines
was reduced in comparison to killing in some of the lines with single transgenes. These
results suggest that killing by overexpression of either ced-3 or ced-4 is more efficient in
a mutant ced-9 background and are consistent with the hypothesis that ced-9 acts to
regulate negatively the activities of both ced-3 and ced-4 (Hengartner et al., 1992; see
Discussion). We also tested the effect of the ced-9 partial loss-of-function allele n1950
n2161 on ALM cell death in strains containing the Pmec-7ced-3-3 transgene and again
observed enhanced killing: ALMs were present on 1/15 (7%) of sides scored in an unc-
69(e587) ced-9(n1950 n2161) background. These results suggest that it is a reduction of
ced-9 activity that allows more efficient killing rather than a specific action of the ced-
9(n2812) allele.
The ced-9 gain-of-function allele n1950 is a point mutation that activates the CED-
9 protein and causes it to prevent the normal cell deaths that occur during C. elegans
development (Hengartner et al., 1992; Hengartner and Horvitz, 1994). We tested the
ability of ced-9(n1950) to prevent the deaths of ALM neurons in animals carrying Pmec-
7ced-13 or Pmec-7ced-4 transgenes. However, as shown in Table 3, the n1950 mutation did
not consistently decrease the abilities of these trangesnes to cause ALM death.
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Overexpression of ced-3 or ced-4 causes programmed cell death
The experiments described above indicated that overexpression of either ced-3 or
ced-4 can lead to an absence of ALM neurons. To determine if these neurons were
missing because they underwent programmed cell death, we directly observed the cell
divisions leading to the formation of the mec-7-expressing neuron PVM (Chalfie, 1993)
in animals carrying transgenes Pmec-7ced-3-1, Pmec-7ced-3-3, and Pmec-7ced-3/4-1 in a ced-
9(n2812); ced-3(n717) background or transgene Pmec-7ced-4-1 in a ced-4(n162) ced-
9(n2812) background. As illustrated in Figure 2A, presumptive PVM neurons in these
lines showed the characteristic refractile appearance of programmed cell deaths viewed
using Nomarski optics (12 animals observed); these deaths were morphologically
indistinguishable from normal programmed cell deaths. We observed four PVMs
through the entire cell death process. Two PVMs died and disappeared within an hour
of their initial refractility, one after approximately an hour and a half and one after
approximately two hours. These kinetics are similar to those of some normal
programmed cell deaths that occur during the L1 stage (Sulston and Horvitz, 1977).
Thus, these ectopic cell deaths were both morphologically and kinetically similar to
normal cell deaths as well.
We also analyzed the ultrastructure of a cell corpse resulting from a PVM cell
death. Figure 2C shows a PVM cell that died and was engulfed by a neighboring cell.
The darkly staining cytoplasm and nucleus, the small cytoplasmic volume, and the
darkly staining matter within the nucleus are all characteristic features of cells that
normally die by programmed cell death, suggesting that the deaths we observed were
ultrastructurally similar to normal programmed cell deaths.
To establish further that the deaths caused by overexpression of ced-3 or ced-4
were similar to programmed cell deaths, we examined L1 ced-l(e1735); ced-4(n1162) ced-
9(n2812) animals containing the Pmec-7ced-4-1 transgene for the presence of unengulfed
ALM corpses. Animals carrying the ced-l(el 735) mutation fail to engulf many of the
corpses that result from programmed cell death (Hedgecock et al., 1983), causing these
corpses to persist for hours or even days. We observed corpses on 11/40 sides near the
BDU cell (the sister cell of the ALM), and we observed corpses in the normal location of
the ALM on 2/40 sides, suggesting that the ALMs often died before migrating
posteriorly, yet somtimes died after migration was complete. 27/40 sides scored did
not have observable corpses probably because the penetrence of ced-1 (el735) can be
quite low (1/100 sides scored for the NSM sister had an NSM sister corpse; Ellis et al.,
1991b). We obtained similar results using the Pmec-7ced-3-3 transgene in a ced-3(n3002)
background (data not shown). These findings suggest that the gene ced-l which is
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required for engulfment of normal programmed cell death corpses, is also required for
the engulfment of the ectopic ALM cell deaths.
The gene nuc-l is required for the degradation of DNA of cells that die by
programmed cell death (Sulston, 1976; Hevelone and Hartman, 1988). We examined the
left sides of ced-3 (n3002); nuc-l(e1392) animals containing the transgene Pmec-7ced-3 -3
that were stained with the DNA stain 4,6-Diamidino-2-phenylindole (DAPI). Near the
position of the BDU cell, 7/10 sides had DAPI-positive structures that did not
correspond to visible nuclei when viewed using Nomarski optics. These findings
suggest that the gene nuc-1 which is required for the degradation of DNA of normally
dying cells, is also required for the degradation of DNA of ectopic ALM cell deaths.
Programmed cell death caused by overexpression of ced-3 or ced-4 requires functional
ced-3 and ced-4 products
To determine if expression of a functional ced-3 or ced-4 cDNA was needed to kill
cells; in the experiments described above, we constructed and analyzed lines containing
ced-3 or ced-4 transgenes with missense mutations. Since we were not interested in
scoring a given array in a number of different genetic backgrounds where the array
must remain identical for accurate results, the above constructs were maintained as
extrachromosomal arrays (which are easier to generate than integrated arrays; Fire,
1986; Way and Chalfie, 1988) and were compared with wild-type ced-3 and ced-4
constructs maintained on extrachromosomal arrays. As shown in Table 4A, 100% of the
ALMs survived in ced-9(n2812); ced-3(n717) animals carrying Pmec-7ced-3 fusion
constructs containing a cysteine-to-alanine substitution at position 358 of the CED-3
protein. This mutation alters a residue that corresponds to a cysteine essential for the
enzymatic activity of ICE (Cerretti et al., 1992; Thornberry et al., 1992) and presumably
for the activity of CED-3 as well. By contrast, only about 50% of ALMs survived in
animals containing the wild-type constructs. This result suggests that active CED-3 is
needed for ALM cell death and supports the notion that CED-3 is a cysteine protease.
Similarly, 100% of the ALMs survived in ced-4(n1162) ced-9(n2812) animals
carrying Pmec_7ced-4 fusions containing an isoleucine-to-asparagine substitution at
position 258 of the CED-4 protein (Table 4B). This mutation introduces a change
identical to that found in the mutant ced-4 allele n1948 (Yuan and Horvitz, 1992). Only
about 50%/0 of ALMs survived in animals containing the wild-type ced-4 constructs. This
result suggests that active CED-4 is needed for ALM killing and confirms that the
change observed in n1948 animals is the cause of the Ced-4 mutant phenotype. Thus,
killing by overexpression of ced-3 or ced-4 requires transgenes that encode functional
CED-3 or CED-4 proteins.
80
To determine if the deaths of the ALM neurons were induced specifically by
overexpression of the cell death proteins CED-3 and CED-4, we tested constructs that
should have overexpressed three other proteins under the control of the mec-7
promoter: E. coli P-galactosidase (using a worm strain that carries the insertion jeIsl; J.
Way, personal communication); murine ICE; and C. elegans NCC-1 protein (which is
similar to cdc-2 kinase; P. Sternberg, personal communication). (ICE and CDC-2 have
been implicated in mammalian cell death; Miura et al., 1994; Shi et al., 1994.) The
presence of these constructs in ced-9; ced-3 or ced-4 ced-9 worms did not cause ALM cell
death (data not shown), suggesting that it is not simply excess or foreign protein that
killed the ALMs in the experiments described above.
Ectopic killing by overexpression of ced-4 may require ced-3 function
To examine the requirement for endogenous ced-3 in the killing of ALMs by Pmec-
7ced--4 transgenes, we introduced these transgenes into ced-3 mutant strains. Table 5
shows that killing of ALMs in all four Pmec-7ced-4 insertion lines was strongly inhibited
by reduction-of-function mutations in the endogenous ced-3 gene by comparison with
the level of killing in a wild-type ced-3 background. For example, in line Pmec-7ced-4-1
ALMs survived on 4/39 (10%) of sides scored in a wild-type background but survived
on 27/38 (71%) of sides scored in a ced-3 background. Similarly, in line Pmec-7ced-4-1
ALMs survived on 0/30 (0%) of sides scored in a ced-4 ced-9 background but survived
on 2'7/38 (71%) of sides scored in a ced-4 ced-9; ced-3 background. Interestingly, even
though reducing ced-9 function enhanced killing of the ALM neurons with respect to a
wild-type background in the presence of a wild-type endogenous ced-3 gene (ced-4 ced-9
column vs. wild-type column), killing was greatly reduced in a strain containing
mutations in both ced-9 and ced-3 (ced-4 ced-9; ced-3 column). These results suggest that
killing by Pmec-7ced-4 is greatly facilitated by the presence of endogenous ced-3 and that
the need for ced-3 function cannot be overcome by eliminating the function of ced-9
using a mutation which is likely to have little if any ced-9 function based on both genetic
and molecular criteria (Hengartner et al., 1994; S. Shaham, unpublished data).
To assess whether only the ced-3 allele n717 used in the above experiments could
prevent killing by Pmec-7ced-4 constructs, and to assess if more penetrant alleles of ced-3
could block killing more efficiently we examined the abilities of several ced-3 alleles to
inhibit killing by ced-4 overexpression. As shown in Table 6, the better the ability of a
ced-3 mutation to cause survival of cells that normally die, the better was its ability to
prevent killing of ALM neurons by Pmec-7ced-4-1. Animals carrying the ced-3 allele
n1040, for example, contained an average of 7.6 extra cells in the anterior pharynx.
These cells would have normally died in wild-type animals. ALMs survived on 35/64
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(55%) of sides scored in line Pmec-7ced-4-1 containing the n1040 mutation. However,
animals harboring the ced-3 allele, n2433, contained an average of 12.4 extra cells in the
anterior pharynx, and ALMs survived on 33/41 (80%) of sides scored in line Pmec-7ced-4-
1 containing this mutation. Although n2433 is the most severe ced-3 allele known (S.
Shaham, unpublished observations; M. Hengartner, personal communication), neither
n2433 nor any other ced-3 allele characterized to date has been shown to completely
eliminate ced-3 function. None of the currently characterized ced-3 alleles is clearly a
null allele by both molecular and genetic criteria (S. Shaham and H. R. Horvitz,
unpublished data; Yuan et al., 1993). Thus, it is possible that the complete elimination
of ced-3 function would totally prevent killing by ectopic ced-4 expression in this line
and hence that ALM killing by a ced-4 trangene absolutely requires ced-3 function.
Ectopic killing by ced-3 overexpression does not require ced-4 function
Similarly, to examine the requirement for endogenous ced-4 in the killing of
ALMs by Pmec-7ced-3 trangenes we introduced these transgenes into ced-4 mutant
strains. For these experiments we used the ced-4 allele n1162, which is a nonsense
mutation that should result in premature termination of the CED-4 protein at amino
acid 79. No detectable ced-4 RNA or protein is produced by this strain (Yuan and
Horvitz, 1992; S. Shaham and H. R. Horvitz, unpublished results), and thus this allele is
an excellent candidate for being a molecular null allele. Columns 1 and 2 of Table 7
show that ALM survival in Pmec-7ced-3- containing lines is not consistently greater in a
ced-4(nl 1 62) mutant background than in a wild-type background. For example, in line
Pmec..7ced-3 -2 ALMs survived on 16/38 (42%) of sides scored in a wild-type background
and on 18/61 (30%) of sides scored in a ced-4(n1162) background. These results suggest
that killing by ced-3 overexpression might be different from killing by ced-4
overexpression. Supporting this notion, eventhough killing in line Pmec-7ced-4-1 is more
efficient in a wild-type background than lines Pmec-7ced-3-2 and Pmec-7ced-3-3, killing in
this line is much weaker in a ced-3 mutant background than lines Pmec-7ced-3-2 and Prmec-
7ced-3-3 in a ced-4 mutant background. Similarly, in line Pmec-7ced-3-3 ALMs survived
on 9/'46 (20%) of sides scored in a wild-type background and on 8/30 (27%) of sides
scored in a ced-4 ced-9; ced-3 background (Table 7), whereas in the same two
backgrounds in line Pmec-7ced-4-l, ALMs survived on 4/39 (10%) and 27/38 (71%) of
sides scored, respectively (Table 5). This observation suggests that killing by a ced-4
construct might be more dependent on endogenous ced-3 than killing by ced-3 is
dependent on endogenous ced-4.
When we compared the extent of ALM survival in Pmec-7ced-3- containing lines in
a ced-9; ced-3 background with survival in a ced-4 ced-9; ced-3 background we noticed
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that the latter background had reduced killing, although this effect was still smaller
than the effect a ced-3 mutant has on Pmec_7ced-4-induced killing. As shown in Table 7,
fewer ALMs survived in the ced-9; ced-3 background than in the ced-4 ced-9; ced-3
background in all Pmec_7ced-3-containing lines. In line Pmec-7ced-3-2, for example, ALMs
survived on 0/37 (0%) of sides scored in a ced-9; ced-3 background, but on 12/32 (37%)
of sides scored in a ced-4 ced-9; ced-3 background. These results suggest that in the
absence of endogenous ced-9, ced-4 can, to some extent, influence killing by ced-3
overexpression, suggesting that endogenous ced-4 can help killing by overexpression of
ced-3. (see Discussion).
Protection by ced-9 against ced-3-induced ALM killing requires ced-4 function
As described above, endogenous ced-9 function inhibited killing by
overexpression of ced-3 and ced-4. Specifically, ALM survival in Pmec-7ced-3 and Pmec-
7ced-4 lines was greater in ced-9(+) strains than in strains containing a ced-9 loss-of-
function mutation (Table 2A). Does ced-9 act to inhibit ced-3 function, ced-4 function or
both? To address this issue, we examined whether ced-9 requires ced-4 function to
inhibit killing by ced-3-overexpression. Table 8A shows that whereas for Pmec-7ced-3-
containing ced-4(+) lines ALMs survive better if ced-9(+) function is present, ALMs in
Pmec.7ced-3-containing ced-4(-) lines survive to similar extents in ced-9(+) and ced-9
mutant backgrounds. For example, in line Pmec-7ced-3-2 ALMs survived on 5/29 (17%)
of sides scored in a ced-4; ced-3 background and on 12/32 (37%) of sides scored in a ced-4
ced-9; ced-3 background, i.e. ced-9 function did not protect against killing by ced-3-
overexpression in the absence of ced-4 function. These results suggest that endogenous
ced-9 inhibits the ced-3 activity in ced-3-overexpression strains by acting at least in part
via ced-4. A similar analysis using Pmec-7ced-4 transgenes is presented in Table 8B.
However, since killing by a Pmec-7ced-4 transgene in a ced-3(-) background was
inefficient, we cannot assess whether ced-3 is required for protection from ced-4 killing
by ced-9.
Overexpression of ced-9 can protect cells killed by overexpression of ced-4
Since endogenous ced-9 could protect against cell death induced by ced-4-
overexpression we wanted to assess whether overexpression of ced-9 would have a
similar effect. We tested whether overexpression of ced-9 in mec-7-expressing cells
would prevent the ectopic cell deaths caused by overexpression of ced-4 in these cells.
We examined the effect of a Pmec-7ced-9 fusion (carried as an extrachromosomal array)
on survival of ALMs in line Pmec-7ced-4-3 in a ced-4 ced-9 background. We found that in
lines transgenic for both Pmec-7ced-4 and Pmec-7ced-9, more ALMs survived than in the
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absence of Pmec-7ced-9 or in the presence of a Pmec-7ced-9 construct containing a
frameshift mutation in the ced-9 gene (see Table 9 and Experimental Procedures). These
results suggest that overexpression of ced-9 is sufficient to protect mec-7-expressing cells
from killing by ced-4 overexpression. We were not able to protect against killing by
overexpression of Pmec-7ced-3-3 with a Pmec-7ced-9 transgene (data not shown).
Overexpression of either ced-3 or ced-4 can kill VD and DD neurons
To see if overexpression of ced-3 or ced-4 could kill cells other than mec-7-
expressing cells, we fused a ced-3 or ced-4 cDNA to the promoter for the unc-30 gene,
which is expressed in the VD and DD neurons as well as in a few other cells (Jin et al.,
1994; Y. Jin, personal communication) (Figure 1B) and obtained lines containing
integrated copies of either Punc-3oced-3 or Punc-3oced-4. As Table 10 shows, we observed
that Punc-30ced-3 and Punc-3oced-4 transgenes could kill DD neurons in ced-9; ced-3 and
ced-4 ced-9 backgrounds, respectively.
We obtained one line containing integrated copies of both Punc-30ced-3 and Plnc-
3ocecd-4 (Punc-30ced-3/4-1). We observed DDs missing in this line as well in both ced-9;
ced-3 and ced-4 ced-9 backgrounds (data not shown). To confirm that these cells were
missing because they were dying by programmed cell death, we observed the pattern of
cell divisions leading to the formation of eight of the 13 VD neurons in the ventral cord
of a transgenic animal carrying both unc-30 fusion constructs. Figure 2B shows that two
of these cells underwent a process morphologically similar to normal programmed cell
death.
Table 10 also shows that an endogenous ced-4 mutation inhibited killing by a
Punc-3oced-3 transgene in ced-9(-) animals and that an endogenous ced-3 mutation
inhibited killing by a Punc-30ced-4 transgene in ced-9(-) animals. These results parallel
our findings with the mec-7 promoter fusion constructs. None of our lines showed
extensive killing of DD neurons in a ced-9(+) background, making it impossible to assess
if ced-3 can bypass the requirement for ced-4 in a ced-9(+) animal, or if ced-4 can bypass
the requirement for ced-3 in a ced-9(+) animal. That ced-3 and ced-4 transgenes failed to
kill DD neurons in ced-9 (+) animals might be a consequence of insufficient expression
from the unc-30 promoter (we never observed complete killing even in a ced-9 mutant
background). Alternatively, this difference might reflect a difference between tunc-30-
and nmec-7- expressing cells.
Discussion
To study the requirements for ced-3 and ced-4 in killing cells by programmed cell
death and to examine the interactions between these genes and with the gene ced-9 we
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expressed ced-3 and ced-4 as transgenes under the control of two cell-type-specific
promoters, the Pmec-7 promoter, which causes gene expression within a set of
mechanosensory neurons, including the ALMs (Savage et al., 1989), and the Punc-30
promoter, which causes gene expression in a different set of neurons, including the DDs
(Jin et al., 1995). Expression of ced-3 or ced-4 killed both ALMs and DDs. We suggest
that expression of ced-3 and ced-4 under the control of other promoters could provide a
useful method for specific cell ablation. Such a method would complement that of laser
microsurgery (e.g., Sulston and White, 1980; Avery and Horvitz, 1987; Bargmann et al.,
1993), which has been used extensively to define cell functions and reveal cell
interactions in C. elegans: whereas laser microsurgery allows the ready killing of any
cell, relatively few cells and animals can be analyzed using this approach. The use of
ced-3 or ced-4 transgenes for cell ablations could allow many cells at many times of
development to be killed and could generate sufficient numbers of animals lacking
specific cells for biochemical studies or mutant hunts. If a strongly expressing promoter
is used, the ablation can be done in a wild-type background (as in the case of the mec-7
promoter). If a weaker promoter is used, the ablation should be done in either a ced-9;
ced-3 or a ced-4 ced-9 background (as with the unc-30 promoter).
Killing by overexpression of ced-3 or ced-4 is similar to normal programmed cell
death
The ectopic cell deaths we observed in lines carrying either Pmec-7 or Punc-30
fusion constructs to ced-3 or ced-4 were similar to programmed cell deaths by a number
of criteria. First, ectopically dying cells had a characteristic refractile appearance when
viewed with Nomarski optics, as do normal programmed cell deaths. Second, the
kinetics of the cell death process, from the initial appearance of a refractile body to the
disappearance of the cell were similar to the kinetics of normal cell deaths that occur
during the same developmental stage. Third, the characteristic ultrastructural features
of programmed cell death -- darkly staining cytoplasm, reduced cytoplasmic volume,
and darkly staining nuclear matter -- were present in the ectopically dying cells.
Fourth, mutations in a gene required for the engulfment of corpses resulting from
normal cell deaths prevented the engulfment of corpses from ectopic cell deaths,
suggesting that the ectopic cell deaths resembled normal cell deaths. Fifth, a mutation
that prevents the degradation of the DNA of cells that normally die also prevented the
degradation of the DNA of ALM cells killed ectopically. Sixth, the extent of killing by
ced-3 or ced-4 overexpression was influenced by endogenous mutations in genes (ced-3,
ced-4 and ced-9) known to affect normal programmed cell deaths, strongly suggesting
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that the molecular components responsible for the ectopic cell deaths correspond to
those involved in normal programmed cell deaths.
ced-3, ced-4 and ced-9 act cell autonomously
All of the ectopic deaths we observed were of cells known to express the
promoter we used. No surrounding cells were ever observed to die. These results
strongly suggest that killing by overexpression of either ced-3 or ced-4 is cell
autonomous. Previously, genetic mosaic analyses demonstrated that wild-type copies
of ced-3 and ced-4 were required in lineages generating cells that normally died to cause
the deaths of those cells (Yuan and Horvitz, 1990). These experiments, however, did not
offer a cellular resolution capable of limiting the requirement for these genes to the
dying cell itself. Our results demonstrate that ced-3 and ced-4 can act cell autonomously
to cause cell death, strongly supporting the hypothesis that ced-3 and ced-4 normally do
so. In addition, we have found that ced-9 can act cell autonomously to prevent cell
death, since overexpression of ced-9 in mec-7-expressing cells rescued killing by
overexpression of ced-4 in the same cells.
ced-3, ced-4 and ced-9 might all normally be expressed in surviving cells
As discussed above, we found that ALM killing by a ced-4 transgene was greatly
reduced and possibly eliminated in animals that lack ced-3 function, suggesting that ced-
4-incduced killing requires ced-3 activity (see Tables 5 and 6). Nonetheless, ced-4
trangenes cause the deaths of ALMs in wild-type animals (see Table 1). Since ced-3 acts
cell autonomously, together these findings suggest that wild-type ALMs have ced-3
function. Similarly, ALM killing by either a ced-3 or a ced-4 transgene was greater in
animals that lacked ced-9 function than in ced-9(+) animals (see Tables 2A, 2B), and ced-9
acts cell autonomously. These findings suggest that wild-type ALMs have ced-9
function. Finally, protection by ced-9 against ALM killing by a ced-3 transgene required
ced-4 function (see Table 8), and yet ALMs did not require the expression of a ced-4
transgene to be protected by ced-9 (see Table 2A). Since ced-4 also acts cell
autonomously, together these findings suggest that wild-type ALMs have ced-4
function. In short, our observations are consistent with the hypothesis that surviving
ALMs contain not only the protective function of ced-9 but also the killing functions of
ced-3 and ced-4.
Presumably these killing functions are inhibited in the ALMs directly or
indirectly by the protective function of ced-9. Since overexpression of either ced-3 or ced-
4 in the ALMs can overcome the protective function of ced-9 (see Table 1), we propose
that in these cells, and perhaps more generally in all C. elegans cells, there is a
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comlpetition between functions that activate (e.g., ced-3 and ced-4) and functions that
inhibit (e.g., ced-9) programmed cell death. Cells might initiate programmed cell death
either by reducing a protective activity or by increasing a killing activity. Interestingly,
not all of our overexpression lines could overcome the protective effects of ced-9 (see
Table 1). This observation suggests that the dosage of the ced-3 or the ced-4 product in
these lines was insufficient to overcome ced-9 protection. Supporting this notion is our
observation that lines heterozygous for the insertions Pmec-7ced-3-2, Pmec-7ced-3-3, and
Pmec-7ced-4-1 showed little ALM death. For example, ALMs survived on 23/25 (92%) of
sides scored in animals heterozygous for the Pmec-7ced-4-1 transgene in a wild-type
background, and ALMs survived on 19/20 (95%) sides scored in animals heterozygous
for the Pmec-7ced-3-3 transgene in a wild-type background, indicating that gene dosage is
important for killing by either ced-3 or ced-4.
Our hypothesis that surviving cells in C. elegans might contain antagonistic
protective and killing cell death functions is consistent with a number of findings from
studies of programmed cell death in other organisms. For example, in many cases cells
can be induced to undergo programmed cell death in the absence of macromolecular
synthesis (reviewed by Vaux and Weissman, 1993), suggesting that the protein
components needed for cell death are present in living cells. Similarly, that many, and
perhaps all, mammalian cells are protected by exogenous growth factors from dying by
programmed cell death has led Raff (1992) to propose that all cells contain cell-death
killing factors and thus are "poised for death."
A genetic pathway for programmed cell death in C. elegans
Killing by overexpression of ced-3 did not require endogenous ced-4 function,
whereas killing by overexpression of ced-4 may require endogenous ced-3 function.
These results suggest either that (1) ced-4 acts upstream of ced-3 and ced-4 function can
be bypassed by high levels of ced-3 activity, or that (2) ced-3 and ced-4 act in parallel,
with ced-3 perhaps having a greater ability to kill. The former model is supported by
the observation that ced-9 acts via ced-4 to protect against cell death mediated by ced-3.
Taken together, these findings suggest that programmed cell death in C. elegans
involves a linear pathway in which ced-9 antagonizes the function of ced-4, which in
turn potentiates or activates ced-3.
Interestingly, in the absence but not in the presence of ced-9 function, ALM
killing by overexpression of ced-3 is potentiated by the presence of a functional ced-4
gene. Why might ced-4 function matter only if ced-9 is inactive? The ALMs are cells that
normally live, and as such presumably have active ced-9 function. This ced-9 activity
might inhibit any endogenous ced-4 function, so that the presence or absence of a ced-
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4(+) allele would be irrelevant. However, if ced-9 were inactivated by mutation, ced-4
might become functional in the ALMs, thus potentiating killing by a ced-3 transgene.
The position of ced-4 in our proposed pathway suggests a similarity between the
action of the CED-4 protein and the action of the mammalian Bax protein.
Overexpression of Bax results in cell death just as does overexpression of ced-4, and bcl-2
overexpression blocks this death (Oltavi et al., 1993) just as ced-9 overexpression blocks
death caused by ced-4 overexpression. Although the CED-4 and Bax proteins do not
share obvious sequence similarity, they might similarly mediate signaling between a
negative regulator of cell death (CED-9/Bcl-2) and a cysteine-protease activator of cell
death (CED-3/ICE-like protease). Alternatively, because both ced-9 and ced-3 have
mammalian counterparts that are involved in programmed cell death, it is possible that
a protein similar in both structure and function to CED-4 might exist in mammals, be
negatively regulated by bcl-2, and positively activate an ICE-like cysteine protease to
cause programmed cell death.
Experimental Procedures
General Methods and Strains
We cultured C. elegans as described by Brenner (1974). All strains were grown at
20°C. The wild-type strain used was C. elegans variety Bristol strain N2. Genetic
nomenclature follows the standard C. elegans system (Horvitz et al., 1979). The
mutations used have been described by Ellis and Horvitz (1986), Hedgecock et al.
(1983), Hengartner et al. (1992), Sulston (1976), or were isolated by us. These mutations
are listed below:
LG I: ced-l (el 735)
LG III: ced-4(n1162), ced-9(n2812, n1950, n1950 n2161), unc-69(e587)
LG IV: ced-3(n717, n718, n1040, n1129, n2433, n3002)
LG X: nuc-l(e1392), lin-15(n765)
Allele designations for the integrated lines are as follows: Pmec-7ced-3-l is nIs33, Pmec-
7ced-3 -2 is nIs38, Pmec-7ced-3-3 is nIs50, Pmec-7ced-4-1 is nIs31, Pmec-7ced-4-2 is nIs44, Pmec
7ced-4-3 is nIs47, Pmec_7ced-4-4 is nIs45, Pmec_7ced-3 /4-1 is nIs32, Pmec-7ced-3 /4-2 is nIs29,
Punc-30ced-4-1 is nIs46, and Punc-30ced-4-2 is nIs48.
The integrated mec-7-lacZ fusion construct is designated as allele jeIsl (J. Way, personal
communication).
Plasmid Constructions
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Pmec-7ced-3: the vector pPD52.102 (A. Fire, M. Hamelin, and J. Culotti, personal
communication) was digested with the restriction enzymes NheI and EcoRV and was
ligated to an SpeI-SmaI fragment obtained from plasmid pS126, which contains the full
length ced-3 cDNA. Pmec-7ced-4: the vector pPD52.102 was digested with the restriction
enzymes NheI and EcoRV and was ligated to an SpeI-SmaI fragment obtained from
plasmid pS125, which contains a full length ced-4 cDNA. Punc-3oced-3: plasmid pS12 6
was digested with the enzyme SpeI, dephosphorylated using calf intestinal alkaline
phosphatase (New EIlgland Biolabs, Beverly, MA) and ligated to a 3.5 kb XbaI fragment
that contains non-coding sequences upstream of the unc-30 start codon sufficient to
express a lacZ reporter gene in the VD and DD neurons of C. elegans (Jin et al., 1994; Y.
Jin, personal communication). Punc-30ced-4: plasmid pS125 was digested with the
enzyme SpeI as above and ligated to the same XbaI fragment used to construct Punc-
30ced-3. Pmec-7ced-9: the ced-9 cDNA insert of plasmid B30 (Hengartner and Horvitz,
1994b) was amplified using the polymerase chain reaction and cloned into the vector
pPD52.102 using its NheI and EcoRV sites. Pmec-7ced-9(f): plasmid Pmnec-7ced-9 was
digested with BamHI, the overhangs were re-polymerized with Klenow enzyme and
religated to create a frameshift mutation (Hengartner and Horvitz, 1994b). Plasmid
pS172 was made as follows: we replaced the sequence TG at the codon encoding
cysteine 358 of CED-3 with the sequence GC using an oligonucleotide mediated site-
directed mutagenesis kit and following the instructions of the manufacturer
(Amersham, Arlington Heights, IL). An oligonucleotide that encodes the peptide
QAARG (5' CGTTTTTGTGCAGGCTGCTCGAGGCGAACGTCGT 3') was used to
introduce the mutation, and plasmid pS126 was used as the template. The sequence of
the entire mutated plasmid was determined to confirm that only the desired mutation
was introduced. The resulting plasmid was then digested with the enzymes SpeI and
Smal and ligated to the plasmid pPD52.102 as described above to generate plasmid
pS172. Plasmid pS178 (which contains a T-to-A substitution at the codon encoding
isoleucine 258 of CED-4) was made as above except that an oligonucleotide encoding
the peptide TNRWA (5' GCTCCTGAGCCCAACGATTTGTTTCTTCTTGAACT 3') was
used to introduce the mutation, and plasmid pS125 was used as the template.
Germline transformation and integration of extrachromosomal arrays
Our procedure for microinjection and germline transformation followed that of
Fire (1986) and Mello et al. (1991). DNA for injections was purified using a Qiagen
system and following the instructions of the manufacturer (Qiagen Inc., Chatsworth,
CA). The concentrations of all plasmids used for injections were between 50-100 ,ug/ml.
All constructs were co-injected with the pRF4 plasmid, which contains the rol-6(su1006)
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allele as a dominant marker. Animals carrying the pRF4 plasmid exhibit a roller (Rol)
phenotype. We transformed strains of genotype ced-9(n2812); ced-3(n717), ced-4(nl162)
ced-9(n2812), or N2. Approximately 30 animals were injected in each experiment, and
50-100 F1 Rol animals were picked onto separate plates. F1 animals segregating Rol
progeny were established as lines containing extrachromosomal arrays (Way and
Chalfie, 1988). To assay the activity of Pmec-7ced-9 and Pmec-7ced-9(f) we injected animals
of genotype ced-4(n 1162) ced-9(n2812); nIs45; lin-15(n765) with each plasmid and with a
plasmid containing the wild-type lin-15 gene (Clark et al., 1994); X. Lu, personal
communication). Approximately 40 F1 non-Lin-15 animals were obtained in each
experiment, and lines transmitting the non-Lin-15 phenotype were established.
To obtain lines containing integrated copies of the Pmec-7ced-3 , Pmec-7ced-4, Punc-
30cea!-3, or Punc-30ced-4 constructs, we exposed a plate of worms containing a given
construct as an extrachromosomal array to y-rays or X-rays at a dose of 4500 rads. 30-50
fourth larval stage animals (L4s) were picked from the plate onto a separate plate and
allowed to generate self progeny. F1 Rol progeny of the mutagenized animals were
picked onto individual plates and allowed to generate self progeny. Six to eight Rol F2
animals were picked from each F1 plate and allowed to generate self progeny. F2 plates
containing 100% Rol animals were maintained as integrated lines. The integration event
was confirmed by a cross with wild-type animals. Putative heterozygote animals from
these crosses were allowed to generate self progeny and shown to segregate
homozygous Rol animals at a frequencey of approximately 1 in 3 animals picked. These
results also showed that all our integrated lines had a dominant Rol phenotype. All
integrated strains we obtained were backcrossed at least twice either to N2 or to another
strain when appropriate. Overall, we screened approximately 30,000 F2 animals to
obtain three independent Pmec-7ced-3 integrants, 30,000 F2 animals to obtain four
independent Pmec-7ced-4 integrants, 10,000 F2 animals to obtain two independent Punc-
3o ced-3 integrants, 10,000 F2 animals to obtain 2 independent Punc-30ced-4 integrants,
5,000 F2 animals to obtain two independent integrants containing both the Pmec-7ced-3
and Pmec-7ced-4 constructs, and 1,000 F2 animals to obtain one integrant containing both
Punc-3oced-3 and Pznc-3oced-4 constructs. None of the integrated lines used in our
experiments exhibited any obvious phenotype besides the Rol, Mec, or Unc-30
phenotypes.
Assays for ALM and DD cell death
ALM cell death was assayed by scoring transgenic animals for the presence of
ALM nuclei as follows: approximately 40 early L1 animals were mounted onto a drop of
50 mM NaN3 in M9 buffer (Sulston and Hodgkin, 1988) on a slide containing a pad of
90
5% agar in water and were covered with a coverslip. Animals were then observed
using Nomarski optics (Sulston and Horvitz, 1977). The Rol phenotype conferred by
the pRF4 plasmid is not expressed in L1 larvae, which thus are easier to score for the
presence or absence of the ALMs. The left side of animals was scored for the presence
of an ALML nucleus, and the right side of the animals was scored for the presence of
the ALMR nucleus. Occasionally, we scored both sides of an individual animal;
however, we avoided scoring sides that were not easily visible. When scoring ALM
survival in lines containing extrachromosomal arrays of a given construct we had to
address the fact that not all L1 animals we scored would contain the transgene. After
scoring ls for the presence or absence of ALMs, we therefore allowed these animals to
mature; only Rol animals or animals segregating Rol progeny were included in our
data.
DD cell death was assayed as follows. Young L1 animals (at a stage prior to the
migration of the P cell nuclei) for an integrated line were scored using Nomarski optics
for the presence of 15 neuronal nuclei located between the retro-vesicular ganglion and
the pre-anal ganglion. Four of these 15 nuclei are DD nuclei (Sulston and Horvitz,
1977), some of which are missing in strains containing Punc-3oced-3 or Punc-30ced-4
constructs.
We also directly observed the deaths of PVM neurons in ced-9(n2812); ced-3(n717)
Pmec-7ced-3/4-1 and in ced-4(n1162) ced-9(n2812); Pmec-7ced-4- animals by following the
QL cell lineage in living larvae (n=12). Occasionally, we also saw the sister of the PVM
neuron, SDQL, undergo programmed cell death. The mec-7 promoter is known to be
weakly expressed in this cell (M. Chalfie, personal communication), supporting our
hypothesis that the level of overexpression of ced-3 or ced-4 is important for the
penetrence of cell killing. We also directly observed the deaths of the VD neurons in
one ced-9(n2812); ced-3(n717); Punc-30ced-3 /4-1 animal by following the P5-P12 cell
lineages in that animal.
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Figure 1. Overexpression constructs.
(A) Pmec-7ced-3 and Pmec-7ced-4 constructs. (B) Punc-30ced-3 and Punc-3oced-4 constructs.
Open boxes indicate the mec-7 or unc-30 promoters, gray boxes indicate ced-4 sequences,
hatched boxes indicate ced-3 sequences, black boxes indicate the unc-54 3' untranslated
region (UTR). See Experimental Procedures for details.
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Figure 2. Cell death induced by overexpression of ced-3 and ced-4 resembles normal
programmed cell death.
(A) Nomarski photomicrograph of a dying PVM cell (arrow) in a ced-9 (n2812); ced-
3(n717) animal carrying the Pmec-7ced-3/4-1 transgene (see text for details). Anterior is to
the left; dorsal is on top.
(B) Nomarski photomicrograph of dying VD5 (small arrow) and VD6 (large arrow)
neurons in a ced-9(n2812); ced-3(n717) animal carrying the Punc-30ced-3/4 transgene.
Anterior is to the left; dorsal is on top.
(C) Electron microscope photomicrograph showing a dying PVM cell (arrow) located
dorsolaterally posterior to the primordial gonad in an L1 animal. The cell was engulfed
by a neighboring hypodermal cell (see text for details).
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Figure 3. Model for programmed cell death in C. elegans
ced-4 acts upstream of ced-3 to activate it and ced-9 is genetically upstream of ced-4,
suggesting that ced-9 can negatively regulate ced-4 by acting biochemically upstream
(left) or downstream (right) of ced-4. See text for additional details.
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Chapter 4
The C. elegans cell death gene ced-4 encodes both death-promoting and death-
preventing transcripts
Shai Shaham and H. Robert Horvitz
Howard Hughes Medical Institute,
Department of Biology, Room 68-425,
Massachusetts Institute of Technology
Cambridge, Massachusetts 02139, USA
This chapter will be submitted for publication
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MUTATIONS in the gene ced-4 prevent programmed cell death in C. elegans.
Sequence comparison of ced-4 genes from the related nematodes C. briggsae and C.
vulgaris revealed that the third intron of these genes is conserved at its 3' end. We
have shown that this region can serve as an alternatively spliced exon resulting in a
novel ced-4 transcript which is 72 nucleotides larger than the one previously
described. Overexpression of this transcript can prevent programmed cell death and
can suppress the lethality associated with ectopic cell deaths in ced-9(l) mutants,
suggesting that this transcript has an opposite role to that of the previously described
transcript. Genetic analysis of the ced-4 mutation n2273, as well as an analysis of the
interactions of ced-4 mutations with other cell death mutations suggest that two
functions are encoded by ced-4 in vivo. We propose that these functions correspond
to the two transcripts described above and that the balance between these functions
can influence the decision of a cell to live or die.
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Programmed cell death is a common aspect of metazoan development and is
used, among other things, to regulate cell number, to rid organisms of harmful or
unwanted cells, and to shape tissues and organsl, 2. In the nematode Caenorhabditis
elegans, of the 1090 somatic cells generated during hermaphrodite development 131
undergo programmed cell death3 ,4 . Genes involved in several aspects of the death
process have been previously defined 2,5-9. Loss-of-function (If) mutations in the genes
ced-3: and ced-4 as well as gain-of-function (gf) mutations in the gene ced-9 prevent
programmed cell death5 ,9. Loss-of-function mutations in the gene ced-9 cause ectopic
cell deaths to occur, and result in lethality9. These, and other results, suggest that ced-3
and ced-4 are necessary for proper execution of the cell killing program in C. elegans,
and -that ced-9 is necessary to inhibit this program9 ,10. The CED-9 protein is similar in
sequence to the mammalian proto-oncoprotein Bcl-2 that can function to prevent
programmed cell deathll-15 . The CED-3 protein is similar to the Interleukin-1f (IL-1)
converting enzyme (ICE) class of cysteine proteases which have been shown to induce
programmed cell death in culture1 6- 2 1. These sequence and function similarities
between the nematode and mammalian cell-death proteins suggest that the molecular
mechanism of programmed cell death has been conserved from worm to man. No
mammalian protein similar to the C. elegans protein CED-4 has yet been described.
To define regions of the ced-4 gene which are important for function we cloned
ced-4 homologues from the related nematodes C. briggsae and C. vulgaris. Analysis of
the genomic sequences of these clones revealed that the third intron of the ced-4 genes
(as defined by previously described C. elegans ced-4 cDNAs2 2) was conserved at its 3'
end among all three nematode species, suggesting that this region is important for ced-4
function. Specifically, intron 3 of C. elegans, C. briggsae and C. vulgaris is 186 bp, 177 bp,
and 205 bp in length, respectively. The 3' 72 bp of these introns are highly conserved
(see figure lb). Immediately upstream of the conserved region is a consensus splice
acceptor sequence (figure lb) suggesting that the conserved region might be used as an
exon. A transcript (ced-4L) resulting from this alternative splice would contain an in-
frame insertion of 72 nucleotides relative to the previously described transcript (ced-4S)
and would encode a protein with a 24 amino-acid insertion relative to the previously
described protein.
To confirm that the C. elegans ced-4 gene encodes a transcript containing the
conserved sequences of intron 3 we hybridized a radioactive probe consisting of the 72
bp conserved sequence to a northern blot of mixed-stage C. elegans polyA+ RNA
prepared from wild-type animals. As shown in figure c, a band slightly larger than
ced-4S can be seen. The abundance of ced-4L, as judged by densitometry, is 10-30 fold
less than that of ced-4S. To confirm that ced-4L is produced by splicing at an acceptor
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site at position 114 of intron 3 we prepared cDNAs from the RNA used for the northern
blot, and amplified the region surrounding intron 3 by the polymerase chain reaction
(PCR) using primers flanking intron 3 (figure d). In addition we used primers
complementary to the conserved region with primers outside intron 3 to amplify
cDNAs containing segments of intron 3 (data not shown). Sequence determination of
these transcripts confirmed that they were spliced as predicted.
We have previously shown that overexpression of ced-4S in the mec-7-expressing
ALM neurons2 3 in animals carrying a mec-7-promoter::ced-4S-cDNA fusion construct
can kill these cells by programmed cell death1 0. To determine the function of ced-4L we
fused a ced-4L cDNA to the mec-7 promoter and established transgenic animals carrying
this fusion construct. None of the ALM neurons died, suggesting that ced-4L can not
kill cells by programmed cell death (data not shown). We next fused a ced-4L cDNA to
two C. elegans heat shock promoters (A. Fire and P. Candido, personal communication)
and established transgenic lines containing both fusion constructs. Interestingly, extra
cells accumulated in transgenic embryos subjected to a heat shock, suggesting that
programmed cell death had been blocked in these animals (table la).
To determine if overexpression of ced-4L blocked programmed cell death we
introduced a construct containing a ced-4L cDNA fused to the constitutive promoter of
the dpy-30 gene (D. Hsu and B. Meyer, personal communication) into animals
containing a loss-of-function mutation in the gene ced-9. Animals homozygous for ced-
9(lj9 mutations die because of massive ectopic cell death 9. ced-9(lf) mutants carrying the
Pdpy30ced-4L transgene were rescued from lethality, suggesting that ced-4L can prevent
programmed cell death (table lb).
The above results suggest that ced-4 encodes two alternative transcripts, ced-4S
and ced-4L, with opposing functions (figure la). ced-4S can kill cells by programmed
cell dLeath10, whereas ced-4L can protect cells from undergoing programmed cell death.
The mammalian gene bcl-x also encodes two transcripts with opposite cell-death
functions 24, however, neither ced-4 product has any significant similarity to bcl-x.
Ellis and Horvitz 5 showed that the egg-laying defect (resulting from the
programmed cell deaths of the HSN neurons which are required for proper egg laying)
in animals heterozygous for the mutation egl-1(n487)25 could be enhanced by
introducing a single copy of the strong ced-4 loss-of-function mutation n1162 (which
prematurely terminates both CED-4L and CED-4S at amino acid 79, and makes no
RNA22 ) into the strain. Specifically, they showed that ced-4/+; egl-1 /+ animals were
more egg-laying defective than egl-1 /+ animals. Thus, eventhough ced-4 function was
reduced, killing was enhanced. This observation suggested to us that ced-4 might
encode a genetic function that prevents cell death in addition to a function known to
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cause cell death. If this function were the same as the function of ced-4L then the
enhanced death of the HSN neurons in ced-4/+; egl-1 /+ animals could be explained as a
reduction in the level of protective ced-4L function in these neurons (figure 2). To
further correlate the ced-4S and ced-4L transcripts to the two genetic functions encoded
by ced-4 we examined the ced-4 mutation n2273.
The n2273 mutation can weakly prevent programmed cell death (table 3, M.
Hengartner, personal communication). This mutation changes a conserved G to an A at
position 186 of intron 322. We examined ced-4 transcripts in this mutation by probing a
northern blot of polyA+ RNA derived from n2273 mutant animals with either a full-
length ced-4S cDNA probe (detecting both ced-4S and ced-4L), or a probe consisting of
the 72 bp conserved region of intron 3 (detecting only ced-4L). As shown in figures lc
and d, expression of ced-4L is enhanced in this strain, however, the total amount of ced-
4 transcript remains the same as in wild-type animals, suggesting that ced-4S expression
is reduced. To determine the nature of the ced-4 transcripts encoded by n2273 mutants
we amplified both ced-4S and ced-4L transcripts from this mutant as described above.
We observed three transcripts. One transcript corresponded to ced-4L, yet contained a
mutation at the conserved G at position 186 of intron 3 causing an arginine to lysine
mutation in CED-4L. One transcript (ced-4SD) corresponded to ced-4S except for a
deletion of three bp immediately downstream of the splice acceptor site at position 186
of intron 3 resulting in the deletion of a single amino acid from CED-4S. The third
transcript represented a ced-4S transcript (ced-4I) that was spliced at position 185 instead
of 186 of intron 3, resulting in an insertion of a T which would result in a truncated
CED-4S protein. No other transcripts were detected (data not shown).
The variant ced-4S products and the lower level of their transcripts in n2273
mutants are consistent with the defect in cell killing defined in n2273 animals. Because
n2273 animals produce a mutated ced-4L product, we surmised that these mutants
might also be defective in the protective function of ced-4L. To test this idea we
sensitized the n2273 background by introducing a weak and viable allele of the ced-9
gene (n1653)9 into this background. Eventhough n1653 animals or n2273 animals
produce viable progeny on their own, the doubly mutant n2273 n1653 animals
produced only dead progeny (table 2, M. Hengartner, personal communication). This
synthetic lethality is identical to that seen in mutants carrying stronger mutations in ced-
9, suggesting that n2273 can enhance the cell-killing effect of ced-9(lf) mutations, and
consistent with the idea that n2273 produces a mutant ced-4L product. To test if this
synthetic lethality resulted from inappropriate activation of the cell death pathway we
introduced the ced-3 mutations n242726, and n243826 into the synthetically lethal strain.
As shown in table 2, n2273 n1653; ced-3 triple mutants are alive, suggesting that the
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synthetic lethality of n2273 n1653 animals is due to inappropriate activation of the cell
death pathway. Furthermore, this experiment suggests that ced-4L might act between
ced-9 and ced-3 in the cell death pathway, as we have similarly proposed for ced-4S10
(figure 2).
To place ced-4L function in the cell death pathway more precisely we examined
the phenotypes of animals containing both n2273 and other cell death mutations.
Hengartner and Horvitz26 have previously shown that animals containing a weak
mutation in ced-3 have surprisingly fewer surviving cells than animals carrying both a
ced-9(lf) and the same ced-3 (weak) mutations. They suggested that an explanation for
this result is that ced-9 might encode a death-promoting function in addition to its
death-preventing function. It is possible, however, that this effect is due not to the loss
of a death-promoting function of ced-9, but to an increase in the death-preventing
function of ced-4L. Specifically, if ced-9 could negatively regulate ced-4L, a reduction in
ced-9 function would cause an increase in the protective function of ced-4L and lead to
more survival. To test this notion we examined the effect of the n2273 mutation on the
enhanced survival described above. n1653; ced-3 mutants show enhanced cell survival
relative to ced-3 mutants alone (table 3, ref. 26). However, n2273 n1653; ced-3 mutant
animals show the same extent of cell survival as n2273; ced-3 mutants (table 3),
suggesting that ced-4L might be the cause of the cell-survival enhancement in n1653; ced-
3 mutants. This result supports the notion that ced-9 normally negatively regulates the
activity of ced-4L (figure 2).
The results described so far are consistent with a model for programmed cell
killing shown in figure 2. Our model suggests that CED-9 can act to negatively regulate
both CED-4L and CED-4S, and that it is the regulation of the balance between the
activities of the latter two (by CED-9, by factors responsible for alternative splicing of
the ced-4 transcripts, or by other factors) which determines if a cell will live or die. A
prediction of this model is that if ced-9 can no longer negatively regulate ced-4L, then cell
survival should be enhanced. This enhancement should be reduced by the n2273
mutation which causes a defect in ced-4L function. The gain-of-function mutation ced-
9(n19'50) results in the enhancement of cell survival and changes a conserved glycine to
an arginine in the BH2 domain required for Bcl-2-Bax interactions27. Interestingly,
n2273 n1950 double mutants contain fewer extra cells than n1950 animals alone (table 3).
This result suggests that perhaps n1950 is defective in the inhibition of ced-4L, and
might explain how a single-amino-acid substitution can "activate" the ced-9 product by
actually inactivating an interaction with ced-4L. Interestingly, n1950 does not prevent
cell death in the gonad (M. Hengartner, personal communication). If ced-4L is not
produced by the gonad, this result would be expected since n1950 and wild-type ced-9
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should behave the same in the absence of ced-4L. A careful analysis of ced-4L expression
could lend support for this interpretation.
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FIG. 1 a, A schematic drawing showing the splicing pattern of ced-4S and ced-4L. Open
boxes are exons present in both ced-4S and ced-4L. The closed box is an exon fragment
specific to ced-4L, and is an intron in the ced-4S transcript. V-shaped lines represent
introns. The AUG start codon and UAA stop codon are indicated as well. b, An
alignment of the terminal 72 bp sequence of intron 3 from the nematodes C. elegans, C.
briggsae, and C. vulgaris. Numbers in the C. elegans sequence correspond to the positions
within intron 3. Residues conserved in all species are boxed. The putative C. elegans
peptide produced by this region is indicated below the alignment. Consensus splice
acceptor sites are indicated by a horizontal bar above the alignment. Arrows above the
alignment indicate positions of splicing in ced-4L and ced-4S. The arrow below the
alignment indicates the change observed in the mutation n2273. c, right, top: A
northern blot of wild-type and ced-4(n2273) polyA+ RNA probed with a full-length ced-
4S cDNA. left, top: An identical blot of wild-type and ced-4(n2273) polyA+ RNA probed
with a 72 bp fragment corresponding to the conserved intron shown in b. left and right,
bottom: same blots as top panels probed with a C. elegans ribosomal protein probe as a
loading control. d, A photograph of an ethidium bromide stained agarose gel showing
two products generated by PCR using primers flanking intron 3 from wild-type and ced-
4(n2273) RNA. These products were cloned into the pBluscript SK(+) vector
(Stratagene, La Jolla, CA) and 20 clones of each band were sequenced. In the wild type
preparation the top band corresponds to ced-4L and the bottom to ced-4S (data not
shown). In the n2273 preparation the bottom band consisted of two cDNAs (ced-4D and
ced-41[, see text for details). The top band corresponds to a single mutated ced-4L
transcript.
METHODS. b, ced-4 genes from C. briggsae and C. vulgaris were cloned by low
stringency hybridization from genomic libraries provided by C. Link and phage DNA
was isolated as described in Sambrook et al. 28. Clones were digested with EcoRI or
HindIII, and blotted for a Southern blot as described in Sambrook et al.28. These blots
were probed with the C. elegans ced-4S cDNA and positive bands were excised and
ligated to a pBluscript SK(+) (Stratagene, La Jolla, CA) vector cut with EcoRI or HindIII.
Insert sequences were determined by shot-gun sequencing 28 on an ABI sequencer
(Applied Biosystems, Inc., Foster City, CA). c, RNA was prepared from wild-type or
from n2273 animals using the Fast-Track polyA+ RNA isolation system (Invitrogen, San
Diego, CA). RNA was blotted as described in Sambrook et al.2 8 . The ced-4S probe was
prepared by random priming28. The 72 bp intron probe was prepared by amplifying
the genomic ced-4 clone C10D8-522 with primers located at the beginning and end of the
sequence shown in b in the presence of 3 2 P-labelled dATP. The ribosomal RNA probe
was prepared by random priming28 of an insert provided by M. Koelle. Quantitation of
band intensity was done using a phosphoimager set up (Molecular Dynamics, Inc.,
Sunnyvale, CA). d, Primers in exon 2 and exon 6 were used to generate cDNAs and
then amplify products from the wild-type and n2273 RNAs prepared in c. Bands were
purified and sequenced using an ABI sequencer (Applied Biosystems, Inc., Foster City,
CA).
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FIG. 2 A model for the regulation of programmed cell killing in C. elegans. The ced-9
gene product can inhibit the activity of either ced-4S or ced-4L gene products. ced-3
activity can be enhanced by CED-4S or inhibited by CED-4L, although we can not rule
out a model in which CED-4L inhibits CED-4S, thus indirectly inhibiting CED-3, or a
model in which CED-4L inhibits a target downstream of CED-3. The bottom pathway is
identical to one we have previously proposed1 0. See text for additional details.
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Table la. Overexpression of ced-4L can prevent programmed cell death.
Heat-shock constructs were made by cloning a ced-4 cDNA into the two heat-shock
promoter vectors (A. Fire, personal communication). The parental strain for all
transgenics was the Bristol N2 strain. Transgenic lines transmitting the Rol-6 phenotype
were obtained as previously describedR. Adults were allowed to lay embryos for 2
hours at 200C, subjected to a 60 minute heat shock at 33°C, allowed to lay embryos for
an additional 2 hours and removed from the plate. Hatched Rol larvae were scored for
extra cells in the anterior pharynx as previously described2 9 ,30 . Numbers in column 1
indicate different transgenic lines. +, with heat shock, -, without heat shock. Numbers
in column 3 are average number of extra cells ± standard error of the mean. Parentheses
in column 3 indicate the number of animals observed. The numbers in column 4
indicate the range of extra cells seen in individual animals.
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Table lb. Overexpression of ced-4L can rescue ced-9(lf) animals from lethality.
The mutations used have been previously described (ref 9, 11, 26) except for n2812
which was isolated by us. Transgenic lines were obtained as in table la. Over 100
animals were scored for each non-transgenic genotype. None of these animals
produced viable progeny and were scored as "-". At least 3 independent transgenic
lines were isolated for each genotype, and 10-30 animals of each line were scored.
Constructs which gave at least two lines that produced viable progeny were scored as
11+
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Table 2. ced-4(n2273) can enhance killing by programmed cell death.
All experiments were done at 20°C. 10-20 animals were allowed to lay embryos for 3-5
days. The number of embryos that progressed past the L3 stage were scored as viable.
The alleles used have been prviously described (ref 9,22,26).
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Table 3. ced-4L might be negatively regulated by ced-9.
Numbers in column 2 indicate the average number of extra cells observed for each
genotype ± the standard error of the mean. Numbers in column 3 indicate the number
of animals observed for each genotype. The alleles used have been previously
described (ref 9, 26).
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Chapter 5
The C. elegans cell death gene ced-3 encodes a killing function separate from its
proteolytic function
Shai Shaham, Brian Davies, and H. Robert Horvitz
Howard Hughes Medical Institute
Department of Biology, Room 68-425
Massachusetts Institute of Technology
Cambridge, Massachusetts 02139, USA
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Abstract
Mutations in the gene ced-3 which encodes an Interleukin-1 convertase (ICE)
- like protease prevent programmed cell death in the nematode Caenorhabditis
elegans. We have characterized the phenotypes conferred by and determined the
sequences of 50 mutations in ced-3. We distinguish five phenotypic classes of alleles
based on the penetrance of the cell death defect. At least two of the mutations
studied are likely to be null for CED-3 proteolytic activity. At least 14 of the recessive
alleles as well as four dominant-negative alleles prevent cell death to a greater extent
than the protease-null alleles, suggesting that these alleles also affect a cell death
function different from the proteolytic function of CED-3. 25 of 29 sites altered by
ced-3 missense mutations are conserved with other ICE-like family members.
Interestingly, we find that mutations in the non-catalytic N-terminal domain of ced-3
also prevent its activity, suggesting that this region has functional importance in vivo.
We found that overexpression of constructs containing point mutations in the active
site cysteine, as well as overexpression of constructs containing the N-terminal
portion of ced-3 fused to a reporter gene can prevent programmed cell death in wild-
type animals, suggesting that this region might be involved in protein-protein
interactions.
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Introduction
Programmed cell death is a process conserved throughout evolution and serves
many functions (Gliicksmann, 1950). For example, selective killing of cells by
programmed cell death can be used to shape tissues and organs, to rid the body of
harmful cells (such as in the immune system) (Cohen and Duke, 1984), and to eliminate
cells whose function is no longer needed. Work on the nematode Caenorhabditis elegans
(C. elegans) has revealed that the molecular mechanisms by which programmed cell
death occurs have been conserved from worm to man (reviewed by Horvitz et al., 1994
and Ellis et al., 1991a). In C. elegans 131 of the 1090 cells born in the hermaphrodite
undergo programmed cell death in a manner which is morphologically and
ultrastructurally similar to the mammalian process of apoptosis (Sulston and Horvitz,
1977). Mutations in 14 genes affecting several different aspects of the death program
have been isolated and ordered in a pathway (Hedgecock et al., 1983; Ellis and Horvitz,
1986; Ellis and Horvitz, 1991; Ellis et al., 1991b; Hengartner et al, 1992). Mutations in
three genes, ced-3, ced-4, and ced-9, globally perturb the process of cell killing (Ellis and
Horvitz, 1986; Hengartner et al., 1992). In particular, mutations in ced-3 and ced-4, as
well as a gain-of-function mutation in ced-9 prevent programmed cell death from
occuring. Loss-of-function (If) mutations in ced-9 result in the inappropriate activation
of the cell death program in cells that should normally survive and hence lead to
lethality. This result suggests that ced-9 is normally required to prevent progrmmed cell
death in cells that survive. The ced-9-associated lethality can be suppressed by
mutations in ced-3 or ced-4 suggesting that the ectopic deaths observed in ced-9(lf)
animals are a consequence of inappropriate activation of ced-3 and ced-4 (Hengartner et
al., 1992). Studies suggest that the activities of the genes ced-3, ced-4 and ced-9 are
required within cells that die for these cells' demise (Yuan and Horvitz, 1990; Shaham
and Horvitz, manuscript in preparation).
The ced-9 gene encodes a memeber of the bcl-2 family of proteins that function in
mammalian cell death (Hengartner and Horvitz, 1994). The ced-4 gene encodes two
novel transcripts, an abundant transcript that can cause cell death, and a rarer transcript
that can prevent programmed cell death (Yuan and Horvitz, 1992; Shaham and Horvitz,
manuscript in preparation). The ced-3 gene encodes a member of the CED-3/ICE
(Interleukin-lp1 convertase) family of cysteine proteases (Yuan et al., 1993).
Overexpression of the mammalian members of this family can result in cell death in
culture (Miura et al., 1993; Kumar et al., 1994; Fernandez-Alnemri, 1994; Wang et al.,
1994). Expression of the viral inhibitor of ICE, crmA, in neurons has prevented the
death of these neurons following factor deprivation (Gagliardini et al., 1994). In
addition, a knock-out mutation of the ICE gene in mice reveals a defect in Fas-mediated
144
killing (Kuida et al., 1995). These results suggest that as with ced-3, overexpression of
the mammalian proteases can kill, and these proteases are likely to be required for
killing. Several of these proteases have the unique substrate specificity of cleavage
following an aspartate residue (Thornberry et al., 1992), a specificity shared with only
one other known eukaryotic protease (fragmentin 2) that is thought to function in cell
death mediated by cytotoxic T cells (Shi et al., 1992a; Shi et al., 1992b; Heusel et al.,
1994). The genes for the ICE-like proteases encode proteins with three major domains:
an N-terminal domain that is not required for protease activity, a large subunit of the
protease containing the active site cysteine, and a small subunit of the protease
(Thornberry et al., 1992). The large and small subunits associate to form the protease
heterodimeric unit. X-ray crystallographic studies of the ICE protease suggest that the
active protease consists of two heterodimers bound to each other (Wilson et al., 1994;
Walker et al., 1994). These proteases can undergo autocatalysis in which the primary
translation product is cleaved at specific aspartate residues separating the various
domains described above (Thornberry et al., 1994).
To better understand the function of this class of proteases in programmed cell
death we have undertaken an analysis of mutations affecting the function of ced-3 in
vivo. We charactarized the phenotypes of 50 mutant strains containing mutations in ced-
3 and determined the molecular nature of the lesion in each mutant strain. Our results
show that most missense mutations affect residues conserved among CED-3 and other
related family members. Some of the mutations encode products that act in a
dominant-negative fashion, suggesting that ced-3 may physically associate with itself or
with other components of the cell death pathway. Interestingly, these dominant-
negative alleles as well as other alleles of ced-3 prevent programmed cell death to a
greater extent than alleles lacking CED-3 proteolytic activity, suggesting that they not
only eliminate the proteolytic function of CED-3 but also interfere with the cell death
process in a different manner. We also find that expression of the N-terminal region of
CED-3 fused to a reporter protein can prevent programmed cell death in wild type
animals, suggesting that this region might be involved in protein-protein interactions.
Results
Characterization of ced-3 mutations
The 50 mutations analyzed in this study were isolated in several different genetic
screens in our lab (see Materials and Methods), however, the majority of the mutations
were identified in screens intended to suppress the lethality of the weak loss-of-function
mutation ced-9(n1950n2161) (M. Hengartner, personal communication; S. S and B. D.,
unpublished results). Loss-of function mutations in the ced-9 gene result in massive
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ectopic cell death and thus result in lethality. Mutations in the gene ced-3 will prevent
this lethality, suggesting that ced-9 normally acts to negatively regulate the activity of
ced-3 (Hengartner et al., 1992, Shaham et al., manuscript in preparation). To quantitate
the reduction in function of a given ced-3 allele we counted the number of extra
surviving cells present in the anterior region of the pharynx of mutant animals as has
been previously described (Hengartner et al., 1992).
Five phenotypic classes of ced-3 mutations can be recognized. Weak mutations in
which none of the animals have more than one extra cell in the anterior pharynx
(category I), weak mutations in which some of the animals have more than one extra
cell in the anterior pharynx but a significant portion do not have any extra cells
(category II), medium strength mutations in which all animals have at least one extra
cell in the anterior pharynx (category III), strong mutations that have a greater number
of extra cells in the anterior pharynx than the putative protease-null alleles (see below)
and are fully recessive (category IV), and strong mutations that have a weakly dominant
phenotype (category V). The alleles n2445, n2854, n2426, n165, n1286, n2444, n2859,
n292.2, n2442, and n2721 could not be reliably assigned to either category III or category
IV because they resulted in a a cell-survival phenotype which was on the border
between these categories, and were arbitrarily divided so that the first 8 were assigned
to category III and the remaining two to category IV.
To determine the molecular nature of the ced-3 mutations studied we used the
polyimerase chain reaction (PCR) to amplify coding regions and exon/intron
boundaries from each mutant strain and determined the sequence of these regions (see
Materials and Methods). In one case (the allele n2452) we could not amplify sequences
downstream of position 3200 in the ced-3 genomic sequence (Yuan et al., 1993),
suggesting that a deletion might be present. All the mutations analyzed were isolated
in screens using ethyl methanesulfonate (EMS) as a mutagen. 45 of the mutations
analyzed resulted in GC->AT transitions which are most often induced by EMS. Two
mutations resluted in TA->AT changes, one mutation resulted in a TA->CG change, two
mutations (n2854 and n2830) altered several nucleotides, and one mutation (n2452)
resulted in a deletion (see below). Of the point mutations isolated 37 were missense
mutations, six were nonsense mutations, and four probably affect splicing. Of the
missense mutations 25 of 29 affected sites are conserved with other CED-3/ICE family
members. Interestingly, four of the 29 sites affected by missense mutations in ced-3 are
in the N-terminal region which is not required for catalytic function. This observation
suggests that the N-terminal region can either influence the proteolytic activity of this
class of proteases, or that it has a separate cell-killing function (also see below). The
non-conserved serine-rich region of ced-3 (amino acids 93 to 205 of the CED-3 protein) is
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not affected by any of the missense mutations examined and its function remains
unknown. We analyzed ced-3 RNA expression in 11 of the mutant strains representing
a range of cell death defects, and a range of molecular lesions (see figure 2). The results
suggest that none of the mutations examined grossly affect the size or level of the ced-3
transcript.
Category I ced-3 mutations can not suppress the lethality caused by strong loss-of-
function mutations in ced-9
The weakest ced-3 mutations consist of the alleles n2923, n2446, n2449, and n2425.
Animals carrying these alleles have on average 0-0.3 extra cells and as such are
indistiguishable from wild-type animals which on average have 0.13 extra cells (table 1).
All of these alleles are recessive and were isolated as suppressors of the lethality of the
weak ced-9 loss-of-function allele n1950n2161. Interestingly, the allele n2425 is not
capable of suppressing a stronger ced-9 mutation which results from a nonsense
mutation at codon 160 of the ced-9 open reading frame (table 2), suggesting that in
animals carrying this allele wild-type ced-3 activity is too high to allow survival in the
complete absence of functional ced-9 product. We suggest that the other alleles in this
category behave in a similar manner.
We have previously argued that both cells that die and those that do not die
contain ced-3 product, and that in the absence of ced-9 function ced-3 is active and kills
both cells that live and cells that die (Shaham and Horvitz, manuscript in preparation).
That the weak ced-3 alleles are capable of suppressing the ectopic cell deaths that occur
in cedl-9(n1950n2161) animals, but do not result in the survival of cells that normally die
(no extra cells in the anterior pharynx) suggests that cells that normally live differ in
their sensitivity to these ced-3 mutations. In particular, this observation suggests that
cells that normally die have more ced-3 function or are capable of transducing a killing
signal from ced-3 in a more efficient manner than cells that die ectopically (as in the ced-
9(n1950n2161) mutants). These observations suggest that the weakest ced-3 alleles
probably retain just enough function to allow normal programmed cell death to occur
but not enough function to allow ectopic cell deaths to occur.
The sequence lesions in these mutations are shown in table 1. Two alleles, n2923
and n2449, are missense mutations in residues which are not conserved among CED-
3/ICE family members. The remaining two alleles, n2446 and n2425, are missense
mutations in residues conserved among CED-3/ICE family members suggesting that
these residues are probably important for the function of these proteins (figure 1).
Category II ced-3 alleles can suppress strong loss-of function mutations in ced-9
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A significant proportion of animals carrying the category II mutations n2447,
n2427, or n2443 do not have any extra cells. 4/15 n2447 animals, 5/19 n2427 animals,
and 4/15 n2443 animals scored had no extra cells. The allele n2438 contains the
identical sequence change as n2427 yet appears to be slightly more defective in ced-3
function. The nature of this difference is not understood but may be related to
additional modifying mutations in the n2438 background (data not shown). The
mutation n2427 and n2443 are capable of suppressing the lethality of strong ced-9 alleles
(table 2; data not shown). However, ced-9; n2427 or ced-9; n2443 animals can be severly
egg-laying defective, suggesting that the HSN neurons which are required for egg-
laying are dying ectopically as in ced-9(lf) animals (Hengartner et al., 1992, data not
shown). These observations suggest that this class of mutations reduces ced-3 function
more than the category I mutations, yet does not completely eliminate ced-3 activity. All
category II alleles are recessive.
The sequence lesions in these mutations are shown in table 1. The mutations
n24417, n2427, and n2438 are missense mutations in residues conserved with other CED-
3/ICE proteins. The n2443 mutation affects a residue that is not conserved.
Category III ced-3 alleles include alleles which are likely to lack proteolytic function
Alleles in category III are all recessive, and have an average of 6.2 - 10.9 extra
cells in the anterior pharynx, representing a broad range of ced-3 activity. 15 of the
alleles in this category are missense alleles (n2436, n2877, n2921, n1040, n2861, n1129,
n2885, n2870, n1163, n2722, n2924, n2429, n2426, n2444, n2922), six of the mutations
result in nonsense codons (n1949, n2998, n2888, n1165, n1286, n2859), one mutation
(n2445) results in the alteration of the stop codon to a lysine resulting in the addition of
26 amino acids to the carboxy-terminus of the protein, one mutation (n2452) is a large
deletion (see below), and one affects splicing (n2854, see below). 14 of the 15 missense
mutations alter residues conserved with other CED-3/ICE family members.
Animals carrying two of the alleles in this category are likely to lack proteolytic
activity based on their molecular lesion. The allele n2452 contains a deletion of at least
3.4 kb which completely deletes the ced-3 coding region from amino acid 179 to the end
of the open reading frame, and thus eliminates the region encoding the active ced-3
protease (figure 3, also see Materials and Methods). The allele n2888 changes codon 154
from an arginine to a nonsense codon, presumably truncating the ced-3 protein
upstream of the region required for proteolytic activity. As shown in table 1 these
alleles have 9.5 1.5 and 10.6 1.7 extra cells respectively, suggesting that loss of ced-3
proteolytic activity leads to the accumulation of about 10 extra cells in the anterior
pharynx of mutant animals. The true number of extra cells for a protease-null allele is
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probably reflected by the deletion mutant n2452. Whether this represents the
phenotype of a complete ced-3 null is unclear since it is possible that the N-terminal
region of ced-3 which remains intact in the two alleles is responsible for part of the
killing function of ced-3 (see below) and that a true ced-3 null allele would have a
stronger phenotype than an allele lacking only proteolytic activity.
Category IV ced-3 alleles inhibit cell death to a larger extent than alleles lacking ced-3
proteolytic activity
Animals carrying the category IV ced-3 alleles have a greater average number of
extra cells in the anterior pharynx than the alleles n2452 and n2888 which are likely to
lack ced-3 proteolytic activity. The number of extra cells in this categoty ranges from
11.0 to 12.2. All of these alleles are recessive. 11 of the alleles in this category are
missense alleles (n2442, n2721, n2889, n2439, n2441, n2720, n2719, n2454, n2432, n718,
n2883). One (n2830) contains two missense mutations, and two of the alleles affect
splicing (n717, n3002, see below). Ten of the 11 missense mutations alter residues which
are conserved with other CED-3/ICE family members.
The observation that category IV alleles prevent programmed cell death to a
greater extent than alleles lacking the ced-3 proteolytic domain suggests that these
alleles are interfering with programmed cell death in a manner which is separate from
the proteolytic activity of CED-3. This additional interaction could take one of two
forms. Either these alleles are preventing another component of the cell death
machinery from acting properly in addition to disrupting the proteolytic activity of
CED-3, or it is possible that the N-terminal region of ced-3 is important for its killing
function, and these alleles perturb both the proteolytic aspect of the killing and the
aspect which is N-terminal dependent (see previous section). Currently we cannot
distiguish between these two models (see below).
Category V ced-3 alleles are weakly dominant negative
Animals carrying category V ced-3 alleles have a greater average number of extra
cells in the anterior pharynx than the alleles n2452 and n2888 which are likely to lack the
ced-3 proteolytic region. This observation suggests that as with category IV alleles,
category V alleles also disrupt a cell death function which is not related to the
proteolytic activity of ced-3. The number of extra cells in this category ranges from 11.7
to 12.4. Three of the alleles in this category are missense alleles (n2871, n2430, n2433)
and one allele results from a splicing defect (n2440, see below). The alleles n2871 and
n2433 affect conserved arginine and glycine residues, respectively, in the conserved
pentapeptide QACRG which surrounds the active site of CED-3 and is characteristic of
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CED-3/ICE-like proteases. The remaining missense allele alters a non-conserved
residue.
Animals heterozygous for these alleles show weak cell survival (0-2 extra cells
per animal) which is noticably different from the other ced-3 alleles (table 1). To confirm
that these alleles are indeed dominant we examined the ability of n2871 /+ to suppress
the lethality of the weak ced-9 allele n1950n2161. As shown in table 3 ced-9; n2871/+
animals segregated live animals which were themselves heterozygous for n2871. A
similar experiment with the ced-3 allele n717 which does not show a dominant
phenotype failed to produce heterozygous progeny. These results confirm the
dominant nature of the n2871 allele and suggest that other members of this category
behave in a similar manner.
To test whether this dominance is due to a haploinsufficiency of the ced-3 locus or
is due to a dominant-negative effect we examined the phenotype of animals
heterozygous for the deficiency sDf21 which uncovers ced-3. As shown in table 1
sDf21 / + animals do not show significant cell survival, suggesting that the dominant
phenotype of category V alleles is due to a dominant-negative interaction. This
dominant-negative effect could be due to two types of interactions. One possibility is
that the products of these alleles interact with another component of the cell death
machinery and inhibit its activity. Another possibility is that these alleles reflect a
possible multimerization of ced-3. Interestingly, the X-ray crystal structure of ICE
suggests that this protease acts as a dimer of p10-p20 heterodimers (Wilson et al., 1994;
Walker et al., 1994), thus it is possible that ced-3 also functions as a dimer of
heterodimers, and that the dominant-negative products of category V alleles result in
non-productive dimer formation and therefore reduce ced-3 activity (see Discussion).
Expression of mutant ced-3 constructs can prevent programmed cell death in wild-
type animals
The observation that some ced-3 alleles act in a dominant-negative fashion
suggested that expression of truncated ced-3 products, or certain mutant ced-3 products
should inhibit programmed cell death in wild-type animals. We initially examined the
effect of introducing into wild-type animals a ced-3 construct containing a heat-shock
promoter fused to a ced-3 cDNA with a mutation in the active site cysteine. As shown in
table 5 animals that were heat-shocked showed significant accumulation of extra cells in
the anterior region of the pharynx, suggesting that programmed cell death had been
inhibited. To further study the regions of ced-3 that could confer a cell survival
phenotype on wild-type animals we developed two classes of fusion constructs. The
first class of constructs consists of the genomic region of ced-3 upstream of the start
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codon fused to 3' deletions of the genomic coding region of ced-3 fused to either of the
reporter genes lacZ or GFP (Table 5, constructs E-G). The second class of constructs
consists of a C. elegans heat-shock promoter fused to a trucated ced-3 cDNA fused to
either the lacZ or GFP reporter genes (Table 5, constructs B-D). Introduction of most
truncation constructs prevented programmed cell death to varying extents. In some
cases we could observe surviving cells staining with the reporter construct. To confirm
that the extra cells were a result of an inhibition of programmed cell death we
introduced construct F (table 5) into ced-9(n1950n2161) or ced-9(n2812) animals. As table
4 shows the lethality of these strains was suppressed by construct G, suggesting that
this construct is capable of preventing programmed cell death.
Interestingly construct C containing fewer than the first 95 codons of ced-3 cannot
prevent programmed cell death (table 5). This observation suggests that a region
between amino acids 95 and 150 of CED-3 (constructs C and D) is necessary for this
protective effect to occur. This region is not required for ced-3 proteolytic activity
suggesting that the N-terminal region of ced-3 might be involved in interactions with
other components of the cell death machinery, consistent with the observations in the
previous section.
Splicing mutants of ced-3
We examined in more detail three (n2854, n717, n2440) of the four mutations
(n2854, n717, n2440, n3002) that are likely to affect splicing. The allele n2854 contains
the sequence AGGCG I gattt in the donor region of intron 5 of ced-3 (table 1) instead of
AGGCG I gttcg present in the wild type. To characterize the ced-3 transcripts made in
animals carrying this ced-3 mutation we prepared RNA from mutant animals (see
Materials and Methods), prepared cDNAs from the RNA and amplified this DNA using
PCR and ced-3- specific primers. The sequence of the resulting band was then
determined. Interestingly, the only product isolated from this mutant spliced at a
position upstream of the normal splice site to give a deletion of 3 bp with respect to the
wild-type message resulting in the deletion of glycine 360 in the ORF of ced-3. Why this
splicing pattern is observed is not understood. The n717 mutation changes a conserved
acceptor site G to an A in intron 7. To characterize the products made in n717 animals
we prepared RNA from mutants and used it for a northern blot probed with a ced-3
cDNA probe (see figure 2). The size and levels of the message were not discernably
different from wild type. We then prepared cDNAs from the n717 RNA and amplified
this DNA using PCR and ced-3 specific primers. Sequence determination of the
resulting bands suggested that multiple splice sites were used around the wild-type
splice location (data not shown). The mutation n2440 changes the sequence
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CCGCAAGTT to CCGTAAGTT apparently changing codon 401 from a glutamine to a
stop codon. However, we noticed that this change also creates a cryptic splice donor
site which could be used instead of the intron 6 splice donor which is immediately
down stream of the mutation site (CC I gtaagtt). To confirm this hypothesis we
determined the sequence of ced-3 cDNAs prepared from n2440 mutant RNAs (see above
and Materials and Methods). Only one class of RNAs was discernable and used the
predicted cryptic donor site. The product produced by this splice is out of frame and is
predicted to form a truncated protein with 13 amino acids downstream of amino acid
400. Thus this mutation is likely not to be a nonsense mutation.
Discussion
ced-3 encodes a killing function separate from its proteolytic function
Studies addressing the functional requirement of the proteolytic activity of CED-
3/ICE-like proteins in programmed cell death have suggested that this activity is
essential for cell killing (Miura et al., 1993; S. Shaham, manuscript in preparation;
Kumar et al., 1994; Wang et al., 1994). In this work we show, however, that ced-3 is
likely to encode a separate function involved in cell killing. Among the 50 alleles
characterized in this study, two are likely to completely eliminate CED-3 proteolytic
function. The allele n2854 contains a deletion which removes all sequences present in
the mature protease. The allele n2888 contains a stop codon upstream of the sequences
encoding the active protease and presumably results in early truncation of the protein.
These two alleles contain an average of 9.5 + 1.5 and 10.6 ± 1.7 extra cells in the anterior
pharynx, respectively, that result from the survival of cells which normally undergo
programmed cell death. Interestingly, at least 18 other alleles of ced-3 contain more
surviving cells on average than the protease-null alleles (table 1). This observation
suggests that these 18 alleles are perturbing cell death in a manner additional to
affecting ced-3's proteolytic activity. We offer two possible models which are not
mutually exclusive to explain these results. First, the products of the 18 alleles with
additional extra cells might interfere both with the proteolytic activity of ced-3 and with
another cell death component present in the cell. Second, since the protease-null alleles
have an intact N-terminus it is possible that this region is also important for cell-killing.
The alleles containing additional extra cells might perturb both the protease function of
ced-3 and the N-terminal cell-killing function. None of the existing ced-3 alleles
eliminate the N-terminal region so that we can not assess the function of such alleles to
distinguish between the two models presented above. Animals carrying the strongest
ced-3 allele n2433 make normal levels of ced-3 RNA. This allele behaves genetically as a
dominant-negative allele (figure 2, see below), suggesting that this allele produces
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protein, and supporting the notion that these alleles might be actively interfering with a
function seperate from the proteolytic function of ced-3.
Dominant-negative alleles of ced-3 hint at protein-protein interaction
Four of the ced-3 alleles studied act in a dominant-negative fashion. Animals
heterozygous for these alleles show a significant amount of additional cell survival,
whereas animals heterozygous for a deficiency uncovering ced-3 do not. This
observation confirms that the dominant cell-survival phenotype does not result from a
loss--of-function of these alleles. At least one of the dominant-negative alleles produces
normal levels of ced-3 transcript (n2433, figure 2), consistent with the notion that this
allele produces a mutated protein that acts to interfere with either ced-3 function or with
another cell death function. Interestingly, X-ray crystallographic studies of ICE suggest
that this protein acts as a dimer of p10O-p20 heterodimers (Wilson et al., 1994; Walker et
al., 1994). If CED-3 functions in a similar manner it is possible that the dominant
negative alleles of ced-3 interfere with this multimerization. The observation that ced-3
encodes a killing function seperate from its proteolytic activity raises the possibility that
this activity is related to the mechanism of action of the dominant negative alleles. If so,
it is likely that the 14 recessive alleles that inhibit programmed cell death to a greater
extent than the protease-null alleles act in a manner similar to the dominant negative
alleles, yet as heterozygotes produce an effect too weak to be detected.
The N-terminal region of ced-3 is essential for function and can interact with
components of the cell death machinery
Mutations in the N-terminal region of ced-3 which is not required for proteolytic
function can severly block programmed cell death (table 1). This observation suggests
that this region is essential for programmed cell death to occur properly. This region
can affect programmed cell death either by normally aiding in the proteolytic activation
of CED-3 or by interacting with another component of the cell death machinery to
induce cell death. These two possibilities are, again, not mutually exclusive.
Overexpression of a number of ced-3 truncation constructs can prevent
programmed cell death in wild-type animals (table 5). In particular, expression of only
the N-terminus fused to a heterologous protein will prevent cell death. This
observation suggests that these constructs are acting in a dominant-negative fashion to
inhibit cell death and that the N-terminal region of ced-3 can mediate this inhibition.
Again, as with the dominant-negative alleles, this inhibition could occur by preventing
mult:imerization of ced-3 or by inhibiting the activity of another component of the cell
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death machinery. Whether this mode of dominance is equivalent to the one described
in the previous section is unclear.
Cells that normally die are more sensitive to the genetic state of ced-3 than cells that
die ectopically
We have previously suggested that ced-3 is expressed in a large number of cells
in C. elegans, being functional only in those that normally die (Shaham and Horvitz,
manuscript in preparation). In ced-9(lf) animals ced-3 gets inappropriately activated
resulting in many ectopic cell deaths (Hengartner et al., 1992; Shaham and Horvitz,
manuscript in preparation). Our results suggest that ced-3 is less active in cells that die
ectopically than in cells that normally die. In particular we demonstrated that weak
mutations of ced-3 can prevent the lethality associated with the ectopic cell deaths of ced-
9(lf) animals, yet do not prevent normal programmed cell deaths. This observation
implies that cells that normally die either produce more ced-3 than ectopically dying
cells, or are better capable of transducing a killing signal mediated by ced-3. The nature
of this difference could lie in the levels of ced-3 expression, or in the presence or absence
of cell death components in cells that normally die versus those that die ectopically. We
propose that this difference is, in part, responsible for determining which cells live and
which cells die.
Materials and Methods
General Methods and Strains
The techniques used for culturing C. elegans were as described by Brenner (1974).
All strains were grown at 20°C. The wild-type strain used was C. elegans variety Bristol
strain N2. Genetic nomenclature follows the standard C. elegans system (Horvitz et al.,
19791). The mutations used have been previously described by Trent et al. (1983),
Hedgecock et al. (1983), Ellis et al. (1991), Ellis and Horvitz (1986), Brenner (1974), Clark
et al. (1988), Hengartner et al. (1992), or were isolated by us and members of our lab.
These mutations are listed below:
LGI: sem-4(n1378), ced-1(e1735)
LGIII[: ced-9(n1950n2161, n1950n2077), ced-11(n2744), ced-5(n2098)
LGIV: ced-3(n2923, n2446, n2449, n2425, n2447, n2427, n2443, n2438, n2436, n2877, n2921,
n1040, n2861, n1129, n2452, n1949, n2885, n2870, n1163, n2998, n2722, n2924, n2429,
n2888, n2445, n2854, n2426, n1165, n1286, n2444, n2859, n2922, n2442, n2721, n2889, n717,
n2439, n2441, n2720, n2719, n2454, n2440, n2432, n2830, n2871, n2430, n718, n3002, n2883,
n2433), dpy-4(e1166), sDf21
LGV: egl-1 (n487)
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Isolating ced-3 alleles and characterizing their phenotypes
The alleles used in this work were isolated in several screens by several members
of our lab. We isolated the alleles n2859, n2861, n2870, n2877, n2883, n2885, n2888,
n2889, n2921, n2922, n2923, n2924, and n3002 as suppressors of the maternal-effect
lethality of the loss-of-function mutation ced-9(n1950n2161). Specifically, unc-69(e587)
ced-9 (n1950n2161) /qC animals were mutagenized using 30 mM ethylmethanesulfonate
(EMS) and allowed to self. Unc-69 Fls were then placed at 10 to a plate and any F2s that
grew to adulthood were picked and used to establish a suppressed strain. The presence
of a ced-3 mutation in the strain was confirmed by a complementation test, followed by
mapping to show that the ced-9 suppressor was linked to chromosome IV. The alleles
we isolated as well as those isolated by others were generally removed from all other
markers in the background except in the cases noted in table 1. To quantitate cell
survival we scored for the presence of extra cells in the anterior region of the pharynx as
has been previously described (Hengartner et al., 1992). Specifically, for each strain
animals were mounted on a 5% agar pad on a slide containing 3-5 ~1 of 50 mM NaN3 in
M9 buffer (Sambrook et al.). A cover slip was applied, and animals were viewed using
Nomarski optics at a magnification of 10OX. The number of nuclei in the pharynx was
counted and compared to that present in wild-type animals. The difference represented
the number of extra cells. In wild-type animals an extra cell can be detected in
approximately 5% of the animals.
Allele sequence determination
To isolate coding regions and exon/intron junctions from mutant strains we
amplified the ced-3 genomic coding region using PCR and a set of 4 primer pairs.
Specifically, primers SHA2 and PCR2 were used to amplify exons 1-3, primers PCR3
and PCR4 were used to amplify exon 4, primers PCR5 and 650 were used to amplify
exons 5-7, and primers BD1 and 1200 were used to amplify exon 8. The sequence and
location of these primers is shown in table 6. DNA was amplified as follows. 1-10
worms were placed in 3 gl PCR lysis buffer (60 gg/ml proteinase K in 10 mM Tris
(pHS.2), 50 mM KC1, 2.5 mM MgC12, 0.45% Tween 20 and 0.05% gelatin) and frozen at
-70°C for 20-30 minutes. Samples were then placed in a PCR machine and allowed to
incubate at 60°C for 1 hr followed by a 15 minute incubation at 950C. Each sample was
then fully used as the DNA source in a standard PCR reaction using one of the primer
pairs described above. Samples were run on a 1.4% agarose gel, purified using 3-
agarase (New England Biolabs, Beverly, MA) and resuspended in 20 gl of TE buffer.
Samples were sequenced using the fmol sequencing kit (Promega Corporation,
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Madison, WI) following instructions of the manufacturer for 33P labeling. Samples
were run on a standard acrylamide sequencing gel (Life Technologies, Gaithersburg,
MD). The gel was dried and exposed to X-ray film for 1-5 days. For each allele we
determined the entire sequence of the ced-3 open reading frame as well as all the
exon/intron junctions. Sites where a potential mutation was identified were generally
resequenced.
RT-PCR, Southern and Northern Hybridization
Southern analysis was performed on n2452 and wild-type genomic DNA as
described in Sambrook et al. (1989) using the restriction enzymes HindIII, XhoI, and
Xba][ (New England Biolabs, Beverly, MA) and using a ced-3 cDNA as a probe. None of
the wild-type bands downstream of exon 3 were detected in the n2452 lanes.
RNA for northern analysis and Reverse Transcriptase PCR (RT-PCR) was
prepared as follows. 1-2 9 cm plates of worms were added to a liquid culture
containing S medium (Sulston and Hodgkin, 1988) and antibiotics. Frozen bacteria
were added to the culture as a food source. Cultures were harvested after 5-7 days, and
mRNA was prepared using the FastTrack mRNA preparation kit (Invitrogen, San
Diego, CA). Northern blots were performed as described in Sambrook et al. (1989)
using either a ced-3 cDNA as a probe or a lin-26 genomic fragment (M. Labouesse,
personal communication) as a control. RT-PCR was performed using the RNA
GeneAmp kit (Perkin Elmer Cetus, Norwalk, CT). The resulting bands were purified as
described in the previous section. The sequences of the n2440, n717, and n2854 products
were determined using and ABI sequencer (Applied Biosystems, Foster City, CA).
Plasmid constructions
Construct A was made by digesting the heat-shock vectors pPD49.79 and
pPD49.83 (A. Fire and P. Candido, personal communication) with the enzymes NheI
and .EcoRV, and ligating to a ced-3 cDNA derived from plasmid pS126 (Shaham et al.,
manuscript in preparation) which had been in vitro mutagenized using an in vitro
mutagenesis system (Amersham, Arlington Heights, IL) to alter the sequence TGT to
GCT resulting in a cysteine to alanine change in the active site of ced-3, and cut with the
enzymes SpeI and SmaI. Construct B was made by digesting the heat-shock vectors
described above with NheI, digesting pS126 using SpeI and partially digesting using
BglII, and digesting the GFP vector Tu#62 (M. Chalfie, personal communication) with
Bam]HI and SpeI, followed by ligation of the mixture. Construct C was produced in the
identical manner to construct B except that the lacZ vector pPD21.28 was used instead of
the GFP vector. Construct D was made in the identical manner to construct C.
156
Construct E was made by digesting the ced-3 genomic plasmid pJ40 (Yuan et al., 1993)
with the enzymes Bgl II and ApaI and ligating to the GFP vector Tu#62 which had been
cut using the enzymes BamHI and ApaI. Construct F was made in the identical manner
to construct E except that the lacZ vector pPD21.28 was used instead of the GFP vector.
Construct G was made by digesting pJ40 with the enzymes SalI and Apa, and ligating to
the acZ vector pPD21.28 which had been cut using the enzymes SalI and ApaI.
Germline transformation
Our procedure for microinjection and germline transformation followed that of
Fire (1986) and Mello et al. (1991). DNA for injections was purified using the Qiagen
system for DNA purification (Qiagen, Inc., Chatsworth, CA) and following the
instructions of the manufacturer. The concentrations of all plasmids used for injections
were between 50-100 [tg/ml. All constructs were co-injected with the pRF4 plasmid
containing the rol-6(su1006) gene as a dominant marker. Animals carrying the pRF4
plasimid exhibit a Rol phenotype. All transformation experiments were into wild-type
animals. Approximately 30 animals were injected in each experiment, and
approximately 50-100 F1 Rol animals were picked onto separate plates. F1 animals
segregating Rol animals were established as lines containing extrachromosomal arrays
(Way and Chalfie, 1988).
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Table 1. Phenotypes and sequence lesions of ced-3 mutants.
Column 1 indicates the allele examined, sDf21 is a deficiency uncovering ced-3
(see materials and Methods). Column 2 indicates the number of extra cells in the
anterior pharynx of animals homozygous for a given allele + standard deviation,
numbers in parentheses indicate the number of animals observed. Column 3 indicates
the number of extra cells in the anterior pharynx of animals heterozygous for a given
allele + standard deviation, numbers in parentheses indicate the number of animals
observed. Column 4 indicates the nucleotide alteration observed in each allele,
undelined residues are altered, wild type sequence is to the left of each arrow, mutant
sequence is to the right. Column 5 indicates the predicted change in the RNA or protein
produced in a given mutant. Numbers indicate the amino acid residue. All of the ced-3
alleles were separated from background mutations except for some which were scored
in the following genetic backgrounds: n1163; egl-1 (n487), sem-4(n1378) ced-1 (e1735); ced-
11(n.2744); n2998, sem-4(n1379); ced-5(n2098) ced-3(n2722), ced-3(n1165); egl-1 (n487), sem-
4(n1378); ced-5(n2098) ced-3(n2721), sem-4(n1378); ced-5(n2098) ced-3(n2719), sem-
4(nl378); ced-5( n2098) ced-3( n2830), ced-3(n2871) dpy-4 (el166), ced-3( n3002) nIs50.
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Mutant/ Mutant no.
extra cells in anterior
pharynx ± SD
0.13 + 0.4 (40)
0 (15)
0.13 + 0.4 (15)
0.2 _ 0.4 (15)
0.3 + 0.6 (17)
0.8 + 0.6 (15)
1.2 + 0.9 (19)
1.8 ±:1.7 (15)
2.1 ± 1.2 (10)
6.2 ±: 1.5 (10)
7.0 ± 1.5 (10)
7.9 : 2.3 (10)
8.3 t: 1.7 (31)
8.4 ± 1.6 (10)
8.7 ± 1.3 (10)
9.5 : 1.5 (15)
9.5 ± 2.3 (10)
9.6 ±: 1.3 (10)
9.7 4:1.6 (10)
10.2 :± 1.7 (15)
10.3 :± 1.7 (15)
10.6 :± 1.0 (15)
10.6 1.7 (14)
10.6 1.6 (15)
10.6 1.7 (10)
10.7 1.1 (13)
10.7 1.8 (10)
10.7 2.1 (10)
10.9 1.5 (15)
10.9 1.5 (15)
10.9 1.9 (10)
C10.9 1.9 (10)
10.9 1.5 (10)
11.0 ±- 1.3 (15)
11.1 - 1.7 (15)
11.1 ±: 1.2 (10)
11.2 : 2.0 (10)
11.3 ± 1.3 (15)
11.5 t: 1.7 (15)
11.6 ± 1.5 (15)
11.6 ± 1.9 (15)
11.6 ±: 2.4 (15)
11.7 t: 1.7 (15)
11.7t: 1.2 (10)
11.7t: 1.5 (15)
11.7 : 1.7 (15)
11.8+: 1.2 (10)
11.8 + 1.1 (10)
12.1 + 1.5 (15)
12.2 + 1.1 (15)
12.4 t 1.0 (10)
Table 1
Mutant/+ no. extra cells
in anterior pharynx +
SD
0.13 ± 0.4 (15)
0.13 ± 0.4 (15)
0.13 ± 0.4 (15)
0.13 ± 0.4 (15)
0.07 ± 0.3 (15)
0 (15)
0.07 + 0.3 (15)
0.07 ± 0.3 (15)
0.13 ± 0.4 (15)
0.3 0.6 (15)
0 (15)
0.13 0.4 (15)
0 (15)
0.07 0.3 (15)
0 (15)
0.3 ± 0.5 (15)
0.07 ± 0.3 (15)
0.2 t 0.4 (15)
0.13 ± 0.4 (15)
0.08 ± 0.3 (12)
0.2 + 0.4 (15)
0.13 ± 0.4 (15)
0.2 + 0.4 (15)
0 (15)
0.13 t0.4 (15)
0.3 + 0.5 (15)
0.3 ± 0.6 (15)
0.13 ± 0.4 (15)
0.07 + 0.3 (15)
0.2 + 0.4 (15)
0.3 ± 0.5 (15)
0.07 + 0.3 (15)
0.13 ± 0.4 (15)
0.07 + 0.3 (15)
0.2 + 0.4 (15)
0 (15)
0 (15)
0.14 0.5 (14)
0.2 0.6 (15)
0.07 0.3 (15)
0.07 0.3 (15)
0.5 ± 0.6 (15)
0.07 ± 0.3 (15)
0.07 + 0.3 (14)
1.0 ± 0.8 (15)
0.73 ± 0.6 (15)
0.07 ± 0.3 (15)
0 (15)
0.13 ± 0.4 (15)
0.5 ± 0.9 (15)
0.07 ± 0.3 (15)
Nucleotide change
GCG->GTG
GTG->TTG
CGC->CAC
GGC->GAC
TCG->TTG
GGA->AGA
CCG-> TCG
GGA->AGA
CTT->TT
CTT-> TTT
CCT->CTT
CTC->_TTC
GGT-> AGT
GCA->GTA
deletion in intron 3
CAA-> TAA
GAG->AAG
AGA->AAA
TCC->TTC
TGG->TAG
GCA->GTA
GAG->AAG
TCA->TTA
CGA->TGA
TAA->AAA
G I gttt->G I gt t
GAG->AAG
CAG->TAG
TGG->TG A
GCA-> ACA
TGG->TAG
GCA-> ACA
GGA->GAA
CAC-> TAC
GAG->AAG
cag I CA->caa I CA
CTC-> TTC
AGA->AAA
CAC-> TAC
GGA->AGA
GCT->ACT
CGCAA->CGTAA
TAC->AAC
GGA->AGA,G GA-
>AGA
CGA->CAA
GCT->GTT
CTC->TTC
GAG I gta->GAG I a ta
TCA->CCA
GGC->AGC
Amino acid /splice
change
A347V
V311L
R51H
G277D
S446L
G474R
P400S
G474R
L269F
L269F
P241L
L27F
G261S
A449V
Q412ochre
E456K
R429K
S486F
W436amber
A418V
E318K
S314L
R154stop
ochre504K
Exon 5 donor
E483K
Q404amber
W428opal
A420T
W406stop
A420T
G243E
H315Y
E318K
Exon 7 acceptor
L30F
R429K
H315Y
G65R
A466T
Q401ochre/splice donor
Y235N
G65R and G474R
R359Q
A466V
G65R
Exon 7 donor
S314P
G360S
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Genotype
Wild type
n12923
n2446
n2449
in2425
n12447
n2427
n12443
n2438
in2436
ni2877
112921
l1 040
ni2861
n1129
n12452
n1949
t12885
n12870
11163
n12998
n2722
n2924
n2429
n2888
rn2445
r12854
rn2426
r,1165
r1286
n2444
K2859
i12922
n2442
n2721
n12889
n1717
n2439
n2441
i12720
n2719
n2454
n2440
n2432
n2830
n2871
n2430
r,!718
n3002
n2883
n.2433
sDJ21
Table 2. Category I ced-3 mutants do not prevent lethality of ced-9(n1950n2077) animals.
Column 1 indicates a given allele. Column 2 indicates the number of
homozygous ced-9 animals observed. Column 3 indicates the number of ced-9
homozygotes producing live progeny. Each ced-9 homozygote could contain zero, one,
or two copies of a given ced-3 allele since they were derived from the self progeny of
ced-9 /+; ced-3 /+ animals. If suppression is occuring, 3/4 of the ced-9 homozygotes
scored should produce viable progeny. If no suppression occurs, none of the ced-9
homozygotes should produce viable progeny. If intermediate numbers occur they
might reflect either a bias in selection of the maternal population or reduced but not
lack of suppression.
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Table 3. ced-3(n2871) is a dominant suppressor of ced-9(n1950n2161) lethality.
The progeny of five animals of an indicated genotype were observed. The ced-9
chromosome was marked with the mutation unc-69(e587), and the ced-3 chromosome
was marked with dpy-4(e1166). The number of Dpy-4 progeny expected if the ced-3
allele is a suppressor is indicated in the last column.
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Table 4. A ced-3-lacZ fusion construct can suppress the lethality of ced-9(lf) animals.
ced-9 (if) alleles were established containing an extrachromosomal array of
construct F (table 5). The presence or absence of progeny that grew past the L4 stage of
a given strain is indicated. +, progeny produced, -, no progeny produced.
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Table 5. ced-3-reporter fusion constructs can prevent programmed cell death.
Constructs are indicated graphically with names A-G indicated to the left of each
construct. Black boxes indicate C. elegans heat shock promoters, slanted hatched boxes
indicate GFP sequences, dotted boxes indicate ced-3 cDNA sequences, checkered boxes
indicate lacZ sequences, vertically hatched boxes indicate endogenous ced-3 promoter
sequences, white boxes indicate ced-3 genomic coding sequences. The genotype into
which each construct was introduced is indicated in column 2. The average number of
extra cells in the anterior pharynx of animals of a given strain is indicated in column 3.
The number of animals observed for each strain is indicated in column 4. The range of
extra cells observed in each strain is indicated in column 5.
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Figure 1. Positions of ced-3 mutations.
An alignment of sequences of CED-3 proteins from the nematodes C. elegans, C.
briggsae, and C. vulgaris (Yuan et al., 1993) with sequences of mouse and human ICE
(Thornberry et al., 1992), mouse Nedd-2 (Kumar et al., 1994), human ICH-1L and S
(Wang et al., 1994), and CPP32 (Fernandez-Alnemri et al., 1994). Shaded regions
represent sequences that are conserved between the nematode species and any one of
the mammalian proteins. Missense mutations are indicated with the allele name and
the altered residue above the wild-type residue. Nonsense mutations are indicated with
the allele name and a stop sign above the altered residue. Introns are indicated by
arrow heads. Mutations in splice donor or acceptor sites are indicated as Do or Ac
respectively followed by the allele name.
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Figure 2. Northern blot of 11 ced-3 mutants.
RNA from 11 ced-3 mutants was blotted and probed (see Materials and Methods)
with either a ced-3 cDNA probe (top panel) or with a lin-26 cDNA probe as a loading
control (bottom pannel).
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Figure 3. ced-3(n2452) deletes regions necessary for CED-3 catalytic activity.
Left panel, southern blot of genomic DNA from ced-3(n2452) and wild-type
animals. DNA was digested with XhoI. Size of bands is shown to the left. Right panel,
southern blot of genomic DNA from ced-3 (n2452) and wild-type animals. DNA was
digested with HindIII. Size of bands is shown to the right. Both blots were probed with
a ced-3 cDNA probe.
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Appendix
The C. elegans cell death genes ced-3 and ced-4 might be expressed in both cells that
die and cells that do not die
Shai Shaham and H. Robert Horvitz
Howard Hughes Medical Institute
Department of Biology, Room 68-425
Massachusetts Institute of Technology
Cambridge, Massachusetts 02139, USA
This chapter represents
3 and ced-4.
a preliminary characterization of the expression patterns of ced-
181
Abstract
Mutations in the genes ced-3 and ced-4 prevent programmed cell death in the
nematode Caenorhabditis elegans. We used lacZ and GFP fusion constructs as well
as RNA in situ hybridization to analyze the expression pattern of the ced-3 gene
during development. Our results suggest that the expression of ced-3 is wide spread
and that the gene can be expressed both in cells that die and cells that do not die. We
also examined expression of the ced-4 gene using both epitpoe tagging experiments
and anti-ced-4 Abs. Our preliminary data suggest that this protein is excluded from
the nuclei of cells overexpressing the gene, and that the gene is expressed in many
cells during embryogenesis.
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Introduction
Programmed cell death is a molecularly conserved process that occurs in all
metazoans examined (Gliicksman, 1950; Ellis et al., 1991). This process plays many roles
during the development of organisms such as shaping tissues, eliminating cells whose
function is no longer needed, and eliminating cells that might be harmful. In the
nematode Caenorhabditis elegans 131 of the 1090 cells born during the development of
the hermaphrodite, undergo programmed cell death (Sulston and Horvitz, 1977; Kimble
and Hirsh, 1979; Sulston et al., 1983). This process usually occurs within an hour after
the cell is born and is morphologically and ultrastructurally similar to the mammalian
process of cell death termed apoptosis. Mutations in the genes ced-3 and ced-4 prevent
programmed cell death in C. elegans (Ellis and Horvitz, 1986) suggesting that the
activity of these genes is necessary for cells to die. Recent work (Shaham and Horvitz,
manuscript in preparation) has demonstrated that overexpression of these genes is
sufficient to cause cells that normally live to undergo programmed cell death under
certain conditions, suggesting that the activity of these genes can be sufficient to induce
programmed cell death. However, it has been suggested, based on genetic criteria
(Shaham and Horvitz, manuscript in preparation) that both ced-3 and ced-4 are
expressed in many cells in the animal and that a network of regulatory interactions
among the products of these two genes and the product of the cell survival gene ced-9
(which is similar to the mammalian bcl-2 gene which also functions in preventing
programmed cell death, Hengartner et al., 1992; Hengartner and Horvitz, 1994; Vaux et
al., 1988) post-translationally mediate activation or suppression of the cell death
program. The ced-3 gene encodes a protein with similarity to the class of mammalian
proteases represented by the protease Interleukin-1 3 converting enzyme (ICE) (Yuan et
al., 1993; Thornberry et al., 1992). Overexpression of members of this family in culture
results in programmed cell death (Miura et al., 1993, Kumar et al., 1994, Wang et al.,
1994; Fernandes-Alnemri et al., 1994). In addition, mice harboring a knockout mutation
in ICE reveal defects in Fas-mediated cell death, suggesting that ICE plays an important
in vivo role in regulating cel death (Kuida et al., 1995). The ced-4 gene encodes two
novel proteins designated CED-4L and CED-4S which have opposite functions (Shaham
and Horvitz, manuscript in preparation; Yuan and Horvitz, 1992). CED-4S can cause
cells to undergo programmed cell death (Shaham and Horvitz, manuscript in
preparation), whereas CED-4L can protect cells from dying.
To better understand the functions of the CED-3 and CED-4 proteins we have
attempted to characterize their expression patterns. Our results suggest that both CED-
3 and CED-4 are likely to be widely expressed in C. elegans. Both proteins are likely to
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be present in both cells that die and cells that do not die. Our results also suggest that
the CED-4 protein is probably excluded from the nuclei of expressing cells.
Results
ced-3-lacZ fusion constructs are expressed in embryos and early larvae as well as in
the tail of L4 and adult males
To determine the expression pattern of ced-3 we constructed translational fusion
constructs between the ced-3 gene and E. coli lacZ gene (see Materials and Methods).
Transgenic lines containing these constructs were stained using X-gal to visualize
expression of the lacZ protein. We examined separate lines containing one of each of
three different translational fusions shown in figure 1. Transgenic animals containing
constructs 1 and 2 showed a similar staining pattern to animals containing construct 3
which did not contain a nuclear localization signal. As figure 2 shows we examined
hermaphrodites of various stages and observed staining in 200 minute-old embryos,
later staged embryos, and first larval stage (L1) larvae. Early embryos, older larvae, and
adults either did not stain at all or contained only a small number of staining cells. This
general staining pattern is consistent with our previous results (Yuan et al., 1993)
suggesting that expression of ced-3 RNA in hermaphrodites is primarily embryonic, and
is greatly reduced in older larvae. Our results are also consistent with the observations
that most programmed cell deaths in hermaphrodites occur in embryos and Lls, and
are consistent with the notion that ced-3 expression is required for cell death to occur.
Interestingly, many of the cells we observed to stain do not die during normal
development, suggesting that the mere expression of ced-3 might not be sufficient to kill
cells in vivo (see Discussion), however, some of the staining cells were cells destined to
die (see below). Many, cells in the male tail undergo programmed cell death during the
L4 stage (Sulston and Horvitz, 1977). We examined the expression of construct 1 during
this stage in males. As figure 2d shows several cells stained in the male tail during this
period and in adult males that did not stain in the hermaphrodites. This result supports
the notion that ced-3 expression is necessary for programmed cell death to occur.
Because these studies used transgenes which are overexpressed we can not rule out the
possibility that aspects of the staining pattern we observed are artefactual.
ced-3-lacZ fusion constructs that prevent cell death are expressed in some cells
destined to die
The lacZ constructs used in the experiments described above can prevent
programmed cell death in wild-type animals (Shaham et al., manuscript in preparation).
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Interestingly, some of the undead cells stain with X-gal, suggesting that cells that
normally undergo programmed cell death actively transcribe the ced-3 gene. Figure 3
shows two surviving tail spike cells which should have died during embryogenesis
(Sulston et al., 1983), but survive in an L1 animal and express the ced-3-lacZ transgene.
This observation is consistent with ced-3-GFP results (see below), and with the notion
that ced-3 activity is necessary within a cell that dies for that cell to die (Yuan and
Horvitz, 1990; Shaham and Horvitz, manuscript in preparation) (see Discussion). Why
expression of ced-3 in some cells is sufficient to drive the death program, and in others is
not is not clear (see Discussion).
A ced-3-GFP fusion construct is expressed in both cells that die and do not die
To further examine the expression pattern of the ced-3 gene we examined
expression of two different trangenes containing a fusion to the GFP reporter gene
(figure 4). Transgene 4 (figure 1) containing a translational fusion to ced-3 at the
identical position as transgene 1 containing lacZ as the reporter gene did not show any
levels of expression as assayed by observation of live animals under a fluoresence
micoscope. Interestingly, this trangene was capable of preventing programmed cell
death (Shaham et al., manuscript in preparation), suggesting that protein was made
from the construct. These observations suggests that the GFP moiety might not be
properly folded, or that its chromophore group is not accessible to the impinging light
and suggests that a transcriptional fusion to GFP might be more appropriate for
examining ced-3 expression. As figure 4 shows, transgene 5 containing a transcriptional
fusion to ced-3 does show expression, yet does not prevent programmed cell death (data
not shown). Using this GFP transgene we observed a similar expression pattern to that
using the lacZ transgenes described above. 200-minute embryos stained strongly with
the construct, and staining persisted into the first larval stage and greatly diminished in
older animals. Expression was detected in many cells that do not die as shown in figure
4. Because we were able to observe GFP expression in live animals we could directly
assay if cells undergoing programmed cell death were expressing our GFP constructs.
As shown in figure 4 we could readily identify cell corpses in embryos that expressed
GFP. This result suggests that some cells that die actively transcribe ced-3, and supports
the indirect observations made in the previous section.
ced-3 RNA is expressed in many cells during embryogenesis
To examine the expression of the ced-3 gene more directly we used RNA in situ
hybridization to follow expression of endogenous ced-3 RNA in embryos (see Materials
and Methods). We were unable to assess the presence of ced-3 RNA in late embryos,
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larvae and adults. However, we were able to observe staining in earlier embryos. As
shown in figure 5 we could identify ced-3 RNA in many cells during mid
embryogenesis. Interestingly, the RNA was mostly localized to the nuclei of expressing
cells in a manner similar to that described by Seydoux and Fire, 1994. Staining was
clearly detected in many cells that do not die, consistent with our observations
described in the previous sections. This result supports our previous hypothesis
(Shaham et al., manuscript in preparation) suggesting that ced-3 is likely to be expressed
in many and perhaps all cells in the animal, however we have not yet performed
adequate controls to rule out staining artefacts in our in situ protocols.
ced-4 encodes a 67 kd protein which is present in ced-3 mutants
To examine the CED-4 protein we generated anti-CED-4 antibodies in rabbits
(see Materials and Methods). After affinity purifying our antibodies we examined their
staining pattern on a Western blot. As figure 6 shows our antibodies recognize a band
of approximately 67 kd, the expected size for the CED-4 protein, which is not present in
animals carrying the mutation ced-4(n 1162) which does not produce any detectable
RNA (Yuan and Horvitz, 1992). Introduction of a transgene containing wild-type ced-4
genomic sequences into n1162 animals restores the 67 kd band (data not shown). This
observation suggests that ced-4 encodes a 67 kd protein as has previously been
previously described (Yuan and Horvitz, 1992). Interestingly, ced-4 encodes two
alternatively spliced messages, ced-4L and ced-4S (Shaham et al., manuscript in
preparation). The ced-4L transcript is at least 10 fold less abundant than ced-4S. We did
not detect two ced-4-specific bands in our western blots, suggesting that CED-4L is
probably less abundant than CED-4S. To test whether mutations in the ced-3 gene
might affect the size or level of CED-4 protein we examined the expression of the
protein in animals containing different ced-3 mutations. As shown in figure 6, none of
the ced-3 mutants showed significant alterations in size or amount of CED-4 protein
produced, suggesting that ced-3 does not grossly affect the nature of the CED-4 protein.
CED-4 protein is likely to be excluded from nuclei and is expressed in many cells
To examine the intracellular localization of the CED-4 protein as well as to
characterize its expression pattern we attempted to observe CED-4 reactivity in situ
with our antibodies. We did not observe any staining in wild-type animals, suggesting
that CED-4 might be present in only a small amount, might be diffuse, or might be
hidden from our antibodies. To check that our antibodies were capable of detecting
CED-4 protein in situ we examined staining in lines presumably overexpressing the
CED-4 protein. Figure 7a shows staining in an embryo transgenic for several copies of
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the ced-4 genomic region. Staining is clearly excluded from the nucleus and seems to be
punctate. The staining pattern also seems to be membrane-associated. We observed an
identical localization in animals carrying a ced-4 transgene containing an epitope tag
which is capable of rescuing the Ced-4 mutant phenotype, suggesting that this construct
is expressed at least in part in the correct location (see Materials and Methods) and
stained with an anti-epitope antibody (figure 7a). We also examined the presence of
CED-4 reactivity in the ALM neurons of animals containing a transgene in which a ced-4
cDNA is transcribed under the control of the mec-7 promoter which is expressed in the
ALM neurons (Savage et al., 1989). Interestingly, although immunoreactivity was
excluded from the ALM nuclei, the punctate staining pattern was not observed, and
staining was more cytoplasmic (figure 7b). Because the mec-7 promoter is highly
expressed it is possible that the difference between the intracellular localizations in the
two experiments described above is due to levels of expression. These observations
suggest that our antibodies are capable of detecting ced-4 expression in situ, and that the
CED-4 protein is excluded from the nuclei of expressing cells.
Discussion
The determination of the intracellular localization and tissue distributions of
proteins involved in cell death is important to understanding their mechanisms of
action. In this appendix we have presented preliminary data concerning the expression
of the C. elegans cell death genes ced-3 and ced-4. Our results suggest that both proteins
are likely to be expressed throughout the animal in both cells that die and cells that do
not die. For ced-3 we demonstrated using transgenes containing lacZ and GFP fusions
to ced-3 genomic sequences that these fusions are expressed in many cells, and results of
RNA in situ hybridization suggest a widespread expression pattern at least during mid-
embryogenesis. For ced-4, epitope tagging experiments as well as antibody stainings
suggest that the protein is present in many cells. These results are consistent with our
previous hypothesis based on genetic evidence that ced-3 and ced-4 are likely to be
expressed in many cells that do not die as well as in cells that do (Shaham and Horvitz,
manuscript in preparation). Our results also suggest that in vivo it is probably not
always the case that expression of either ced-3 or ced-4 is sufficient to kill cells, since
many cells that do not normally die seem to express both proteins. We have previously
described a set of potential post-translational regulatory interactions among the
products of the ced-3 and ced-4 genes and the product of the ced-9 gene (Shaham and
Horvitz, manuscript in preparation; Shaham and Horvitz, manuscript in preparation;
Hengartner et al., 1992). It is possible that these interactions directly determine the cell
death fate of a cell and that expression of ced-3 and ced-4 is not the unique determining
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factor of that fate. The fact that not all the cells we observed stained using the
techniques outlined above could be interpreted in a number of ways. One possibility is
that we have not optimized staining conditions in the experiments described above. It
is also possible that protein at the required levels is normally present in all cells, but is
only transcribed in a smaller subset of cells. This perdurance would result in staining
patterns in animals transgenic for either transcriptional fusions to reporter genes or in
animals containing many copies of a given gene that would not be expressed in all cells.
It is also possible that the animals we observed were mosaic for the transgenes used,
and were thus not expressing in all cells. Finally, it is possible that the staining patterns
we observed are similar to the endogenous distributions of the CED-3 and CED-4
proteins. The latter possibility seems less likely since cells which have been suggested
to contain CED-3 and CED-4 protein (such as the PVM neuron, Shaham and Horvitz,
manuscript in preparation) have not stained using the techniques described above.
It is likely that the CED-4 protein is excluded from nuclei of expressing cells as
shown in figure 7. However, we can not reliably indicate a localization outside the
nucleus. CED-4 staining patterns in animals transgenic for multiple copies of the ced-4
gene seem to contain immunoreactivity which is punctate and is plasma membrane
associated. Interestingly, the CED-4 protein terminates in a dicysteine sequence which
has been shown to be a substrate for geranyl geranylation in some instances. Addition
of this hydrophobic moiety would serve to anchor the protein in the membrane. Two
observations shed some doubt about the membrane localization and its mode. First,
sequences of CED-4 genes from related nematodes do not terminate in dicysteines (S.
Shaham, data not shown) suggesting that geranyl geranylation might not be important
for CED-4 function. Second, CED-4 immunoreactivity in ALM neurons expressing a
ced-4 cDNA under the control of the mec-7 promoter is not confined to the membrane
and is equally distributed in the cytoplasm (figure 7b).
Our results suggest preliminary possibilities for the localization and cell
distribution of CED-3 and CED-4. More refined analyses using reagents that can detect
expression of the endogenous products is necessary to more precisely define these
parameters.
Materials and Methods
Plasimid constructions
All the plasmids described in this work have been prviously described (Shaham
et al., manuscript in preparation) except for the ones described below. Plasmid 3 was
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constructed in the identical manner to plasmid 1 except that a lacZ gene not containing a
nuclear localization signal was used. Plasmid 5 containing a transcriptional ced-3-GFP
fusion was constructed as follows: plasmid pJ40 (Yuan et al., 1993) was amplified using
the M13 reverse primer (New England Biolabs, Beverly, MA) and a 21 nucleotide
primer complementary to sequences immediately upstream to the ATG and containing
a SalI site at its 5' end. The resulting product, as well as pBluescript (Stratagene, La
JollaL, CA), was digested with the enzymes BamHI and SalI and ligated. The resulting
plasmid was then digested with SalI and NotI and ligated to the GFP insert of plasmid
Tu#62 (M. Chalfie, personal communication) cut with SalI and EagI. The epitope
tagged ced-4 genomic fragment was constructed as follows. In vitro mutagenesis on the
plasmid C10OD8-5 (Yuan and Horvitz, 1992) was performed using the primer CED-4-
OLIGO-1 (5'
CCGATGCCTGTTGGATACCCATACGACGTCCCAGACTACGCTGAAAAAGAAGA
AGAT 3') and following the instructions of the manufacturer. This resulted in the
insertion of a nine amino acid flu epitope (Kolodej and Young, 1991) having the
corresponding 12CA5 antibody epitope at the carboxy terminous of the CED-4 protein.
RNA in situ hybridization and antibody techniques
Techniques for RNA in situ hybridizations were as described in Mitani et al.,
1993 using the oligo CED-3 ANTI2 (5'CACGAGTGAATTTTAAGCG
TAGTCTGGGACGT(CGTATGGGTAGACGGCAGAGTTTCG 3'). Antiserum against
the CED-4 protein was generated as follows: gel purified CED-4 protein generated from
the plasmid pJ76 (Yuan and Horvitz, 1992) was electroeluted from the gel, dialyzed
against PBS (Sambrook et al., 1989), emulsified with complete Freund's adjuvant and
injected into New Zeland White rabbits. The rabbits were boosted twice with a protein
produced in E. coli from the pMal-c plasmid (New England Biolabs, Beverly, MA)
containing the E. coli malE gene fused to the BamHI-EcoRI fragment of the ced-4 cDNA
containing the terminal 340 amino acids (Yuan and Horvitz, 1992). This protein was
purified on an amylose resin, dialyzed against PBS and injected with incomplete
Freund's adjuvant into rabbits. Whole serum or affinity purified serum was used to
detect CED-4 protein on methanol/paraformaldehyde fixed animals. Fixation of
animals was done as described in Finney and Ruvkun (1990) or using a modified
method (M. Finney and G. Ruvkun, personal communication) except that we used a 30
minute 2-mercaptoethanol treatment. Fixed animals of mixed stages were incubated at
room temperature with 1% serum diluted in PBS and 1% BSA (Bovine Serum Albumin)
overnight. Animals were then washed with PBS three times for 20 minutes each,
incubated at 37°C with 5% goat anti-rabbit antibodies conjugated to FITC (Cappel,
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Durham, NC) for two hours, washed again three times for 20 minutes each, and
resuspended in 30 gl of PBS. Five microliters of the final suspension were mixed with
five microliters of phenylenediamine (Sigma, St. Louis, MO; lmg/ml in 90% glycerol in
PBS) and mounted on a slide for observation using a fluorescent microscope with a
100X objective. Only lines containing extra copies of the ced-4 gene showed any
staining. Western blots were performed as described in Harlow et al., 1988 using an
alkaline phosphatase conjugated secodary antibody (Cappel, Durham, NC).
lacZ and GFP staining procedures
lacZ staining procedures were as described by Fire et al., 1992. GFP detection
procedures were as described by Chalfie et al., 1994.
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Figure 1. Reporter constructs used to assay ced-3 expression.
Constructs are described in Materials and Methods. White boxes represent ced-3
genomic coding sequences, black boxes represent a nuclear localization signal, stippled
boxes represent ced-3 sequence 5' of the ATG, hatched slanted boxes represent GFP,
hatched vertical boxes represent lacZ. Construct are named 1-5 as indicated to the left of
each construct.
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Figure 2. ced-3-lacZ expression pattern.
Transgenic animals carrying construct 2 (figure 1) stained for lacZ expression (see
Materials and Methods). a, embryos, b, L1 larva, c, older larvae, d, Adult male tail.
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Figure 3. Undead tail spike cells express a ced-3-lacZ transgene.
Transgenic L1 animal carrying construct 2 (figure 1) stained for lacZ expression
(see Materials and Methods). Arrows are pointing at the two tail spike cells
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Figure 4. ced-3-GFP expression pattern.
Transgenic embryos carrying construct 5 were visualized under a fluoresence
microscope. a, embryo, b, Nomarski phtograph of an embryo, arrow indicates a cell
corpse, c, fluorescent image of the same embryo shown in b, arrow pointing at the same
cell corpse shown in b.
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Figure 5. ced-3 RNA in situ hybridization.
Wild-type embryos stained for ced-3 RNA expression using an in situ
hybridization technique (see Materials and Methods). Arrows indicate some staining
cells.
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Figure 6. CED-4 is expressed at normal size and levels in ced-3 mutant backgrounds.
Western blot showing reactivity of anti-CED-4 antibody (see Materials and
Methods). Lanes are labeled with the relevant genotype. Arrow indicates the location
of the CED-4 band.
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Figure 7. CED-4 protein is excluded from nuclei.
a, ced-4 mutant animal transgenic for several copies of a flu epitope tagged ced-4
genomic fragment stained using an anti-epitope antibody. Arrows indicate some
staining cells. b, An ALM neuron overexpressing CED-4 in an animal transgenic for a
Pniec-7ced-4 fusion construct stained with anti-CED-4 antibodies. Arrow indicates the
staining cell.
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Speculations on a few issues
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In this section I would like to discuss a number of issues relating the work
described in the previous chapters to cell death in general. Key questions remain
concerning the applicability of the findings in worms to mammals, and even in C.
elegans it is not clear how the various cell death genes interact on a molecular level.
Below are described a number of these issues peppered with rampant speculations
about what the answers might be.
What determines if a cell lives or dies?
The work described in previous chapters has alluded to the fact that cells that
normally die in C. elegans have a greater propensity to die than cells that normally
survive. Two observations are the following. 1) Cells that normally die die, and cells
that normally live live. This observation clearly shows a difference between living cells
and dying cells, and since in most cases in C. elegans cell death is thought to have a cell-
autonomous component it is reasonable to assume that the differences between dying
cells and living cells might, in part, reside within each cell. 2) Weak mutations in ced-3
block ectopic cell deaths induced by loss-of-function mutations in ced-9 but will not
block the deaths of cells that normally die. This observation suggests that there is an
inherent difference between cells that normally live and normally die, and that this
difference is in some way related to the function of ced-3. Cells that normally die are
either more sensitive to the activity of ced-3 or are more sensitive to some aspect of the
regulation of ced-3 activity. Thus, it seems plausible that some aspect of ced-3 function is
responsible for the differences between cells that live and those that die. This difference
could occur upstream or downstream of ced-3. A number of hypotheses are presented
below.
One intriguing observation presented in chapter 3 is that of the effect of
endogenous ced-4 activity on the ability of overexpression of ced-3 to cause cell death. It
turns out that it is irrelevant whether the endogenous ced-4 gene is wild-type or mutant
when the ALM neurons are killed by overexpression of ced-3 in an otherwise wild-type
background. However, if a loss-of-function mutation in ced-9 is introduced into the
background the ced-4 mutation does make a difference. In fact, in the absence of ced-9, a
ced-4 mutation will inhibit some of the killing activity of the overexpressed ced-3. Based
on the model proposed in chapter 3, one possible interpretation of these results is as
follows. The ALM neurons are cells that normally do not die, and thus their
endogenous cell death machinery should exist in an inactive form. If we assume that
ced-9 normally acts to inhibit the activity of ced-4S in cells that live, then it would make
sense that the state of endogenous ced-4 is irrelevant to killing by ced-3 overexpression
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in a wild-type background. When a wild-type ced-4 product is present it should be fully
inhibited by the wild-type ced-9, and hence will be inactive. This is the same as not
having any ced-4 around at all as in the case of the mutated ced-4. However, in the
absence of wild-type ced-9 ced-4 is now not subject to negative regulation. Thus, if ced-4
is wild-type it will help activate ced-3, but if ced-4 is mutated it will not activate ced-3,
leading to reduced killing. This interpretation suggests that one way in which cells that
live and cells that die are different is in the state of their ced-9 product. Active ced-9
results in survival, and inactive ced-9 results in death. This conclusion is, in fact, similar
to that described by Hengartner et al. (1992)1. In their paper the authors concluded that
since the absence of ced-9 results in ectopic cell death, then it is possible that the state of
ced-9 regulates the survival decision.
However, it seems that control of the difference between cells that die and those
that survive is likely to be regulated on other levels as well. We demonstrated in
chapter 4 that the ced-4L product is likely to protect cells from cell death. Mutations in
this transcript are likely to make cells that normally live more sensitive to death and
overexpression of this transcript will prevent the deaths of cells that normally die.
These characteristics of ced-4L are very similar to those of ced-9. Does ced-4L act
similarly to ced-9? We do not have a mutation in ced-4L which does not also affect the
ced-4S product. However, it is tempting to speculate that selective inhibition of ced-4L
will result in lethality and ectopic cell death, just as does elimination of ced-9. Thus,
according to this model, neither ced-9 nor ced-4L are sufficient on their own to protect
from cell death. Both are needed for protection to occur. This model is completely
consistent with that outlined in the previous paragraph. Thus, it is also possible that the
state of ced-4L is crucial to the decision of whether a cell lives or dies. In the case of ced-
4L we have an inkling into how this product might be regulated. Since ced-4L results
from alternative splicing of the ced-4 locus it is possible that splicing plays a key role in
regulating the decision of a cell to live or die.
This last point brings up the final major difference that is likely to exist between
cells that live and cells that die. Expression of all the components of the cell death
pathway involved in killing is a prerequisite for any cell to die. It is possible that
expression of key components such as ced-3 or ced-4S is restricted only to a certain set of
cells, and thus, cells not expressing these products will never die. This possibility,
although quite attractive, is made less plausible by two observations. First, experiments
in chapter 3 have demonstrated that it is likely that ced-3, ced-4S, and ced-9 are all
expressed in at least a number of cells that do not die, including all mec-7- and unc-30-
expressing cells. Second, experiments described in the appendix of this thesis suggest
that ced-4 and ced-3 are likely to be expressed in many cells, including cells that
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normally do not die. Thus, although it is certainly possible that some cells in C. elegans
survive because they do not express ced-3 or ced-4, it is unlikely that this is the main
mechanism for differentiating between cells that live and cells that die.
How is ced-3 regulated by ced-9 and ced-4?
The issues raised above beg the question of how ced-9 and ced-4 act to inhibit or
activate ced-3 respectively. Although no biochemical experiments have been performed
to address this question a number of hypothesis exist and can be tested biochemically.
The results of genetic analysis presented in chapter 3 suggest that ced-9 does not
act to directly inhibit the activity of ced-3. Rather, it seems likely that a major
component of negative regulation in the cell death pathway in C. elegans involves the
negative regulation of ced-4S by ced-9. It is, of course, possible that ced-9 does have some
direct regulatory role on ced-3 but this is likely to be minor. Thus, the original question
posed above can be split into at least four questions. How does ced-4S activate ced-3,
how does ced-9 inhibit ced-4S, how does ced-9 inhibit ced-4L, and how does ced-4L inhibit
cell death? To address these question biochemical interaction studies among the
various components of the cell death pathway must be performed. Currently the
answer to the last question posed above is more difficult to assess because it is not clear
if ced-4L prevents cell death by acting upstream, downstream or in parallel to ced-3.
The first question posed above might be answered by considering an interesting
observation. Within the genetic pathway presented in chapter 4 ced-9 can either inhibit
or cause cell death. Thus, ced-9 acts in a permissive way to decide if ced-3 gets activated
or not. One possible model for the regulation of ced-3 is thus that ced-9 is actually
irrelevant in some respect, and that there is a competition between ced-4L and ced-4S to
block or activate ced-3, respectively. This suggests that ced-4S might bind ced-3 and be
involved in regulating autocleavage of ced-3, and that ced-4L could bind ced-3 but not be
able to regulate autocleavage. Other models are also clearly possible.
The n1950 mutation of ced-9 is likely to be an interesting mutation to study in the
context of the second and third questions posed above concerning interactions between
ced-9 and ced-4L and ced-9 and ced-4S. Experiments in chapter 4 suggest that it is
possible that n1950 results in survival of cells that normally die by being unable to
negatively regulate ced-4L yet still capable of negatively regulating ced-4S. This
intriguing possibility suggests that perhaps ced-9 normally interacts with both ced-4L
and ced-4S and that in n1950 this interaction is selectively perturbed. This possibility is
readily amenable to biochemical analysis. Binding studies should reveal if this idea is
correct. Again, many other models are plausible and it is certainly possible that ced-9,
ced-3 and ced-4 do not interact at all.
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The role of CED-3/ICE-like proteases in mammalian programmed cell death
The results described in this thesis about the regulation of programmed cell
death suggest that perhaps a similar set of genes and interactions exist in mammalian
systems. Two issues are critical to address when making these comparisons. First, are
the molecular players similar between worms and man? Second, are interactions
among cell death genes in mammals similar to those observed in C. elegans?
It has become clear that mammals contain a number of proteins similar to both
CED-32-7 and CED-98- 10. In most cases all of these components have been shown to
exhibit some sort of death-related activity. However, only in three cases has this
assertion been rigorously tested by knockout mutations. Elimination of ICE in mice
does not seem to have a devastating effect on the animals, at least from a cell death
point of view. The only cell death defect detectable in these animals is a debatable
inability for some cells to undergo Fas-induced cell death1 1 . Thus, it is unlikely that ICE
on its own is the only cysteine protease required for cell death in mammals. Because a
large family of these proteases exists and because they have relatively different tissue
distributions one possibility is that within each mammalian cell there exist at least two
CED-3-like proteases that become induced during programmed cell death. Thus, one
model suggests that there is a redundancy in the cysteine-protease killing activity. This
model makes sense particularly in the immune system where it is often very important
to eliminate cells that are potentially harmful to the animal, and thus it is advantageous
to ensure that the death program is properly executed. However, this redundancy also
suggests that it would be more difficult to regulate the activity of two genes as opposed
to a single gene. Thus, diversity of negative regulators of cysteine-proteases involved in
cell death is important (see below). Of course, it is also possible that there is normally
only one protease involved in mammalian programmed cell death and that it is not ICE.
Elimination of the bcl-2 gene in mice results in generally few cell death defects,
although some defects are eventually observed in the immune system where massive
cell death can be demonstrated 1 2. Similar observations exist for mice deficient in the
bcl-x 8 gene although in this case the mice die embryonically from what seem to be cell
death related defects. Thus, both bcl-2 and bcl-x are likely to have genuine roles in the
negative regulation of cell death in mammals. Because the expression patterns of these
genes are different it is possible that they each act in a different set of tissues. However,
the redundancy model might also apply here. Thus, both bcl-2 and bcl-x might be
important in keeping a given cell alive, although either alone might not always be
sufficient.
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Thus, genetic evidence suggests that at least some of the molecular components
of cell death that have sequence similarity to the C. elegans genes have similar functions
as well. Yet, clearly the mammalian situation is more complex.
It seems that some of the ICE-like genes and some of the BCL2-like genes in
mammals interact in a way consistent with the way in which ced-9 negatively regulates
ced-3. Overexpression of bcl-2 will prevent death induced by overexpression of ICE2 or
ICH-13, suggesting that in mammals bcl-2 acts to negatively regulate the activity of
cysteine proteases.
An intriguing issue which is currently unresolved is whether a mammalian
equivalent of the ced-4 gene exists. Currently, all efforts to isolate ced-4-like genes in
mammals have failed, suggesting that if a ced-4-like gene exists it does not share more
than 30-40% identity (the limit of detection by hybridization) with the C. elegans gene. It
is, of course, possible that ced-4 does not exist in mammals, however, it seems likely that
proteins sharing a similar function to that of ced-4 in C. elegans must exist. If one
assumes the pathway in C. elegans to be applicable to mammals then since ced-9-like
proteins can negatively regulate ced-3-like proteins in mammals, ced-4-like function
must also exist. Thus, one possibility is that a functional homolog of ced-4 exists in
mammals which shares little if any sequence similarity to ced-4. In fact, it is possible
that two classes of proteins exist in mammals, those with functions similar to ced-4L,
and those with functions similar to ced-4S. These might not share any sequence
similarities to the C. elegans proteins. Further work on the mammalian cell death
systems will reveal how parallel these systems are to C. elegans.
Isolating more cell death genes in C. elegans
Finally, the work described in this thesis has suggested a number of genetic ways
to try and identify new components of the cell death pathway in C. elegans. Because
many screens have been performed looking for mutations resulting in the prevention of
normally occurring cell death it is likely that any remaining components fall into one of
two classes. Mutations in these killing components could result in lethality for some
reason. Or there might exist as sets of redundant genes ordered in redundant
pathways, each of which is sufficient to activate cell death. Screens for mutations in
genes involved in protection from cell death have not been extensively explored and
some possibilities are presented below.
Since overexpression of ced-3 or ced-4 can induce cell death in the appropriate
background then suppressors of these deaths can reveal new cell death components.
Weak mutations in genes that are essential might be revealed, as well as dominant
mutations in genes that prevent cell death.
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Enhancer screens to enhance the weak ced-3 alleles should be tried to obtain
mutations in genes that are involved in killing. This screen might isolate weak
mutations in essential genes or mutations in redundant pathways (assuming there isn't
complete redundancy).
Finally, looking for cell survival genes by screening for lethals balanced by a ced-
3 dominant negative extrachromosomal array should reveal additional ced-9-like genes.
I used this strategy to isolate the ced-9 allele n2812.
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